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Calcium homeostasis
The tight control of blood calcium (Ca2+) levels within a narrow range is essential to the 
performance of many vital physiological functions. Muscle contraction, blood clotting, 
intracellular signaling, neuronal excitation, and bone formation all acquisitively require 
Ca2+ (1, 2). Disturbances in the Ca2+ balance result in serious symptoms, which include 
seizures, rickets, and heart failure. It is the concerted action of intestine, bone, and kidney 
that controls the Ca2+ balance through the regulation of intestinal absorption, bone 
(de)mineralization and renal excretion of Ca2+, respectively (figure 1). The vast majority of 
whole body Ca2+ is stored in the skeleton. In blood 45% of Ca2+ is present as the free, 
ionized form, while 45% is bound to proteins. A small fraction, 10%, forms complexes with 
anions including citrate, sulphate, and phosphate. Intestinal Ca2+ absorption occurs largely 
in the duodenum, though also takes place along the other intestinal parts (3). Furthermore, 
fine-tuning of Ca2+ excretion from the body via the urine takes place in the kidney and 
preserves a constant Ca2+ concentration in the blood. The tight regulation of active Ca2+ 
(re)absorption in the intestine and kidney leads to whole body Ca2+ homeostasis.
Paracellular and transcellular Ca2+ transport
Ingested Ca2+ is absorbed in multiple segments of the small intestine and is functionally 
coupled to sodium (Na+) uptake. Active absorption of Na+, together with other solutes like 
chloride, sugars, and amino acids, drives net water absorption throughout the length of 
the intestine. This occurs mainly in the jejunum and ileum, where Ca2+ is concomitantly 
taken up with water in a passive, paracellular manner, down its concentration gradient. The 
duodenum actively absorbs Ca2+, occurring transcellular, in a hormonally regulated 
fashion. Transcellular intestinal Ca2+ absorption (figure 2) begins with luminal entry into 
the cell through the epithelial Ca2+ channel, transient receptor potential vanilloid member 
6 (TRPV6) (4). Ca2+ is subsequently bound by the Ca2+ binding protein calbindin-D9K and 
shuttled to the basolateral side of the cell. This process is completed by active Ca2+ 
extrusion to the interstitium via the plasma membrane Ca2+-ATPase (PMCA1b) (5). From the 
blood Ca2+ is filtered at the glomerulus in the kidney, thereby entering the lumen of the 
renal tubule. Along the course of the nephron first passive, paracellular Ca2+ reabsorption 
occurs in the proximal tubule (PT) and the thick ascending limb of Henle’s loop (TAL). 
Finally, a small (10-15%), highly regulated amount of Ca2+ is reabsorbed in the distal 
convoluted tubule (DCT) and the connecting tubule (CNT) by an active transcellular 
process from the urine into the blood (3, 6). A three-step process, similar to the duodenal 
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cytosol of the intestinal and renal epithelial cells by TRPV5 and TRPV6, is tightly regulated 
and represents the rate-limiting step in transcellular Ca2+ (re)absorption (3, 7, 8).
Regulation of the body Ca2+ balance
Ca2+ homeostasis is preserved by the classically recognized calciotropic hormones, including 
the active form of vitamin D (1,25(OH)2D3), parathyroid hormone (PTH) and calcitonin (figure 1). 
Central to this process is the Ca2+-sensing receptor (CaSR), which is expressed in the 
parathyroid glands where it senses blood Ca2+ levels (9, 10). In response to changes in the 
blood Ca2+ concentration, the CaSR regulates PTH-release into the circulation. Specifically, 
hypocalcemia inhibits the CaSR that in turn promotes the secretion of PTH. This hormone 
stimulates Ca2+ mobilization from bone and the conversion of inactive vitamin D to 
1,25(OH)2D3 by the renal cytochrome P450 enzyme 25-hydroxyvitamin D3-1α-hydroxylase 
(1α-OHase) in the PT (11). Increased 1,25(OH)2D3 levels activate vitamin D receptor 
route, mediates this active Ca2+ reabsorption in the DCT and CNT (figure 2), involving the 
epithelial Ca2+ channel TRPV5, transport through the cytosol via calbindin-D28K to the 
basolateral cell membrane, and extrusion into the peritubular capillaries by the Na+-Ca2+-
exchanger (NCX1) and PMCA1b (3). The active entry of Ca2+ ions from the lumen into the 
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Figure 1  Key players in Ca2+ homeostasis  
The concerted interplay of intestinal uptake, reabsorption in kidney, and bone  (de)minerali-
zation establishes the maintenance of a normal Ca2+ balance. The calcium-sensing receptor 
that is present in the thyroid gland, senses blood Ca2+ levels and triggers secretion of the 
calciotropic hormones; PTH and calcitonin. PTH-induced 1α-OHase production in the kidney 
stimulates 1,25(OH)2D3-mediated Ca2+ (re)absorption. Calcitonin inhibits Ca2+ resorption 
from bone. TK and the anti-aging hormone klotho, both produced in the kidney, stimulate 
TRPV5-mediated Ca2+ reabsorption. Ovarian-produced estrogen enhances renal Ca2+ reab-
sorption and stimulates bone mineralization. A negative feedback mechanism prevents the 
accumulation of klotho since 1α-OHase-mediated 1,25(OH)2D3 production is inhibited by 
klotho. PTH, parathyroid hormone; TK, tissue kallikrein; 1,25(OH)2D3, active metabolite of 
vitamin D; 1α-OHase, the renal cytochrome P450 enzyme 25-hydroxyvitamin D3-1α-
hydroxylase; +, stimulation; -, inhibition.
Figure 2  Transcellular Ca2+ transport across renal and intestinal epithelia  
Apical Ca2+ influx is mediated by TRPV6 in the duodenum and TRPV5 in the renal distal 
 convoluted and connecting tubules. Subsequently, Ca2+ diffuses to the basolateral 
 membrane by Ca2+-binding proteins calbindin-D9K (intestine) and calbindin-D28K (kidney). 
Extrusion to the interstitium takes place via the plasma membrane Ca2+-ATPase (PMCA1b) in 
the intestine and the Na+/Ca2+ exchanger (NCX1) and PMCA1b in the kidney.
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demonstrated a stimulatory effect of klotho on TRPV5-mediated active Ca2+ transport, in vitro 
(31). This regulatory function substantiates the important role of klotho in Ca2+ homeostasis, 
specifically by altering the Ca2+ permeability of the renal luminal membrane. Van Abel et al. 
revealed that estrogen exerts an effect on the renal Ca2+ handling via the increase of TRPV5 
expression at the transcriptional level (32). Administration of estrogen to ovariectomized rats 
was shown to alter TRPV5 expression, independently of 1,25(OH)2D3. In 2006, Gkika et al. 
described the molecular mechanism through which TK stimulates TRPV5-mediated active Ca2+ 
reabsorption. TK is a proteolytic enzyme that is secreted into the pro-urine by renal epithelial 
cells that activates the bradykinin receptor stimulating the phospholipase C / 1,2-diacylglycerol/
protein kinase C (PLC/DAG/PKC) pathway. This results in increased plasma membrane 
expression of TRPV5, possibly due to an inhibition of TRPV5 endocytosis (28). Previous studies 
demonstrated that high Ca2+ intake is an important regulator of the renal Ca2+ transport 
proteins in a 1,25(OH)2D3 deficient status and thereby contributes to the body Ca2+ homeostasis 
(14). Remarkably, large variations in Ca2+ intake produce only small alterations in blood Ca2+ 
levels due to the tight regulation of Ca2+ reabsorption by the combined action of the 
above-mentioned signaling molecules (2, 33, 34).
TRP channels
The molecular identification of the epithelial Ca2+ channels, TRPV5 from rabbit kidney and 
TRPV6 from rat duodenum (4, 35), has been an important milestone in our understanding of 
the molecular mechanism mediating transcellular Ca2+ transport. Moreover, further insight into 
the regulation of the Ca2+ balance is gained through the detailed characterization of TRPV5 
and TRPV6. Since their discovery, both channels have been identified in many other species (36, 
37). Two distinct genes, juxtaposed on human chromosome 7q35, encode these channels. 
Each consists of 15 exons, encoding proteins of approximately 730 amino acids that share 75% 
homology (12, 13, 38-40). Furthermore, both channels display high sequence homology with 
other members of the transient receptor potential (TRP) superfamily, which comprises a 
diversity of non-voltage operated cation channels (41-43). The structural topologies of TRPV5 
and TRPV6 display the typical features shared by all members of the TRP channel superfamily 
(figure 3). Six transmembrane domains, a short hydrophobic stretch between transmembrane 
segment 5 and 6, which is predicted to form the Ca2+ pore, and large intracellular N- and 
C-terminal domains can be distinguished (3). These latter terminal domains contain important 
regions for interaction with intracellular signaling molecules, hormones and therapeutic 
compounds thereby altering TRPV5 and TRPV6 expression, cellular localization, and channel 
activity (44). The functional form of TRPV5 and TRPV6 is a homo- or heterotetrameric complex 
(VDR)-mediated gene transcription, resulting in an increased expression of Ca2+ transporters 
in the above-mentioned Ca2+-transporting organs. Ultimately, this results in the stimulation 
of Ca2+ (re)absorption, enabling the retention of Ca2+ by the body (12-16). Inactivating 
mutations of the gene encoding the CaSR result in elevated blood PTH and Ca2+ levels, 
parathyroid hyperplasia, bone abnormalities, and retarded growth in humans, whereas the 
CaSR knockout mouse demonstrates similar symptoms (17, 18). Hypercalcemia has the 
opposite effect involving activation of the CaSR, thereby inhibiting PTH release and 
stimulating the secretion of calcitonin from the parafollicular cells of the thyroid gland. 
Calcitonin decreases osteoclast-mediated bone resorption and thus promotes a decrease in 
blood Ca2+ levels (19). In humans, gain-of-function mutations of the CaSR reduce blood PTH 
levels and thereby Ca2+ reabsorption (20, 21) that eventually leads to hypocalcemia (22-24). 
Newly described hormones involved in Ca2+ homeostasis include estrogen, which promotes 
bone mineralization and Ca2+ (re)absorption (25-27), tissue kallikrein (TK), which is excreted into 
the urine by renal tubular epithelial cells leading to an increase in Ca2+ reabsorption (28), and 
the anti-aging hormone klotho. Klotho is a transmembrane protein with an extracellular 
domain that is secreted into blood, urine, and cerebrospinal fluid (29, 30). Chang et al. 
Chapter 1 General Introduction
Figure 3  Structural topology of the epithelial Ca2+ channels TRPV5 and TRPV6  
TRPV5 and TRPV6 both contain a core domain that consists of six transmembrane segments. 
This domain is flanked by intracellular amino (NH2) and carboxyl (COOH) termini. Between 
transmembrane segment 5 and 6 a hydrophobic stretch is present, which forms the 
 functional pore forming region of the Ca2+ channels.
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Ca2+-selective channels. A single aspartate residue (TRPV5-D542 and TRPV6-D541), present in 
the putative pore-region of these channels, is responsible for their selectivity. These 
characteristics of TRPV5 and TRPV6 are consistent with a central role for both channels in the 
epithelial entry step of transepithelial Ca2+ (re)absorption (3, 8, 46).
Knockout mouse models
In vivo studies of specific knockout mouse models have significantly contributed to our 
knowledge of renal and intestinal Ca2+ handling. Here, the phenotypes of TRPV5, TRPV6, 
1α-OHase, and CaSR knockout mice are outlined, providing the reader background to 
understand the rational for the work detailed herein. Genetic ablation of TRPV5 in mice 
allowed us to investigate the requirement of TRPV5 functioning in maintaining the Ca2+ 
balance. TRPV5 knockout mice were generated by deletion of exon 13, the exon that 
encodes the functional pore region (1). Mice lacking TRPV5 in the DCT/CNT segment of the 
nephron displayed a significant hypercalciuria, excreting 6-10 times more Ca2+ compared 
with control littermate mice (figure 4D). Blood 1,25(OH)2D3 levels were elevated, PTH 
concentration was normal, whereas normocalcemia was maintained in TRPV5 ablated mice 
(figure 4B). Bone mineral density was decreased and bone thickness was diminished 
compared with controls (figure 4C). Polyuria and a decrease in urinary pH were consistently 
present in TRPV5 knockout mice (figure 4E and F). Furthermore, hyperphosphaturia was 
present in these mice, predisposing them to an increased risk of Ca2+-phosphate 
precipitation. Both polyuria and increased urinary acidification might promote the 
excretion of large amounts of Ca2+ without it being precipitated in the renal collecting 
duct system (CD). Quantification of the renal Ca2+ transporters revealed a greatly 
diminished expression of calbindin-D28K and NCX1 in TRPV5 knockout mice (1).
To assess whether the absence of TRPV5 or the downregulation of calbindin-D28K was 
responsible for the phenotype observed in the TRPV5 knockout animals, double knockout 
mice, genetically ablated for both TRPV5 and calbindin-D28K, were generated. These mice 
did not have a further increase in Ca2+ loss relative to TRPV5 knockout mice, confirming 
that TRPV5 and not calbindin-D28K is the rate-limiting transporter in active Ca2+ reabsorption 
(47). The downregulation of calbindin-D28K and NCX1 in TRPV5 knockout mice indicated 
that proteins downstream of TRPV5 are regulated in a TRPV5-dependent manner. 
Bianco et al. generated a TRPV6 knockout mouse to investigate the role of this epithelial 
Ca2+ channel in intestinal Ca2+ absorption in vivo and its function in other organ systems 
of the individual six transmembrane domains surrounding a central pore, through which Ca2+ 
flows (45). Electrophysiological analyses have shown that TRPV5 and TRPV6 are highly 
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Figure 4  TRPV5 knockout mice phenotype, compared with controls and  
heterozygoth mice  
(A) Ca2+ reabsorption takes place along the different nephron segments in a passive manner 
(65%) in the proximal tubule (PT) and the thick ascending limb of Henle’s loop (TAL; 20%). 
Active Ca2+ reabsorption (10-15%) in the distal convoluted tubule (DCT) and connecting 
tubule (CNT) determines the final amount of Ca2+ reabsorbed from the pro-urine. Ca2+ entry 
from the urine into the DCT/CNT cells is mediated by the epithelial Ca2+ channel TRPV5.  
(B) Blood 1,25(OH)2D3, PTH, and Ca2+ levels in control, TRPV5 heterozygoth, and TRPV5 
 knockout mice. (C) Bone phenotype of TRPV5 knockout mice. Representative X-ray images 
of the femoral head, the lesser trochanter, and the diaphysis in control and TRPV5 knockout 
mice. (D,E, and F) Total Ca2+ excretion levels, diuresis, and urinary pH levels,  respectively. 
Data are averaged values ± SEM from mice at an age of 8 weeks. * P < 0.05, significant 
 difference from control mice. Control, wild-type littermate mice; +/-, TRPV5  heterozygoth 
littermate mice; -/-, TRPV5 knockout littermate mice; PTH, parathyroid  hormone; PT, proximal 
tubule; DCT/CNT, distal convoluted and connecting tubule; dotted line indicates the 
nephron segment in which TRPV5 is expressed.
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calcimimetic compounds that activate the CaSR in the parathyroid glands, reducing blood 
PTH levels (56). Hypocalcemia can result in muscle cramping, depression, psychosis, and 
seizures. Causes include diminished Ca2+ absorption, 1,25(OH)2D3 deficiency or resistance 
(57), lack of sunlight (58), decreased bone resorption, a complication of thyroid surgery (i.e. 
parathyroidectomy) (59), or renal Ca2+ wasting. Oral Ca2+ and 1,25(OH)2D3 supplementation, 
and ultraviolet light exposure evoking the production of 1,25(OH)2D3 in the skin (60) are 
current treatment strategies implemented for hypocalcemia.
Hypercalciuria and kidney stones
Hypercalciuria is a risk factor for renal stone formation and therefore significantly contributes 
to this health and socio-economic problem (61-63). Urolithiasis forms a worldwide problem, 
occurring in every geographical, cultural, or racial group. In the United States (US) more 
than 5% of the population develops a clinically significant episode of kidney stone disease 
during life of which the economic impact is approximately $2 billion annually (64, 65). 
Hypercalciuria has been classified into at least three different forms. Absorptive hypercalciuria 
is caused by Ca2+ hyperabsorption from the GI tract, renal hypercalciuria is the result of a 
defect in Ca2+ reabsorption, whereas resorptive hypercalciuria manifests urinary Ca2+ 
wasting secondary to increased bone resorption. Other than these three types of 
hypercalciuria comprise the largest group of patients that lack an explanation for their 
hypercalciuria. This group has been classified as idiopathic hypercalciuria. Urinary crystal 
and stones may consist of different solutes that are present in the urine. Depending on the 
urinary composition, saturation values are reached after which precipitation can occur. 
Furthermore, an important determinant in crystal formation is urinary pH, decisive in the 
configuration of the solutes, present in the urine. Ca2+-containing stones are by far the most 
common, accounting for more than 80% of stones (66-68). Other forms are uric acid, 
cystine, and struvite ((NH4)MgPO4·6(H2O)) stones. Urolithiasis can be caused by dietary 
habits, genetic predisposition, urinary tract infection, and other disorders generally 
characterized by a disturbance in body ion handling (69). Clinical manifestations are renal 
colic (severe pain), dysuria, hematuria, and ultimately renal failure. New advances in 
treatment technologies are under current investigation (70), though shock-wave lithotripsy 
or surgery are the common therapies for urolithiasis, depending on the size of the stone. 
Pharmacological treatment, lifestyle, and dietary modifications are implemented in people 
at risk for kidney stones, as the chance for recurrence is 60-75% (71, 72). Further investigations 
are necessary to elucidate the exact causes of hypercalciuria-related kidneys stones and will 
permit the fine-tuning of therapeutic strategies that are currently employed.
(48). Consistent with known TRPV6 localization the knockout animals exhibited a 60% 
reduction in intestinal Ca2+ absorption as well as hypercalciuria and decreased bone 
mineralization compared with control mice (48). Further, TRPV6 knockout mice had 
secondary hyperparathyroidism, hypervitaminosis D, and were normocalcemic. This 
signified that TRPV6 is central to 1,25(OH)2D3-regulated Ca2+ absorption and overall Ca2+ 
homeostasis. Additionally, TRPV6 knockout mice displayed skin abnormalities due to a 
decreased Ca2+ content in their epidermis and showed impaired fertility. These abnormalities 
present in multiple organs in TRPV6 knockout mice underlined the importance of this 
channel in other body tissues. While TRPV5 clearly functions as a gatekeeper of active Ca2+ 
reabsorption from the lumen of DCT and CNT, these recent findings suggest that TRPV6 is 
a key player in active Ca2+ transport during embryonic and placental development (48).
Two research groups independently generated 1α-OHase knockout mice in the past. 
The phenotype of these mice was characterized by a severely disturbed Ca2+ balance, 
including hypocalcemia, hyperparathyroidism, rickets, and growth retardation (49, 50). 
Interestingly, a downregulation of the renal Ca2+ transporters TRPV5, calbindin-D28K, NCX1, 
PMCA1b, and intestinal TRPV6, calbindin-D9K, and PMCA1b was present in the 1α-OHase 
knockout mice. 1,25(OH)2D3 supplementation rescued the phenotype of 1α-OHase 
knockout mice. This regime caused an upregulation of TRPV5, TRPV6, calbindins, NCX1, and 
PMCA1b expression, which resulted in the normalization of blood Ca2+ levels. Dietary Ca2+ 
supplementation in 1α-OHase knockout mice produced a similar rescue and suggested 
that dietary Ca2+ can regulate Ca2+ transporters expression independent of 1,25(OH)2D3 (14).
Hypercalcemia and hypocalcemia
Disturbances in both blood and whole body Ca2+ levels can cause severe pathological 
conditions, the etiology of which is both complex and variable. Hypercalcemia can result 
from Ca2+ hyperabsorption in the gastrointestinal (GI) tract, decreased urinary Ca2+ excretion, 
or increased bone resorption. Elevated blood PTH levels secondary to hyperparathyroidism 
or a hypophosphatemic state cause increased Ca2+ absorption from the GI tract (51, 52). 
Increased Ca2+ loss from bone can be due to elevated PTH (53, 54) and/or 1,25(OH)2D3 levels, 
or skeletal metastasis (55), while severe dehydration increases circulatory Ca2+ levels without 
altering the total Ca2+ amount in blood. Symptoms of hypercalcemia include fatigue, 
electrocardiogram-abnormalities, nausea, vomiting, constipation, anorexia, abdominal pain, 
hypercalciuria, and kidney stone formation. Treatment of hypercalcemia depends on the 
severity of the abnormality and ranges from dietary adaptations to the administration of 
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are candidate genes possibly involved in the genetic causes for hypercalciuria (1, 48). To date, 
mutation analysis of the TRPV5-encoding gene has not revealed a primary role for this 
channel in idiopathic hypercalciuria (76). However, the involvement of TRPV5 or TRPV6 in 
hypercalciuria has not been definitively excluded. Specific single nucleotide polymorphisms 
(SNPs) or haplotypes of the TRPV5 and TRPV6 encoding genes may modulate channel activity 
and might therefore be responsible for altered renal Ca2+ excretion (77). Further investigation 
is necessary to identify mutations in TRPV5 and TRPV6 associated with disease.
Genetic susceptibility to renal stone formation
Individuals with a positive family history are themselves prone to develop kidney stones (69, 
73, 74). This strongly suggests that genetic factors are involved in the pathogenesis of 
hypercalciuria (75). As there is a myriad of potential disturbances in the Ca2+ balance that can 
cause hypercalciuria, while many genes encode proteins involved in Ca2+ homeostasis, 
hypercalciuria may be monogenic, polygenic, or multifactorial in its etiology. TRPV5 and 
TRPV6 gene ablation in mice leads to hypercalciuria. Therefore, these epithelial Ca2+ channels 
A
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Figure 5  Schematic overview of renal bicarbonate reabsorption and proton 
excretion  
(A) In the proximal tubule, protons (H+) are secreted via apical Na+/H+ exchangers (NHE) and 
vacuolar H+-ATPases. The secreted H+ combines with filtered bicarbonate (HCO3-) under the 
influence of a membrane-bound carbonic anhydrase (CA IV) to form water (H2O) and carbon 
dioxide (CO2). After diffusion into the cell, CO2 is rehydrated by cytosolic carbonic anhydrase II 
(CA II), H+ is secreted again, and HCO3- is released into the interstitium via basolateral Na+/HCO3- 
co-transporters (NBC1). (B) Type A intercalated cells are characterized by the  expression of the 
basolateral Cl-/HCO3- exchanger (AE1) and the presence of an apical  vacuolar H+-ATPase. H+ and 
HCO3- are formed by a cytosolic CA II and secreted into the lumen and the interstitium, respec-
tively. Type A intercalated cells express H+-K+-ATPases at the apical side. (C) Type B intercalated 
cells are characterized by the absence of the  basolateral AE1 and the presence of the vacuolar 
H+-ATPase on both sides of the cells. In addition, type B  intercalated cells express an apical  
Cl-/HCO3- exchanger (pendrin).
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inability to acidify the urine (84). Mice genetically ablated for AE1 demonstrate distal renal 
tubular acidosis (dRTA) and renal Ca2+ precipitations (85). In humans, mutations in the AE1 
and H+-ATPase genes cause dRTA as well (86-93). The inability to acidify the urine during 
dRTA leads to a metabolic acidosis, hypercalciuria, alkalination of the urine, and often 
causes renal stone formation. Many factors like hormones, dietary habits, drugs, physical 
activity, and body electrolyte status regulate renal acid/base transport. Endothelin and 
aldosteron were implicated in the stimulation of NHE3 and H+-ATPase activity (94-98). 
The identification of several proton-sensing G protein-coupled receptors suggested the 
existence of pH-sensing proteins that regulate acid/base transporter activity throughout 
the body (99-101). Specifically, the expression of ovarian cancer G protein-coupled receptor 
1 (OGR1) and G protein-coupled receptor 4 (GPR4) in the kidney indicated important roles 
for these pH sensors in renal acid/base homeostasis. Furthermore, the existence of HCO3- 
and CO2 sensing receptors was investigated (102). This route of acid/base regulation via 
kidney specific pH sensors is still under investigation.
Outline of this thesis
The Ca2+ balance is maintained by the concerted action of intestine, kidney, and bone, in 
which renal Ca2+ handling determines the final amount of Ca2+ retained in the body and 
excreted via the urine. Insight into the function and regulation of Ca2+ transport proteins 
assists the understanding of the machinery underlying the (patho)physiological 
mechanisms taking place during body Ca2+ management. The epithelial Ca2+ channel 
TRPV5 is the gatekeeper of renal transcellular Ca2+ reabsorption that determines the 
rate-limiting step of active Ca2+ entry into cells. Genetic ablation of TRPV5 leads to severe 
hypercalciuria in mice. The exact physiological mechanism compensating for this renal 
Ca2+ loss is not known. Moreover, TRPV5 gene mutations have not been identified in 
humans so far. The aim of this thesis was to provide insight in the physiological role of 
TRPV5 in Ca2+ metabolism. The characterization of TRPV5 knockout mice was implicated to 
identify new mechanisms contributing to the maintenance of the Ca2+ balance, whereas 
human TRPV5 gene alterations were investigated in hypercalciuria patients. Chapter 2 
describes the crucial function of hypervitaminosis D in the maintenance of the Ca2+ 
balance in TRPV5 knockout mice. TRPV5/1α-OHase double knockout mice were generated, 
decreasing blood 1,25(OH)2D3 concentrations to undetectable levels in TRPV5 knockout 
mice. Intestinal and renal Ca2+ transporter expression was investigated, whereas X-ray and 
Renal acid/base handling
Acid/base homeostasis is important for the maintenance of the blood pH within in a 
narrow physiological range (pH 7.35 - 7.45). The acid/base status of our body is the 
consequence of interactions between metabolic processes, the exhalation of CO2 by the 
lungs, and the renal reabsorption of acid and base. Disturbances in the acid/base balance 
are known to alter body Ca2+ handling (78). Metabolic acidosis refers to a state of increased 
blood acidity that can be due to enhanced acid production, a defect in renal acid excretion, 
or decreased proximal tubular bicarbonate (HCO3-) reabsorption. An increase in blood pH 
is called metabolic alkalosis and is caused by a loss of H+ ions via the urine or by vomiting, 
increased HCO3- reabsorption, or alkalotic medication. Metabolic acidosis causes increased 
Ca2+ mobilization from bone and concomitant hypercalciuria (79, 80), whereas metabolic 
alkalosis decreases urinary Ca2+ excretion (3). The exact mechanisms responsible for the 
urinary Ca2+ wasting and sparing effects in metabolic acidosis and alkalosis respectively 
need further investigation. 
Interestingly, many transporters are involved in renal acid/base handling (figure 5), 
comprising three major processes: HCO3- reabsorption in the proximal tubule and TAL, H+ 
excretion in the CD, and the excretion of titratable acids that bind and facilitate the 
excretion of H+ (81). In the PT, and to a lesser extent the TAL, HCO3- is reabsorbed, requiring 
the luminal carbonic anhydrase (CA) type IV that forms CO2 and H2O from HCO3- and H+ 
(figure 5A). Subsequently, CO2 diffuses into the cell, where it is converted to HCO3- and 
H+ by the cytosolic type II CA. HCO3- is extruded into the blood via basolateral electrogenic 
Na+/HCO3- cotransporters NBC, whereas protons are secreted into the urine via the apical 
Na+/H+ exchangers (NHE) and H+-ATPase (82). In the CD, primary cells involved in water and 
Na+ reabsorption can be distinguished from intercalated cells (ICs), responsible for the 
fine-tuning of urinary acid/base excretion (83). The type A ICs establish the final urinary 
acidification (figure 5B). In these cells the vacuolar H+-ATPase at the apical membrane 
transports protons from the cells into the urine that together with HCO3- are the result of 
cytosolic CA type II action. The basolateral anion exchanger AE1 transports the HCO3- to 
the blood. In contrast, type B ICs excrete HCO3- into the urine via the apical Cl-/HCO3- 
exchanger pendrin, whereas protons are extruded into the blood via a basolateral 
H+-ATPase (figure 5C) (82).
Mice, genetically ablated for the B1 subunit of H+-ATPase (Atp6v1b1 knockout mice) display 
an increase of the urinary pH compared with littermate control mice, confirming their 
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micro computed tomography analyses determined bone phenotypes of TRPV5, 1α-OHase 
knockout, and TRPV5/1α-OHase double knockout mice compared with wild-type 
littermates. In chapter 3 the molecular mechanism evoking the increased urinary 
acidification and polyuria in TRPV5 knockout mice, preventing renal stone formation, was 
elucidated. Quantification of the renal water channel AQP2, activity measurements of the 
proton pump H+-ATPase in isolated outer medullary collecting ducts, and the generation 
of TRPV5/Atp6v1b1 double knockout mice that formes renal Ca2+-phosphate stones led to 
the understanding of these adaptations. The effect of chronic metabolic acidosis and 
alkalosis on renal active Ca2+ and Mg2+ reabsorption was addressed in chapter 4. Here, we 
extensively evaluated the contribution of Ca2+ and Mg2+ transporters in the altered renal 
Ca2+ and Mg2+ handling during metabolic acidosis and alkalosis in mice. The ongoing 
search for hypercalciuria patients that demonstrate alterations in the TRPV5 gene and 
display symptoms similar to the TRPV5 knockout mice was described in chapter 5. 
The TRPV5 coding region was sequenced and analyzed in renal hypercalciuria patients. 
TRPV5 gene polymorphisms were functionally characterized by electrophysiological 
channel measurements. The final conclusions are discussed in chapter 6, whereas chapter 
7 summarizes all the outcomes of this thesis.
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Abstract
Vitamin D plays an important role in Ca2+ homeostasis by controlling Ca2+ (re)absorption 
in intestine, kidney, and bone. The epithelial Ca2+ channel TRPV5 mediates the Ca2+ entry 
step in active Ca2+ reabsorption. TRPV5 knockout (TRPV5-/-) mice show impaired Ca2+ 
reabsorption, hypercalciuria, hypervitaminosis D, and intestinal hyperabsorption of Ca2+. 
Moreover, these mice demonstrate upregulation of intestinal TRPV6 and calbindin-D9K 
expression compared with wild-type mice. For addressing the role of the observed 
hypervitaminosis D in the maintenance of Ca2+ homeostasis and the regulation of 
expression levels of the Ca2+ transport proteins in kidney and intestine, TRPV5/25-
hydroxyvitamin-D3-1α-hydroxylase double knockout (TRPV5-/-/1α-OHase-/-) mice, which 
show undetectable serum 1,25(OH)2D3 levels, were generated. TRPV5-/-/1α-OHase-/- mice 
displayed a significant hypocalcemia compared with wild-type mice (1.10 ± 0.02 and 2.54 
± 0.01 mM, respectively; P < 0.05). mRNA levels of renal calbindin-D28K (7 ± 2%), 
calbindin-D9K (32 ± 4%), Na+/Ca2+ exchanger (12 ± 2%), and intestinal TRPV6 (40 ± 8%) and 
calbindin-D9K (26 ± 4%) expression levels were decreased compared with wild-type mice. 
Hyperparathyroidism and rickets were present in TRPV5-/-/1α-OHase-/- mice, more 
pronounced than observed in single TRPV5 or 1α-OHase knockout mice. It is interesting 
that a renal Ca2+ leak, as demonstrated in TRPV5-/- mice, persisted in TRPV5-/-/1α-OHase-/- 
mice, but a compensatory upregulation of intestinal Ca2+ transporters was abolished. 
In conclusion, the elevation of serum 1,25(OH)2D3 levels in TRPV5-/- mice is responsible for 
the upregulation of intestinal Ca2+ transporters and Ca2+ hyperabsorption. Hypervitaminosis 
D, therefore, is of crucial importance to maintain normocalcemia in impaired Ca2+ 
reabsorption in TRPV5-/- mice.
Introduction
Ca2+ is one of the most important cations in the human body as it is essential for many 
physiological functions including neuronal excitation, cardiac muscle contraction, blood 
clotting and bone mineralization. Therefore, Ca2+ balance is tightly controlled by the 
concerted action of intestinal Ca2+ absorption, exchange of Ca2+ from bone and Ca2+ 
reabsorption in the kidney (1). The active form of vitamin D, 1α,25-dihydroxyvitamin D3 
(1,25(OH)2D3), along with parathyroid hormone (PTH) and calcitonin, are the calciotropic 
hormones known to be involved in the maintenance of plasma Ca2+ concentration (2, 3). 
Ca2+ absorption from the intestinal lumen and Ca2+ reabsorption in the renal tubules is 
promoted by 1,25(OH)2D3 (4-6). Synthesis of 1,25(OH)2D3 requires the renal cytochrome 
P450 enzyme 25-hydroxyvitamin D3-1α-hydroxylase (1α-OHase) (7). In addition, PTH 
stimulates 1,25(OH)2D3 production by 1α-OHase activation, and the release of Ca2+ from 
bone to maintain plasma Ca2+ levels, whereas calcitonin lowers the plasma Ca2+ 
concentration by inhibition of bone resorption (2).
1,25(OH)2D3-stimulated transepithelial Ca2+ transport in kidney and intestine involves Ca2+ 
entry across the apical membrane via the epithelial Ca2+ channels TRPV5 and TRPV6, 
respectively. TRPV5 is localized at the luminal membrane of the late distal convoluted 
tubule (DCT) and connecting tubule (CNT) in kidney (8, 9). TRPV6 is the homologues Ca2+ 
channel localized in the brush-border membrane of duodenum (1, 10-13). Following entry 
of Ca2+ through TRPV5 and TRPV6, Ca2+ bound to Ca2+-binding proteins (calbindins) 
diffuses to the basolateral membrane of the cell. Ca2+ is finally extruded to the extracellular 
compartment by the Na+/Ca2+ exchanger (NCX1) in the kidney and the plasma membrane 
Ca2+-ATPase (PMCA1b) in intestine and kidney (9).
Recently, several animal models were designed to investigate Ca2+ absorption mechanisms 
and maintenance of Ca2+ balance. TRPV5 knockout (TRPV5-/-) mice were generated by 
targeted ablation of the TRPV5 gene. These mice displayed robust renal Ca2+ wasting due 
to impaired Ca2+ reabsorption in DCT and CNT (14). Furthermore, elevated 1,25(OH)2D3 
serum levels, intestinal Ca2+ hyperabsorption and reduced bone thickness and 
mineralization were demonstrated. In addition, Dardenne et al. created an animal model 
for vitamin D deficiency rickets type 1 by genetic ablation of the 1α-OHase gene (15). These 
1α-OHase knockout mice (1α-OHase-/-) mice showed a phenotype characterized by 
undetectable serum levels of 1,25(OH)2D3, severe hypocalcemia, hyperparathyroidism, 
Chapter 2 Hypervitaminosis D and Ca2+ hyperabsorption in TRPV5 knockout mice
34 35
Urine and serum analyses
Urine and serum Ca2+ concentrations were analyzed using a colorimetric assay kit (Roche, 
Mannheim, Germany). An electronic ion analyzer was used to determine urinary pH. Serum 
vitamin D levels were determined with a [125I]1,25(OH)2D3 RIA assay (IDS Inc., Fountain Hills, 
AZ). Mouse serum PTH was measured using an immunoradiometric assay (Immutopics Inc., 
San Clemente, CA).
Real-time quantitative PCR analysis
To investigate mRNA expression levels of renal and duodenal Ca2+ transport proteins, total 
RNA from kidney and duodenum was isolated using TriZol Reagent (Life Technologies BRL, 
Life Technologies, Breda, the Netherlands) according to the manufacturer’s protocol. RNA 
was treated with DNase (Promega, Madison, WI) to prevent contamination with genomic 
DNA. Total RNA was subjected to reverse transcription using Moloney-Murine leukemia 
virus-reverse transcriptase (Life Technologies BRL, Life Technologies, Breda, the Netherlands) 
(11). Renal mRNA expression levels of calbindin-D28K, calbindin-D9K, NCX1, and duodenal 
TRPV6, calbindin-D9K, and PMCA1b mRNA levels were quantified by real-time quantitative 
PCR as described previously (19, 20), using the ABI Prism 7700 Sequence Detection System 
(PE Biosystems, Rotkreuz, Switzerland). The expression level of the housekeeping gene 
hypoxanthine-guanine phosphoribosyl transferase (HPRT) was used as an endogenous 
control.
Immunoblotting
Total kidney lysates of TRPV5-/- and TRPV5-/-/1α-OHase-/- mice were prepared as described 
previously (21). The protein concentration of the homogenates was determined with the 
Bio-Rad protein assay (Bio-Rad München, Germany). Samples were submitted to 16.5% 
(wt/v) sodium dodecyl sulfate-polyacrylamide gel electrophoresis and blotted to 
polyvinyldifluoride-nitrocellulose membranes (Immobilon-P, Millipore Corporation, 
Bedford, MA). Blots were incubated with a rabbit anti-calbindin-D28K polyclonal antibody 
(1:10,000) (22) or a rabbit anti-calbindin-D9K polyclonal antibody (1:5,000) (Swant, Bellinzona, 
Switzerland) at 4°C for 16 hours. Subsequently, blots were incubated with a goat anti-rabbit 
peroxidase labeled secondary antibody (1:10,000; Sigma, St Louis, MO). Immunoreactive 
protein was detected by the chemiluminescence method (Pierce, Rockford, IL). 
Immunopositive bands were scanned using an imaging densitometer (Bio-Rad Gs-690) to 
determine pixel density (Molecular Analyst Software; BioRad Laboratories, Hercules, CA).
bone abnormalities and retarded growth (15-17). Until now, data on detailed urine analysis 
of the 1α-OHase-/- mice was not available. Previous studies demonstrated that 1,25(OH)2D3 
supplementation rescues the severe phenotype of 1α-OHase-/- mice, which is accompanied 
by an up-regulation of TRPV5, TRPV6, calbindins, NCX1, and PMCA1b expression, resulting 
in the normalization of serum Ca2+ levels. It is interesting that dietary Ca2+ supplementation 
in 1α-OHase-/- mice resulted in a similar rescue in the absence of 1,25(OH)2D3. Taken 
together, these studies suggest a pivotal role of the Ca2+ transport proteins in maintaining 
Ca2+ balance, partly independent of 1,25(OH)2D3 (18).
To investigate the contribution of elevated 1,25(OH)2D3 levels to the phenotype of TRPV5-/- 
mice and to elucidate the involvement of 1,25(OH)2D3 in the compensatory Ca2+ 
hyperabsorption, we generated a mouse model in which both TRPV5 and 1α-OHase were 
inactivated. In this study, we describe the phenotype of TRPV5/1α-OHase double knockout 
(TRPV5-/-/1α-OHase-/-) mice, including bone analysis and semiquantification of mRNA and 
protein expression levels of Ca2+ transport proteins and provide an extensive comparison 
with TRPV5 and 1α-OHase single knockout mice.
Methods
Animal experiments
TRPV5-/- mice were generated as described previously (14). 1α-OHase-/- mice were provided 
by René St-Arnaud (Shriners Hospital for Children Montreal, QU, Canada) (15). Cross-
breeding of 1α-OHase-/- and TRPV5-/- mice resulted in offspring that were heterozygous for 
both TRPV5 and 1α-OHase (TRPV5+/-/1α-OHase+/-). This offspring was subsequently 
intercrossed to obtain TRPV5-/-/1α-OHase-/- mice. Genotypes were determined by PCR 
analysis, using specific primers as described previously (14, 15). To obtain 24 h urine 
samples from all mouse genotypes, 8-wks old mice were kept in a light- and temperature-
controlled room, in metabolic cages that enabled 24 h urine analyses. Standard pelleted 
chow (in % [wt/wt]: 1.0 Ca; 0.2 Mg; 0.2 Na; 0.7 P; 0.9 K) and drinking water were available ad 
libitum. After the experiment, blood was collected and mice were killed. Kidney, 
duodenum, tibia and fibula were sampled. The animal ethics board of the Radboud 
University Nijmegen, the Netherlands, approved all animal experimental procedures.
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of TRPV5 and 1α-OHase single or combined gene ablation on mRNA and protein expression 
levels were determined by real-time PCR analysis and semi-quantitative immunoblotting. 
Calbindin-D28K, calbindin-D9K and NCX1 mRNA expression levels were decreased in 
kidneys of TRPV5-/- and 1α-OHase-/- mice compared to wild-type mice (figure 2). 
Interestingly, a further significant decrease in the expression of these Ca2+ transporters was 
detected in TRPV5-/-/1α-OHase-/- mice. On the protein level, calbindin-D28K and calbindin-
D9K protein abundance was significantly decreased in TRPV5-/-/1α-OHase-/- mice compared 
to TRPV5-/- mice (figure 3).
Duodenal mRNA expression of Ca2+ transport proteins
To evaluate the contribution of 1,25(OH)2D3 to expression of the duodenal Ca2+ transporters, 
mRNA levels of TRPV6, calbindin-D9K and PMCA1b were determined. TRPV5-/- mice showed 
a significant increase in duodenal TRPV6 and calbindin-D9K mRNA levels compared to 
wild-type mice (figure 4). Additional 1α-OHase-ablation resulted in a significant decrease 
in TRPV6 and calbindin-D9K expression in duodenum. Furthermore, 1α-OHase-/- mice 
demonstrated a down-regulation of TRPV6 and calbindin-D9K mRNA expression. PMCA1b 
expression levels did not differ significantly between the studied mouse genotypes.
Bone analyses
To evaluate the effects of TRPV5 and 1α-OHase-ablation on bone homeostasis, bone 
thickness, mineralization and epiphyseal growth plate development were determined in 
tibiae from wild-type, TRPV5-/-, 1α-OHase-/- and TRPV5-/-/1α-OHase-/- mice using 
microcomputed tomography (Skyscan 1072, SkyScan, Antwerp, Belgium). Tibiae and 
fibulae were fixed in 4% (v/v) PBS-buffered formaldehyde and routinely processed for 
plastic embedding (23). The bones were scanned using the SkyScan 1072 microtomograph 
(SkyScan, Antwerp, Belgium) and digital cross-sections were made at the site of the 
diaphysis and epiphysis. X-ray imaging of tibiae and fibulae was performed to compare 
bone lengths and mineralization in all mouse genotypes.
Statistical analyses
Values are expressed as means ± SEM. Statistical significance (P < 0.05) was determined by 
one-way ANOVA. All analyses were performed using the Statview Statistical Package (Power 
PC version 4.51, Abacus Concepts Inc.) on an iMac computer (Apple computer Inc.).
Results
Animal experiments
TRPV5-/- mice showed hypercalciuria along with normal serum Ca2+ levels, a significant 
increase of serum 1,25(OH)2D3 levels and normal serum PTH levels. Moreover, TRPV5-/- mice 
displayed an increased diuresis and a decrease of urinary pH (figure 1 and table 1). 
1α-OHase-/- mice displayed hypocalciuria, hypocalcemia, undetectable serum 1,25(OH)2D3 
levels and a significant hyperparathyroidism. In comparison to wild-type mice, diuresis and 
urinary pH were normal in 1α-OHase-/- mice. TRPV5-/-/1α-OHase-/- mice demonstrated a net 
urinary Ca2+ excretion that did not differ from wild-type mice, but was inappropriately high 
given the significant hypocalcemia, and undetectable serum 1,25(OH)2D3 levels. Serum 
PTH levels were further elevated in TRPV5-/-/1α-OHase-/- mice compared to 1α-OHase-/- 
mice. Diuresis and urinary pH were normalized in TRPV5-/-/1α-OHase-/- mice. 1α-OHase-/- 
and TRPV5-/-/1α-OHase-/- mice showed a reduced bodyweight compared to litter-matched 
wild-type mice. Moreover, 1α-OHase-/- and TRPV5-/-/1α-OHase-/- mice had a decreased 
lifespan in comparison to wild-type and TRPV5-/- mice.
Renal expression of Ca2+ transport proteins
To investigate the specific regulation of renal Ca2+ transporters by 1,25(OH)2D3 the effects 
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Figure 1  Urinary Ca2+ excretion and serum Ca2+ concentration  
Urinary Ca2+ excretion (A) and serum Ca2+ levels (B) were determined in wild-type, 
1α-OHase-/-, TRPV5-/-, and TRPV5-/-/1α-OHase-/- mice. Data are presented as means ± SEM.  
* P < 0.05, significant difference from all groups.
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Discussion
This study demonstrated that hypervitaminosis D in TRPV5-/- mice is responsible for the 
up-regulation of intestinal Ca2+ transport proteins and the resulting Ca2+ hyperabsorption. 
Hereby, TRPV5-/- mice maintain normocalcemia, a feature absent in TRPV5-/-/1α-OHase-/- 
mice, which exhibit a significant hypocalcemia. The urinary Ca2+ leak demonstrated in 
TRPV5-/- mice persists in the TRPV5-/-/1α-OHase-/- mice as an inappropriately high urinary 
Bone analyses
Bone analyses showed that TRPV5-/- mice (figure 5, J, and N) and 1α-OHase-/- mice 
(figure 5, K, and O) demonstrated reduced bone thickness in both the trabecular and 
the cortical compartments compared with wild-type mice (figure 5, I and M). 
This reduction was more severe in 1α-OHase-/- mice (figure 5, K, and O). In addition, the 
degree of bone mineralization was reduced in TRPV5-/- mice (figure 5, F, J and N) and 
1α-OHase-/- mice (figure 5, G, K and O) compared with wild-type mice (figure 5, E, I, 
and M). Moreover, the epiphyseal growth plate was widened in 1α-OHase-/- mice (figure 
5, G versus E), which was not observed in TRPV5-/- mice (figure 5, F versus E). Tibial bone 
length was reduced in 1α-OHase-/- mice (figure 5, C versus A and B). In TRPV5-/-/1α-
OHase-/- mice, the thickness of cortical bone and trabeculae was decreased and 
mineralization was diminished compared wtih all other mouse genotypes (figure 5, H, 
L, and P). Moreover, tibial bone length was severely reduced and epiphyseal growth 
plate widening was more pronounced in TRPV5-/-/1α-OHase-/- mice than demonstrated 
in 1α-OHase-/- mice (figure 5, D and H versus C and G). Taken together, the TRPV5-/-/1α-
OHase-/- mice exhibited an aggravated skeletal phenotype in comparison with TRPV5-/- 
and 1α-OHase-/- mice (figure 5, D, H, L, and P).
A
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Table 1  Urine and serum analyses and body weight 
   Control 1α-OHase-/- TRPV5-/- TRPV5-/-
      1α-OHase-/- 
Urine Diuresis (ml/24h) 1.8 ± 0.2 2.3 ± 0.3 4.4 ± 0.6* 1.8 ± 0.5
  pH 7.6 ± 0.2 7.9 ± 0.1 6.1 ± 0.1* 7.8 ± 0.2
Serum 1,25(OH)2D3 (pmol/L) 193 ± 27 < 6 632 ± 63* < 6
  PTH (pg/ml) 44 ± 10 1444 ± 123* 29 ± 6 2328 ± 212*
Body weight (g) 24.6 ± 1.7 14.1 ± 0.4* 21.7 ± 0.8 12.8 ± 1.1*
Data are presented as means ± SEM. 1α-OHase-/-, 1α-OHase knockout mice; TRPV5-/-, TRPV5 knockout mice; 
TRPV5-/-/1α-OHase-/-, TRPV5/1α-OHase double knockout mice; PTH, parathyroid hormone. The minimum 
detection level of the 1,25(OH)2D3 assay was 6 pmol/L. *P < 0.05, significant difference from wild-type mice. 
Figure 2  Renal mRNA expression of Ca2+ transport proteins  
Renal mRNA expression levels of calbindins-D28K (A), calbindins-D9K (B), and NCX1 (C) in 
wild-type, 1α-OHase-/-, TRPV5-/-, and TRPV5-/- 1α-OHase-/- mice, assessed by real-time PCR 
analysis as the ratio to hypoxanthine-guanine phosphoribosyl transferase (HPRT) mRNA 
levels. Expression levels are presented relative to wild-type mice. Data are expressed as 
means ± SEM. * P < 0.05 significant difference from wild-type mice; # P < 0.05 significant 
difference from all groups.
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Ca2+ hyperabsorption (14). We hypothesized that the increased serum 1,25(OH)2D3 levels 
constitute a compensatory mechanism in an effort to correct for the significant renal Ca2+ 
leak. Additional gene inactivation of 1α-OHase in TRPV5-/- mice was performed to investigate 
the effects of the elevated serum 1,25(OH)2D3 levels present in TRPV5-/- mice. This double 
gene ablation resulted in undetectable serum 1,25(OH)2D3 levels and down-regulation of 
duodenal Ca2+ transport protein expression. Moreover, a hypocalcemia developed in the 
TRPV5-/-/1α-OHase-/- mice. These data clearly showed that the increased expression of the 
intestinal Ca2+ transporters TRPV6 and calbindin-D9K and the resulting Ca2+ hyperabsorption 
in TRPV5-/- mice are due to a secondary hypervitaminosis D. These effects compensate for 
the renal Ca2+ leak to maintain normal serum Ca2+ levels in TRPV5-/- mice.
TRPV5-/- mice show a striking hypercalciuria. Previous micropuncture experiments 
demonstrated that Ca2+ reabsorption in DCT and CNT is abolished in these mice, illustrating 
a primary defect in renal active Ca2+ reabsorption (14). On the contrary, 1α-OHase-/- mice 
demonstrated a significant hypocalciuria, a feature not described before, although 
explained by the downregulation of intestinal and renal Ca2+ transport proteins and, 
therefore, impairment of Ca2+ absorption and reabsorption. It is interesting that additional 
Ca2+ excretion with respect to the hypocalcemia. Moreover, bone degradation is present 
in TRPV5-/-/1α-OHase-/- mice, more severe than observed in TRPV5-/- mice. Therefore, the 
absence of Ca2+ hyperabsorption results in a more aggravated phenotype than described 
for TRPV5 single-ablated mice. Thus, 1,25(OH)2D3 is of crucial importance to compensate 
the renal Ca2+ leak and to maintain normal serum Ca2+ levels in TRPV5-/- mice.
1,25(OH)2D3 is an important regulatory hormone in Ca2+ and bone homeostasis (2). In 
duodenum, 1,25(OH)2D3 regulates the expression of Ca2+ transport proteins (24). Moreover, 
1,25(OH)2D3 is synthesized from its precursor by the renal enzyme 1α-OHase (7). 1α-OHase-/- 
mice were previously generated as a mouse model for vitamin D deficiency rickets type I 
(15, 16). Inactivation of 1α-OHase resulted in undetectable levels of serum 1,25(OH)2D3, a 
significant hypocalcemia, and reduced expression levels of duodenal Ca2+ transport 
proteins. In contrast, TRPV5-/- mice demonstrated a normocalcemia with a significant 
hypervitaminosis D and increased duodenal Ca2+ transport protein expression leading to 
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Figure 4  Duodenal mRNA expression of Ca2+ transport proteins  
Duodenal mRNA expression levels of TRPV6 (A), calbindins-D9K (B), and PMCA1b (C) in wild-
type, 1α-OHase-/-, TRPV5-/-, and TRPV5-/- 1α-OHase-/- mice, assessed by real-time PCR analysis 
as the ratio to HPRT mRNA levels. Expression levels are presented relative to wild-type mice. 
Data are expressed as means ± SEM. * P < 0.05 versus wild-type mice; # P < 0.05 significant 
difference from all groups.
Figure 3  Renal calbindin-D28K and calbindin-D9K protein expression  
Immunoblots of total kidney homogenates from TRPV5-/- and TRPV5-/- 1α-OHase-/- mice 
probed with anti-calbindin-D28K (A) and anti-calbindin-D9K (B). Intensities of  immunopositive 
bands were quantified by densitometry. Calbindin-D9K and calbindins-D28K expression levels 
were depicted relative to TRPV5-/- mice. Data are expressed as means ± SEM. * P < 0.05 
 significant difference from TRPV5-/- mice.
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gene-ablation of 1α-OHase in TRPV5-/- mice normalized 24-h urinary Ca2+ excretion to 
values not significantly different from wild-type mice. Nevertheless, relative to the severe 
hypocalcemia, these double knockout mice still excreted inappropriately high amounts of 
Ca2+. Moreover, given the expression of the renal Ca2+ transporters in 1α-OHase-/- mice, it 
can be concluded that active Ca2+ reabsorption is still present, although severely impaired 
despite the absence of 1,25(OH)2D3. Ca2+ reabsorption through TRPV5 therefore could be 
partly independent on 1,25(OH)2D3, which is in line with the results of previous studies in 
which the rescue of 1α-OHase-/- mice by dietary Ca2+ was described, showing the 
regulation of Ca2+ transport proteins independent on 1,25(OH)2D3 regulation (18, 25).
Hypercalciuria increases the risk for the formation of Ca2+-containing urinary crystals 
(26,27). In addition to hypercalciuria, TRPV5-/- mice displayed a significant polyuria and 
urinary acidification. Polyuria facilitates the excretion of large quantities of Ca2+, and 
urinary acidification creates an environment in which formation of crystals is restrained 
(28, 29). It is interesting that in the double knockout mice, net calciuresis did not differ from 
wild-type mice and neither did urinary pH or diuresis. This indicated that the hypercalciuria 
in TRPV5-/- mice, which originates from the DCT and CNT, could indeed influence diuresis 
and pH in more distal located nephron segments. Previously, thiazide treatment leading to 
a decrease in Ca2+ excretion in TRPV5-/- mice was shown to normalize urinary pH and blunt 
polyuria (30). It was postulated that calcium-sensing receptor (CaSR) signaling in the apical 
membrane of the collecting duct functionally links renal Ca2+ and water metabolism (31). 
CaSR activation by high luminal Ca2+ concentrations might result in a decrease in water 
permeability of the collecting duct by downregulation of aquaporin-2 water channels and 
consequently increase the urinary volume (32, 33). We suggest that regulation of specific 
acid-base transport proteins, possibly as a result of CaSR activation, is involved in the 
observed urinary acidification in TRPV5-/- mice. The exact mechanisms that are responsible 
for the urinary acidification and polyuria in TRPV5-/- mice need further investigation.
The majority of the body Ca2+ content is stored in bone, where the balanced processes of 
bone formation and resorption maintain bone homeostasis (34). Detailed microcomputed 
tomography and X-ray analyses showed bone abnormalities in all three studied mouse 
models compared with wild-type mice. TRPV5-/- mice displayed reduced trabecular and 
cortical bone thickness (14), which could be a consequence of the negative Ca2+ balance 
as a result of the renal Ca2+ leak. Moreover, it was previously suggested that high serum 
1,25(OH)2D3 levels reduce cortical bone thickness, bone stiffness, and strength (35). 
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Figure 5  Bone phenotypes  
Lower legs from 8-wks old wild-type, TRPV5-/-, 1α-OHase-/-, and TRPV5-/- 1α-OHase-/- mice 
were analyzed using X-ray imaging (A through D). Microcomputed tomography was used to 
generate tibial overviews (E through H), from which digital cross-sections were made at the 
site of the epiphysis (arrow; I through L) and the diaphysis (arrow head; M through P). 
Representative images are shown for each genotype. Epiphyseal growth plates are indicated 
by asterisks (*) and outlined by dotted lines (G and H).
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However, 1,25(OH)2D3 levels were not detectable in TRPV5-/-/1α-OHase-/- mice, which 
demonstrated a significant decrease in bone thickness, reduced bone mineralization, and 
rickets, noticeably more severe than the bone abnormalities observed in TRPV5-/- and 
1α-OHase-/- mice (14, 15). This suggested that TRPV5 gene ablation might, at least in part, 
be directly responsible for the detected bone abnormalities, independent of the elevated 
serum 1,25(OH)2D3 levels. It is interesting that the expression of TRPV5 and TRPV6 in bone 
tissue was previously described and these epithelial Ca2+ channels therefore could serve as 
direct Ca2+ providers in bone (20). However, this hypothesis is hampered by the absence of 
comprehensive data on the exact actions of these Ca2+ channels in bone. Alternatively, the 
aggravated bone phenotype demonstrated in TRPV5-/-/1α-OHase-/- mice could be 
explained by the secondary hyperparathyroidism leading to renal osteodystrophy.
Zheng et al. (36) recently studied the vitamin D receptor (VDR)/calbindin-D28K double 
knockout mouse compared with VDR or calbindin-D28K single gene-ablated mice. It is 
interesting that the VDR/calbindin-D28K double knockout mice displayed downregulation 
of intestinal and renal Ca2+ transport proteins and a more aggravated phenotype, including 
hypercalciuria and hyperparathyroidism, a further decrease in bone mineral density and 
bone length, increased distortion of the growth plate, a decrease in body weight, and a 
decreased lifespan compared with the single gene-ablated mice. In line with our results, 
this study clearly revealed the critical role of vitamin D and Ca2+ transport proteins in Ca2+ 
homeostasis and, moreover, the crucial regulatory function of 1,25(OH)2D3 in the expression 
of intestinal and renal Ca2+ transport proteins.
On the basis of the present data, we ascertained the important function of the renal Ca2+ 
transport protein TRPV5 in Ca2+ reabsorption and its possible involvement in bone Ca2+ 
transport, concomitant with a crucial role of 1,25(OH)2D3 in active Ca2+ (re)absorption by 
regulating epithelial Ca2+ transport and Ca2+ transport protein expression. The observed 
polyuria and urinary acidification in TRPV5-/- mice will need further investigation to obtain 
more insight into the responsible mechanisms.
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Abstract
Kidney stones form a major socio-economic problem in humans, involving severe pain, 
recurrent treatment, and eventually renal insufficiency. Hypercalciuria is a risk factor for 
urolithiasis and renal adaptive mechanisms are crucial in the prevention of renal stones. 
Transient receptor potential vanilloid 5 (TPRV5) knockout (TRPV5-/-) mice exhibit robust 
urinary calcium (Ca2+) wasting and concomitant hyperphosphaturia, but lack kidney 
stones. These hypercalciuric mice display significant polyuria and increased urinary 
acidification, pointing toward adaptive mechanisms preventing renal stone formation. 
Here, we demonstrated that exposure of dissected mouse outer medullary collecting 
ducts to 5.0 mM Ca2+ stimulates H+-ATPase activity and increases the intracellular pH 
recovery rates compared to 0.1 mM Ca2+. Ca2+-sensing receptor (CaSR)-mediated activation 
of H+-ATPase provoked urinary acidification, whereas downregulation of aquaporin-2 
water channels induced polyuria in the TRPV5-/- mice. Gene ablation of the collecting 
 duct-specific B1-subunit of H+-ATPase in TRPV5-/- mice abolished the increased urinary 
acidification resulting in severe tubular precipitations of Ca2+-phosphate in the renal 
medulla. In conclusion, activation of CaSR by augmented urinary Ca2+ levels triggers 
urinary acidification and polyuria. These beneficial adaptations facilitate the excretion of 
large amounts of soluble Ca2+, which is crucial in the prevention of kidney stones.
Introduction
Hypercalciuria constitutes the main risk factor in urolithiasis and forms a major 
socio-economic problem in developed countries. Patients suffering from renal stone 
disease experience severe pain, a high rate of recurrence, slowly progressing tissue 
damage, and eventually renal insufficiency, while recurrent clinical treatment is needed 
(1, 2). Different types of hypercalciuria are known for which diverse disturbances of the 
Ca2+ balance are responsible. In this respect absorptive, renal, and resorptive hypercalciuria 
are distinguished, in which intestinal Ca2+ hyperabsorption, impaired renal Ca2+ 
reabsorption, and increased bone resorption, respectively are primarily involved (3-6). 
Current treatment strategies of renal stones consist of (pain) medication, dietary 
adjustments, hydration, extracorporeal shock wave treatment, or surgery. 
The transient receptor potential vanilloid member 5 (TRPV5), the epithelial Ca2+ channel 
which is expressed in the renal distal convoluted tubule (DCT) and the connecting tubule 
(CNT), constitutes the major apical entry step of Ca2+ from the pro-urine into the renal cells 
(7). TRPV5 knockout (TRPV5-/-) mice demonstrate a robust hypercalciuria with hyper-
phosphaturia, predisposing these mice to an increased risk for renal Ca2+-phosphate stone 
formation (8). Concomitantly, TRPV5-/- mice display intense polyuria and increased urinary 
acidification. Urinary acidification occurs along different segments of the nephron and is 
of crucial importance in acid/base homeostasis (9, 10). 
The activity of acid/base transporters in intercalated cells (ICs) of CNT and collecting duct 
system (CD) accomplish the fine-tuning of urinary pH. In type A ICs, the multi-subunit 
vacuolar ATP-driven proton-pump (H+-ATPase) is expressed at the apical membrane, which 
is mainly responsible for proton excretion (11). Inactivating mutations in the genes 
encoding individual subunits of the H+-ATPase proton pump are associated with distal 
renal tubular acidosis (dRTA), characterized by the inability of ICs to acidify the urine (12-14). 
Due to the formation of alkaline urine dRTA patients are susceptible to urolithiasis as the 
crystallization of Ca2+-phosphate occurs via the conversion of phosphate to its divalent 
form (HPO42-) in an alkaline rather than in an acidic environment (15, 16). Previously, 
insufficient urinary acidification was demonstrated in recurrent stone formers (17, 18). 
Currently, there are no clinical trials documented that describe the prevention of stone 
formation by stimulating urinary acidification.
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and kidneys were sampled. To perform renal histology experiments, control, TRPV5-/-, 
Atp6v1b1-/-, and TRPV5-/-/Atp6v1b1-/- mice at 1 and 5 wks of age were sacrificed and kidneys 
were sampled. The animal ethics board of the Radboud University Nijmegen and the Kanton 
Zurich Animal Veterinary Authority approved all animal experimental procedures.
Urine and serum analyses
Urine and serum Ca2+ concentrations were analyzed using a colorimetric assay (Roche, 
Mannheim, Germany). Urine osmolarity was measured with an Osmette A automatic 
osmometer (Precision Instruments, Sudbury, MA, USA). Urinary pH was measured with an 
electronic ion analyzer. Urine and serum phosphate concentrations were measured by the 
phosphomolybdate method with an Aeroset analyzer (Abbott Diagnostics, Abbott Park, IL, 
USA). Urinary creatinine and ammonium were measured by using a kit (Sigma) and the 
Berthelot test, respectively. Urinary titratable acidity was determined as described previously 
(26). Briefly, equal volumes of urine and 0.1 N HCl were mixed and boiled for 2 min to remove 
CO2/HCO3- from the sample. Subsequently, after cooling to 37 °C, the mix was titrated with 
0.1 N NaOH to pH 7.4. Urine bicarbonate was measured by injecting urine into a blood gas 
analyzer (ABL800, Radiometer, Kopenhagen, Denmark) using gas-tight syringes. Obtained 
pCO2 values were converted to bicarbonate concentrations using the Henderson-Hasselbalch 
equation considering urine pH and temperature. In order to perform correlation analyses, 
experimental data was collected and combined of adult TRPV5-/- and control mice.
Renal histology
At 1 and 5 wks of age, TRPV5-/-, Atp6v1b1-/-, TRPV5-/-/Atp6v1b1-/-, and control littermate mice 
were transcardially perfused with a 0.1 M phosphate buffer (PB), pH 7.4, until all blood was 
removed and subsequently with 4% (wt/v) paraformaldehyde in PB. Kidneys were dissected, 
placed in 4% (v/v) buffered formaldehyde fixative at room temperature (RT) for 2 h, and 
subsequently incubated overnight at 4º C in PB containing 15 % (wt/v) sucrose for cryoprotection. 
Subsequently, kidney samples were frozen in liquid nitrogen and 5-7 mm cryosections were 
cut. Von Kossa staining was performed to stain Ca2+-containing deposits. In short, sections 
were hydrated in demineralized water, incubated with 1% (wt/v) AgNO3 in front of a 100 watt 
light bulb for 1 h, and rinsed with water. Non-reacted silver was removed by fixation in 5% 
(wt/v) Na2S2O3 for 5 min. Sections were dehydrated and embedded in permanent mounting 
medium. Images were made using a Dialux22 microscope (Leitz, Wetzlar, Germany) with a 
polarizing lens, equipped with a Coolpix990 digital photo camera (Nikon, Japan). To analyze 
the renal tubular Ca2+ precipitations by transmission electron microscopy kidney samples were 
Aquaporin-2 (AQP2) is the water channel localized at the apical membrane of the CNT and 
CD that is responsible for vasopressin-regulated urinary water reabsorption (19, 20). 
Previous studies linked Ca2+ and water homeostasis, implying a functional role for the 
G-protein coupled Ca2+/polyvalent cation-sensing receptor (CaSR) (21-23). The localization 
of the CaSR along the apical membrane of the distal part of the nephron and the CD 
facilitates the activation of the receptor during a hypercalciuric state (24). Hereby, a 
CaSR-mediated decrease of the urine concentrating ability could eventually lead to 
polyuria, assisting the excretion of large amounts of Ca2+ (21, 23). 
The aim of the present study was to elucidate molecular mechanisms involved in the 
adaptations that prevent renal stone formation during hypercalciuria. The TRPV5-/- mouse 
model was employed as polyuria and increased urinary acidification naturally occur in 
these hypercalciuric mice. The crucial roles of the functional H+-ATPase proton pump, the 
AQP2 water channel, and the CaSR are demonstrated in these hypercalciuria-related 
adaptations. This study provides new insight into processes applicable in Ca2+-phosphate 
renal stone formation and prevention.
Methods
Animal experiments
TRPV5-/- mice were generated by targeted gene ablation of TRPV5 and genotyped, as 
described previously (8). Control and TRPV5-/- mice were kept in a light and temperature 
controlled room. Standard pelleted chow (in wt/wt: 1.00 % Ca; 0.22 % Mg; 0.24 % Na; 0.70 % 
P; 1.02 % K; SSNIFF Spezialdiäten GmbH, Soest, Germany) and drinking water were available 
ad libitum. At 8 wks of age the animals were housed in metabolic cages (Tecniplast, 
Buguggiate, Italy) enabling 24 h urine collections under mineral oil. Mice were sacrificed and 
blood, kidneys, and ileum were sampled. Atp6v1b1-/- mice were generated by targeted 
Atp6v1b1 gene ablation and genotyped, as described previously (25). Cross breeding 
TRPV5-/- and Atp6v1b1-/- mice resulted in heterozygous (TRPV5+/-/Atp6v1b1+/-) mice. Offspring 
was subsequently crossed to obtain TRPV5/Atp6v1b1 double knockout (TRPV5-/-/Atp6v1b1-/-) 
mice. Control, TRPV5-/-, Atp6v1b1-/-, and TRPV5-/-/Atp6v1b1-/- mice were kept in a light and 
temperature-controlled room. Standard pelleted chow as above-mentioned and drinking 
water were available ad libitum. At 5 wks of age the animals were housed in metabolic cages 
(Tecniplast, Buguggiate, Italy) enabling 24 h urine collections. Mice were sacrificed, blood 
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USA) at 4 ºC for 16 h. Subsequently, all blots were incubated with a goat anti-rabbit 
peroxidase labeled secondary antibody (1:5,000; Sigma) at RT for 1 h. Immunoreactive 
protein was detected by the chemiluminescence method (Pierce, Rockford, IL, USA). 
Immunopositive bands were scanned and analyzed, as described previously (27).
Tubule preparations and intracellular pH measurements
Mice were anesthetized and transcardially perfused with a digestion buffer (in mM: 140.0 
sucrose, 112.0 NaH2PO4, 28.0 Na2HPO4, pH 7.4) containing 1 mg/ml collagenase (Sigma), to 
obtain renal OMCDs from control, TRPV5-/-, and Atp6v1b1-/- mice for H+-ATPase activity 
measurements, as described previously (31-33). In brief, kidneys were harvested, 1-2 mm 
slices were prepared and the outer medulla was dissected. The outer medulla was transferred 
to the above-described digestion buffer and incubated at 37 ºC for 30 min, washed and 
eventually dissolved in 5 ml of a 4 ºC HEPES buffer (in mM: 125.0 NaCl, 5.0 KCl, 0.1 CaCl2, 9.0 
glucose, and 32.2 HEPES, titrated to pH 7.4 with NaOH or KOH) and stored on ice until further 
use. OMCDs were placed in a perfusion chamber at 37 ºC, containing glass cover slips 
pre-coated with the cell adhesive Cell-Tak (Becton-Dickinson, Franklin Lakes, NJ, USA). To 
monitor pHi, OMCDs were loaded with the acetoxymethyl ester of the pH-sensitive dye 
BCECF AM (1 mM, Molecular Probes) for 10 min and subsequently washed to remove all non 
de-esterified dye. BCECF was successively excited at 495 and 440 nm from a monochromator 
light source and emission was monitored at 535 nm using an intensified charge-coupled 
device camera. Data points were acquired every 5 sec. The resulting 495/440 intensity ratio 
data were converted to pHi values using the high K+/nigericin technique, as described 
previously (34). Cells were successively exposed to the above-mentioned HEPES buffer, a 
Na+-free HEPES buffer (NaCl being replaced by 127 mM N-methyl-D-glucamine to abolish 
Na+/H+ exchanger activity and titrated to pH 7.4 with HCl), subsequently acidified using the 
NH4Cl (20 mM) pre-pulse technique in the absence of Na+, washed into the Na+-free HEPES 
buffer, and eventually exposed to the Na+-containing HEPES buffer, as described previously 
(32). The rate of H+-ATPase activity was determined as the concanamycin-sensitive pHi 
alkalization rate in the absence of Na+, in which concanamycin (100 nM) is an inhibitor of 
H+-ATPase activity. Ca2+, neomycin, and concanamycin were added to the perfusion system 
from stock solutions at the given concentrations for each experimental protocol.
Video imaging of [Ca2+]i using Fura-2 AM
HEK293 cells were co-transfected with the CaSR in the pcDNA 3.1 vector and the pCI-Neo 
vector and seeded on fibronectin-coated coverslips (Ø 25 mm). After 24 h, cells were 
fixed in 2.5 % (wt/v) glutaraldehyde dissolved in 0.1 M cacodylate buffer, pH 7.4, at RT for 2 h 
after dissection. Samples were washed three times with 0.1 M sodium cacodylate buffer and 
postfixed with 1 % (wt/v) osmium tetroxide in 0.1 M sodium cacodylate buffer at RT for 1 h. 
Samples were then dehydrated and processed for embedding in epon resin. Polymerization 
was performed in a 60 °C oven. For morphology studies sections were cut using a diamond 
knife and mounted on copper grids (100 mesh). Sections were stained with uranyl acetate and 
lead citrate, and examined using a Jeol 1200 EX II. For energy-dispersive X-ray microanalysis 
(EDX) measurements, section thickness was approximately 200 nm, postfixation was omitted, 
not contrasted, and subsequently examined using a Jeol 1200 / STEM in combination with a 
Thermo Noran microanalysis SIX system (Thermo Fisher Scientific, Inc., Waltham, MA, USA). 
Accelerated voltage of 60 keV was used for X-ray microanalysis. X-ray spectra and maps for Ca2+ 
and phosphorus distribution were acquired.
Protein isolations
To quantify the renal AQP2, the H+-ATPase B1-subunit, and the Na+-phosphate cotransporter 
NaPi-IIa protein expression levels in 8 wks old control and TRPV5-/- mice, renal protein lysates 
were prepared as described before (27). Specifically, total kidney proteins were isolated for the 
H+-ATPase B1-subunit determination, renal medulla lysates were generated for the AQP2 
analyses, whereas renal cortex proteins were used for NaPi-IIa quantification. Membrane fractions 
were isolated from renal medulla tissue that was homogenized with a Pro 200 homogenizer (Pro 
Scientific Inc., Oxford, CT, USA) in ice-cold solubilization buffer (28), according to centrifugation 
methods described by Shaw et al (29). For renal AQP2 quantification in the control, TRPV5-/-, 
Atp6v1b1-/-, and littermate TRPV5-/-/Atp6v1b1-/- mice, kidneys were dissected at an age of 5 wks, 
after which renal proteins were isolated as described before (27). Ileum brush border membrane 
vesicles (BBMVs) were isolated to quantify Na+-phosphate cotransporter NaPi-IIb protein 
expression levels in TRPV5-/- compared with control mice, as described previously (30). 
Immunoblotting
Protein samples (for AQP2, NaPi-IIa, NaPi-IIb and b-actin detection: 10 mg of protein; 
B1-subunit of H+-ATPase detection: 30 mg of protein) were loaded on 12 % (wt/v) sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and blotted to 
polyvinylidine difluoride (PVDF)-nitrocellulose membranes (Immobilon-P; Millipore Corp., 
Bedford, MA, USA). Blots were incubated with polyclonal antibodies raised in rabbits 
against AQP2 (1:3,000), NaPi-IIa (1:3,000), NaPi-IIb (1:3,000), the B1-subunit of H+-ATPase 
(1:3,000), or the monoclonal mouse anti b-actin antibody (1:25,000; Sigma, St Louis, MO, 
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decreased urinary osmotic values. Urinary pH was significantly lower in TRPV5-/- mice 
compared to control mice. The 24 h ammonium and HCO3- excretion levels were 
unchanged (table 2). Furthermore, urinary titratable acidity (TA) was significantly increased 
in TRPV5-/- mice. Consequently, renal net acid excretion (NAE), which is the sum of renal 
ammonium excretion and TA minus HCO3- excretion, was elevated in TRPV5-/- mice. Ca2+ 
loaded with Fura-2 AM (3 µM, Molecular Probes) at 37 ºC in DMEM medium, for 20 min (35). 
After loading, cells were washed twice and allowed to equilibrate for another 10 min in 
Ca2+-free HEPES-Tris buffer (in mM: 132.0 NaCl, 4.2 KCl, 1.0 MgCl2, 5.5 D-glucose, and 10.0 
HEPES, titrated to pH 5.5 or 7.4 with Tris-HCl). Next, cells were placed in an incubation 
chamber and attached to the stage of an inverted microscope (Axiovert 200M, Carl Zeiss, 
Jena, Germany). Changes in extracellular [Ca2+] from 0 to a range of 0 to 10 mM at pH 5.5 
or 7.4 were facilitated using a perfusion system. Changes in cytosolic [Ca2+] were monitored 
with Fura-2 excited at 340 and 380 nm using a monochromator (Polychrome IV, TILL 
Photonics, Gräfelfing, Germany). Fluorescence emission light was directed by a 415DCLP 
dichroic mirror (Omega Optical Inc., Brattleboro, VT) through a 510WB40 emission filter 
(Omega Optical Inc.) onto a CoolSNAP HQ monochrome CCD-camera (Roper Scientific, 
Vianen, the Netherlands). The integration time of the CCD-camera was set at 200 msec with 
a sampling interval of 3 sec. All hardware was controlled with Metafluor 6.0 software 
(Universal Imaging Corporation, Downingtown, PA). Quantitative image analysis was 
performed with Metamorph 6.0 (Molecular Devices Corporation, Sunnyvale, CA, USA). For 
each wavelength, the mean fluorescence intensity was monitored in an intracellular region 
and, for purpose of background correction, an extracellular region of identical size. After 
background correction, the fluorescence emission ratio after excitation at 340 nm and 380 
nm was calculated. In each experiment, the value at t = 0 of every cell was set at 100 %, to 
which all other values were related.
Statistical analyses
Values were presented as means ± SEM and tested for statistical significance (P < 0.05) 
using paired and unpaired student’s t-tests, analysis of variance, and linear regression 
analysis, using GraphPad InStat® version 3.0b software (GraphPad Software Inc., San Diego, 
CA, USA) on an Apple iMac computer (Apple computer Inc.).
Results
Metabolic studies
At 8 wks of age TRPV5-/- and littermate control mice were housed in metabolic cages for 
24 h and sacrificed. Genetic ablation of TRPV5 resulted in robust hypercalciuria, while these 
mice remained normocalcemic (table 1). In addition, TRPV5-/- mice displayed 
hyperphosphaturia with normal serum phosphate levels and a significant polyuria with 
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Table 1  Physiological parameters of control and TRPV5-/- mice 
Table 2  Urinary titratable acidity in control and TRPV5-/- mice 
   Control TRPV5-/-
Urine   
 Ca2+ (mmol/24h) 10 ± 2 132 ± 31*
 Phosphate (mmol/24h) 65 ± 8 142 ± 13*
 Volume (ml/24h) 1.5 ± 0.3 3.6 ± 0.5*
 pH  7.4 ± 0.1 5.5 ± 0.1*
 Osmotic value (mOsmol/kg) 1928 ± 201 1222 ± 175*
Serum   
 Ca2+ (mM) 2.36 ± 0.02 2.42 ± 0.02
 Ionized Ca2+ (mM) 1.27 ± 0.01 1.30 ± 0.01
 Phosphate (mM) 2.5 ± 0.2 2.3 ± 0.1
Urine and serum biochemical parameters of 8 wks old control and TRPV5-/- mice. Data are presented as 
means ± SEM (n = 5). * P < 0.05; significant difference from control mice. TRPV5-/-, TRPV5 knockout mice. 
   Control TRPV5-/-
 NH3/NH4+ (mmol/24 h) 0.033 ± 0.006 0.036 ± 0.007
 TA (mEq/24 h) 0.048 ± 0.007 0.121 ± 0.006*
 HCO3- (mmol/24 h) 0.002 ± 0.001 0.001 ± 0.001
 NAE (mEq/24 h) 0.083 ± 0.012 0.157 ± 0.012*
 pH  6.2 ± 0.1 5.6 ± 0.1*
Urinary titratable acidity in a novel experiment with 8 wks old control and TRPV5-/- mice (n = 7). Data are 
presented as means ± SEM. * P < 0.001; significant difference from control mice. TRPV5-/-, TRPV5 knockout 
mice; TA, titratable acidity; NAE, net acid excretion.
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TRPV5-/- mice, TRPV5-/-/Atp6v1b1-/- mice were generated, which were genetically ablated 
for both TRPV5 and the ICs-specific B1-subunit of H+-ATPase (Atp6v1b1). Hypercalciuria 
remained present in 5 wks old TRPV5-/-/ATP6v1b1-/- mice, though less robust as in TRPV5-/- 
mice (figure 1C). Urinary pH was normalized (figure 1D), while diuresis was further 
increased in TRPV5-/-/ATP6v1b1-/- mice in comparison with TRPV5-/- mice (figure 1E).
Phenotypic analysis of the TRPV5-/-/ATP6v1b1-/- mice
TRPV5-/-/Atp6v1b1-/- mice were retarded in their growth directly after birth, compared to 
littermate mice (figure 2A). At 5 wks of age TRPV5-/-/Atp6v1b1-/- mice were easily identified 
because of severe growth retardation (figure 2B). Moreover, 80 % of the TRPV5-/-/Atp6v1b1-/- 
mice died within 6 wks after birth (figure 2C). These double knockout mice showed 
bilateral hydronephrosis (figure 2D) and abnormal dilatation of the CD (figure 2E). 
Von Kossa stainings in kidneys of 1 wk old TRPV5-/-/Atp6v1b1-/- mice showed massive 
tubular Ca2+-precipitations in the medullary CD (figure 2F, G). Subsequently, kidney 
samples that included the observed stones were analyzed by energy-dispersive X-ray 
microanalysis (EDX) using a Jeol 1200 / STEM in combination with a Thermo Noran 
microanalysis SIX system (figure 2H). The X-ray maps and spectrum unequivocally showed 
the presence of Ca2+ and phosphorus (figure 2H2, 3 and I) in the precipitates present in 
the lumen of the CD suggesting Ca2+-phosphate crystals.
Renal and intestinal expression of water, acid, and phosphate transporters
To address renal AQP2 expression levels in control and TRPV5-/- mice, immunoblot analyses 
were performed. AQP2 was significantly downregulated in TRPV5-/- mice compared to 
control mice at an age of 8 wks (figure 3A). Moreover, a further AQP2 downregulation was 
detected in TRPV5-/-/Atp6v1b1-/- mice compared to TRPV5-/- mice, analyzed at an age of 
5 wks (figure 3B). Membrane fractions were isolated from renal medulla tissue of 8 wks old 
TRPV5-/- and control mice. Analysis of AQP2 protein expression in the membrane fractions 
revealed a significant downregulation in kidneys of TRPV5-/- compared to control littermate 
mice (figure 3C). Immunoblotting for the B1-subunit of H+-ATPase revealed no differences 
in expression levels between TRPV5-/- and control mice (figure 4A). Furthermore, a 
significant downregulation of the renal type IIa NaPi cotransporter (NaPi-IIa) was revealed 
in TRPV5-/- mice (figure 4B). In contrast, expression of the intestinal type IIb NaPi 
cotransporter (NaPi-IIb) was increased in brush border membrane vesicles (BBMV) isolated 
from ileum of TRPV5-/- mice compared to control mice (figure 4C).excretion levels correlated linearly with urinary volume as well as pH (figure 1A, B, 
respectively). To address the contribution of H+-ATPase activity to the acidified urine in 
A
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Figure 1  Urinary Ca2+ excretion, volume, and pH  
Correlation of urinary Ca2+ excretion with (A) diuresis and (B) urinary pH in control and 
TRPV5-/- mice. Each dot represents single mouse data. Linear regression analysis confirmed 
significant correlations of urinary Ca2+ excretion with diuresis (r2=0.83; P < 0.0001; n=62), and 
urinary pH (r2=0.70; P < 0.0001; n=42). (C) Urinary Ca2+ excretion was determined in 24 h 
urine samples of 5 wks old control, TRPV5-/-, TRPV5-/-/Atp6v1b1-/-, and Atp6v1b1-/- mice. 
TRPV5-/- and TRPV5-/-/Atp6v1b1-/- mice showed a significant hypercalciuria, while  
hypo calciuria was present in Atp6v1b1-/- mice compared to control mice. (D) TRPV5-/- mice 
demonstrated a significant decrease in urinary pH compared to control mice, whereas 
TRPV5-/-/Atp6v1b1-/- mice exhibited urinary pH levels similar to controls. (E) An increased 
diuresis was  demonstrated in TRPV5-/- compared to control mice. TRPV5-/-/Atp6v1b1-/- mice 
displayed a further increase in 24 h urinary volume compared to TRPV5-/- mice. Impaired 
urinary acidification in Atp6v1b1-/- mice resulted in an increase of urinary pH. In figure C-E 
data are presented as means ± SEM. * P < 0.05 (n=6); significant difference from control. # P 
< 0.05 (n=6); significant difference from TRPV5-/- mice. Control, wild-type littermate mice; 
TRPV5-/-, TRPV5 knockout mice; TRPV5-/-/Atp6v1b1-/-, TRPV5/Atp6v1b1 double knockout mice; 
Atp6v1b1-/-, Atp6v1b1 knockout mice.
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Comparison of pHi recovery rates in control and TRPV5-/- mice OMCDs exposed to 0.1 mM 
[Ca2+] revealed no significant differences in H+-ATPase activity (figure 5B, D). To confirm 
the specific involvement of the H+-ATPase proton pump the following experiments were 
performed. First, OMCDs were incubated with 100 nM concanamycin, a specific H+-ATPase 
inhibitor, which prevented the stimulatory action of 5.0 mM [Ca2+] on the pHi recovery rate 
in OMCDs of control as well as TRPV5-/- mice. Second, the pHi recovery rates were not 
affected by 5.0 mM compared to 0.1 mM [Ca2+] in OMCDs of Atp6v1b1-/- mice underlining 
an essential role of H+-ATPase in this acidification process (figure 5E). OMCDs from control 
mice were exposed to the CaSR-agonist neomycin (200 mM) during the measurements to 
investigate the molecular mechanism of this Ca2+-mediated increase of H+-ATPase activity. 
Effect of Ca2+ on H+-ATPase activity of outer medullary collecting ducts
Outer medullary collecting ducts (OMCDs) were enzymatically isolated from mouse renal 
tissue to perform pHi measurements. The activity of H+-ATPase was determined from the 
pHi recovery rate (DpHi/min) after intracellular acidification by NH4Cl (25). The effect on 
H+-ATPase activity of low (0.1 mM), normal (1.0 mM), and high (5.0 mM) extracellular [Ca2+] 
was investigated. Representative recordings are depicted in figure 5A and C. Exposure of 
OMCDs to 5.0 mM [Ca2+] significantly increased H+-ATPase-mediated pHi recovery rates in 
control (figure 5B; n=178 cells; 15 OMCDs; 5 mice) and TRPV5-/- mice (figure 5D; n=124 
cells; 9 OMCDs; 4 mice) compared to OMCDs exposed to 0.1 mM [Ca2+] from control mice 
(n=159 cells; 12 OMCDs; 4 mice) and TRPV5-/- mice (n=149 cells; 13 OMCDs; 5 mice). 
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Atp6v1b1-/- mouse (left: magn. 100x; right: magn. 250x). (F) Von Kossa staining in renal sections 
of a 1 wk old TRPV5-/-/Atp6v1b1-/- mouse (left: magn. 100x; right: magn. 250x). (G) Transmission 
electron microscopy image of a tubular precipitate in the medullary  collecting duct of a 1 wk 
old TRPV5-/-/Atp6v1b1-/- mouse (magn. 2500x). (H) STEM image of (1) a precipitate, X-ray maps 
separately depicting (2) Ca2+, and (3) phosphorus content. (I) Energy Dispersive X-ray micro-
analysis of the renal precipitate (arrow in figure 2H)  demonstrating Ca2+ and phosphorus 
 content, representing spot measurements performed (n=35 spots).
Figure 2  Analysis of TRPV5-/-/Atp6v1b1-/- mice  
(A) Growth curves comparing body weights of mouse genotypes, representing a litter  
containing one TRPV5-/-/Atp6v1b1-/- mouse that died at an age of 14 days (dotted line), and 4 
littermates (solid lines). (B) Growth retardation in TRPV5-/-/Atp6v1b1-/- mice, demonstrating 5 
wks old control (left) and TRPV5-/-/Atp6v1b1-/- (right) mice. (C) Mortality rate of TRPV5-/-/
Atp6v1b1-/- (solid line; n=10) and littermate (dotted line; n=55) mice. (D) Kidneys from 5 wks old 
control (left) and TRPV5-/-/Atp6v1b1-/- mice (right). (E) Renal histology of a 5 wks old TRPV5-/-/
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Figure 3  Immunoblotting of renal aquaporin-2  
Representative immunoblots for aquaporin-2 (AQP2), revealing 29 kDa and 35 to 50 kDa 
bands representing non-glycosylated and glycosylated AQP2, respectively, which were all 
included in the semi quantitative determination of renal AQP2 protein abundance from   
(A) 8 wks old control versus TRPV5-/- mice (n=4). (B) Renal AQP2 protein abundance 
 comparing 5 wks old control, TRPV5-/-, TRPV5-/-/Atp6v1b1-/-, and Atp6v1b1-/- mice (n=3).  
(C) AQP2 expression levels in renal medullary membrane fractions from control and TRPV5-/- 
mice (n=4). Broad range protein and pre-stained marker bands are depicted, indicating 
protein size. Expression levels were corrected for b-actin expression. Data were calculated as 
IOD (arbitrary units) and depicted as percentage of control mice, presented as means ± SEM. 
* P < 0.05; significant difference from control. # P < 0.05; significant difference from TRPV5-/-. 
Control, wild-type littermate mice; TRPV5-/-, TRPV5 knockout mice; Atp6v1b1-/-, Atp6v1b1 
knockout mice; TRPV5-/-/Atp6v1b1-/-, TRPV5/Atp6v1b1 knockout mice; AQP2, aquaporin-2.
Figure 4  Renal H+-ATPase B1-subunit, NaPi-IIa cotransporter, and NaPi-IIb 
cotransporter protein expression  
(A) Representative immunoblots for H+-ATPase B1-subunit (B1), revealing a 56 kDa band in 
total kidney protein lysates of control and TRPV5-/- mice (n=5). Representative immunoblots 
for (B) type IIa sodium phosphate cotransporter (NaPi-IIa), revealing a ~80 kDa band in renal 
cortex (n=5), and (C) type IIb sodium phosphate cotransporter IIb (NaPi-IIb), revealing a ~80 
kDa band in brush border membrane vesicles isolated from total ileum of control and TRPV5-/-  
mice (n=4). Expression levels were normalized for b-actin expression. Broad range protein 
marker bands are depicted. Data were calculated as IOD (arbitrary units), depicted as 
 percentage of control mice, and presented as mean ± SEM. * P < 0.05; significant difference 
from control. Control, littermate wild-type mice; TRPV5-/-, TRPV5 knockout mice; B1, 
H+-ATPase B1-subunit.
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Neomycin induced a significant increase in the pHi recovery rate (n=100 cells; 8 OMCDs; 4 
mice) compared to non-exposed OMCDs in the presence of 1.0 mM [Ca2+] (n=90 cells; 9 
OMCDs; 4 mice) indicating the involvement of CaSR activation (figure 5F).
pH-dependence of CaSR activation
The pH sensitivity of the CaSR was measured by determination of intracellular Ca2+ levels 
([Ca2+]-i) using the Ca2+ indicator Fura-2 in human embryonic kidney (HEK293) cells 
transiently expressing the CaSR. These cells were activated by extracellular [Ca2+] at an 
acidic pH level of 5.5 and at a neutral pH level of 7.4 and subsequently analyzed for the 
[Ca2+]-i. At an acidic pH of 5.5, a [Ca2+]-dependent activation of the receptor with an EC50 
value of 4.7 ± 0.1 mM Ca2+ was measured, whereas the EC50 value was shifted to 6.5 ± 0.4 
mM Ca2+ at pH 7.4 (figure 6). An increase in [Ca2+]i was not observed in mock-transfected 
cells (data not shown).
Discussion
As illustrated in the present study, activation of the CaSR by increased urinary Ca2+ levels 
triggers urinary acidification and polyuria that are crucial adaptations in the prevention of 
renal stone formation during hypercalciuria. This conclusion is based on the following 
observations. First, TRPV5-/- mice display a robust hypercalciuria due to impaired active 
Ca2+ reabsorption, concomitant hyperphosphaturia, polyuria, and increased urinary 
acidification, whereas renal Ca2+ precipitations are not detected. Second, additional gene 
ablation of Atp6v1b1 in TRPV5-/- mice prevents the increased urinary acidification and 
evokes massive Ca2+-phosphate stone formation. Third, activation of the renal CaSR by 
elevated luminal Ca2+ levels stimulates H+-ATPase-mediated H+ excretion and renal AQP2 
protein downregulation, responsible for the consistent increased urinary acidification and 
polyuria, respectively, in hypercalciuric TRPV5-/- mice.
Fine-tuning of renal acid excretion is generally accomplished in the CD where the 
H+-ATPase proton pump is localized at the apical side of type A ICs. Exposure to a 5.0 mM 
Ca2+ concentration significantly enhanced H+-ATPase activity in OMCDs, a specific 
stimulatory effect that was absent in OMCDs from Atp6v1b1-/- mice. Also the CaSR agonist 
neomycin increased H+-ATPase activity, emphasizing that CaSR activation modulates 
urinary acid excretion. In TRPV5-/- mice, an increased luminal Ca2+ concentration is 
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Figure 5  Effect of Ca2+ and neomycin on vacuolar H+-ATPase activity  
(A, C) Original pHi traces from control mouse single outer medullary collecting duct intercalated 
cells (OMCD ICs) exposed to low (0.1 mM) and high (5.0 mM) [Ca2+], respectively. Bars indicate the 
alternating HEPES, Na+-free HEPES, and NH4Cl-containing buffers applied to the cells.  
(B, D) Summary of the data from the experiments performed in control and TRPV5-/- mice OMCD 
ICs, respectively. (E) ATP6v1b1-/- OMCD ICs exposed to a high (5.0 mM) [Ca2+]. (F) Effect of 
 neomycin (200 mM) on H+-ATPase activity in control mouse OMCD ICs. Bar charts (B,D,E,F) 
represent pH recovery rates (DpH/min), which are presented as mean ± SEM. * P < 0.05, 
 significant difference from control 0.1 mM [Ca2+]; # P < 0.05, significant difference from control 
5.0 mM [Ca2+]; § P < 0.05; significant difference from TRPV5-/- 0.1 mM [Ca2+]; ‡ P < 0.05, significant 
difference from TRPV5-/- 5.0 mM [Ca2+]; $ P < 0.05, significant difference from control 1.0 mM 
[Ca2+]; Conc,  concanamycin (100nM); pHi, intracellular pH; Control, wild-type littermate mice; 
TRPV5-/-, TRPV5 knockout mice; Atp6v1b1-/-, Atp6v1b1 knockout mice; Neo, neomycin.
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Additional gene ablation of Atp6v1b1 in TRPV5-/- mice normalized urinary pH and caused 
tubular precipitation of Ca2+-phosphate in the medullary CD. These observations 
unequivocally revealed that increased H+-ATPase-mediated urinary acidification in TRPV5-/- 
mice prohibits renal Ca2+-phosphate stone formation. As the formation of alkaline urine 
adds to the risk for urinary Ca2+-phosphate precipitation (38, 39), renal stones occur in 
distal renal tubular acidosis (dRTA) patients, who display a urinary acidification defect and 
hypercalciuria (15). In accordance with our findings, previous studies demonstrated that 
extracellular Ca2+ levels modulate gastric acid secretion, generally controlled by 
H+-K+-ATPase (11, 31, 40-42). CaSR activation enhanced H+-K+-ATPase activity in isolated 
parietal cells of gastric glands, allowing maximal ionization of dietary Ca2+ and establishing 
enhanced Ca2+ absorption from the intestine (31, 40-42). Together with our data, this 
strongly underlines a key role of the CaSR in linking Ca2+ metabolism and acid secretion.
Polyuria can diminish the risk for renal stone formation by reducing the urinary Ca2+ 
concentration. In mice, calciuresis linearly correlated with diuresis since an increase of Ca2+ 
excretion leads to an enhanced urinary volume. The consistent polyuria in hypercalciuric 
TRPV5-/- mice, assessed by a substantial decrease in urinary osmolarity, was caused by 
downregulation of renal AQP2 water channels. Specifically, immunoblot analysis revealed 
a significant downregulation of AQP2 protein expression levels in isolated renal medullary 
membrane fractions from TRPV5-/- compared to control mice. Importantly, this is in line 
with previous studies performed in rats, which suggest that activation of the apical CaSR 
reduces the CD water permeability when the luminal Ca2+ level rises (21, 23, 43). Recently, 
Bustamante and coworkers showed an attenuated AQP2 expression in a mouse CD cell line 
after exposure to extracellular Ca2+, neomycin, or Gd3+ (44). Thus, hypercalciuria activates 
the apical CaSR in the CD and reduces AQP2-mediated water reabsorption, permitting the 
disposal of excess urinary Ca2+, and preventing the formation of stones.
The B1-subunit of the renal H+-ATPase proton pump, encoded by the Atp6v1b1 gene, is 
important for urinary acidification in the renal CD (25, 45). Atp6v1b1-/- mice displayed a 
higher urinary pH compared to control mice (25). Consequently, gene ablation of the 
Atp6v1b1 gene in TRPV5-/- mice normalized urinary pH. Interestingly, TRPV5-/-/Atp6v1b1-/- 
mice evoked a more severe polyuria than displayed by the TRPV5-/- mice. To explain the 
increased diuresis in TRPV5-/-/Atp6v1b1-/- mice the CaSR response as a function of the 
extracellular pH was investigated by intracellular Ca2+ measurements in HEK293 cells 
transiently expressing the CaSR. At pH 7.4, the dose-response curve was shifted to the left, 
consistently present in the renal DCT, CNT, and CD (8). This could activate the apical CaSR, 
increasing H+-ATPase activity, thereby initiating the observed acidic urinary pH. Importantly, 
genetic ablation of TRPV5 increased NAE, which is attributed to a significant rise in urinary 
TA due to hyperphosphaturia. In this perspective the hyperphosphaturia observed in 
TRPV5-/- mice could potentially present an acid load to the animals, initially caused by an 
increase in NaPi-IIb-mediated phosphate absorption. However, previous investigations 
showed that phosphate administration in healthy volunteers evokes metabolic alkalosis 
with a concomitant increase of urinary pH and remarkably only transient increases of TA 
and NAE (36). Although a higher dietary acid load cannot be completely ruled out, it did 
not cause a significant change in the acid-base homeostasis of the TRPV5-/- mice. A mild 
metabolic acidosis would also have increased urinary ammonium excretion, which was not 
observed. Therefore, the decline of the urinary pH in TRPV5-/- mice represents a significant 
renal acid loss in the presence of hyperphosphaturia. Previously, Nijenhuis et al. showed 
that TRPV5-/- mice display normal blood pH and HCO3- levels under basal conditions. These 
mice become even more alkalotic than wild-types when given a NaHCO3 diet via the 
drinking water (37) indicating that TRPV5-/- mice have no metabolic acidosis. Together with 
these observations, our data demonstrate that TRPV5-/- mice have increased urinary 
acidification without an altered systemic acid-base status.
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Figure 6  pH dependence of CaSR activation   
Dose-dependent CaSR activation was monitored by intracellular Ca2+ measurements in HEK293 
cells transiently transfected with the CaSR. Cells were exposed to Ca2+-free HEPES-Tris buffer of 
acidic pH 5.5 (dashed line) or neutral pH 7.4 (solid line) and subsequently perfused with the same 
medium containing different extracellular Ca2+ concentrations ranging from 0-10 mM. Data 
points are depicted as means ± SEM, representing 3 independent experiments.
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NKCC2 knockout mice, a mouse model of Bartter’s syndrome that displayed polyuria and 
concomitant hydronephrosis as well (52). The less robust hypercalciuria observed in the 
TRPV5-/-/Atp6v1b1-/- mice in comparison with the single TRPV5-/- mice could be due to the 
severe increase in diuresis resulting in a slight dehydration in these mice. This could evoke 
increased proximal tubular Ca2+ reabsorption as a compensatory mechanism, decreasing 
Ca2+ wasting via the urine. 
In conclusion, the increased urinary acidification and polyuria in response to hypercalciuria 
are prerequisites to prevent the formation of renal Ca2+-phosphate stones in TRPV5-/- mice. 
Interestingly, these adaptations involve luminal CaSR activation by increased urinary Ca2+ 
levels, inducing enhanced H+-ATPase activity and AQP2 downregulation. Renal 
Ca2+-phosphate stone formers could benefit from the induction of a decrease in urinary 
pH as well as polyuria that is accomplished by increased water intake. Knowledge of the 
occurring adaptive mechanisms that are crucial in the prevention of kidney stones is of 
great importance in the implementation and the development of therapeutic strategies in 
renal stone disease. 
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indicating an increased sensitivity of the CaSR to Ca2+ at neutral pH levels, compared to an 
acidic pH. This is in line with previous studies showing the functional modulation of the 
CaSR by extracellular pH (46, 47). The increased diuresis in TRPV5-/-/Atp6v1b1-/- mice 
compared to TRPV5-/- mice was explained by a further AQP2 downregulation, demonstrated 
by immunoblotting. We postulate that the extended decrease of AQP2 expression in the 
TRPV5-/-/Atp6v1b1-/- mice is evoked by the higher sensitivity for Ca2+ of the CaSR at a 
neutral urinary pH. Based on our experimental data, we conclude that in the absence of 
increased urinary acidification in TRPV5-/- mice, a more severe reduction in water 
reabsorption is induced in an attempt to prevent renal stone formation. Despite the severe 
polyuria, TRPV5-/-/Atp6v1b1-/- mice developed renal Ca2+-phosphate precipitations 
obstructing the CD system at an early age. Thus, these results underline the crucial 
importance of increased urinary acidification in the local prevention of renal Ca2+-phosphate 
stones.
TRPV5-/- mice also displayed, besides the hypercalciuria, a profound hyperphosphaturia, 
increasing the risk of Ca2+-phosphate precipitation. To maintain normocalcemia, TRPV5-/- 
mice presented hypervitaminosis D, since the increased circulating 1,25(OH)2D3 levels 
upregulate the intestinal Ca2+ transporters resulting in Ca2+ hyperabsorption (8, 27). 
Moreover, 1,25(OH)2D3 is an important key player in phosphate homeostasis (30, 48, 49) 
increasing the abundance of intestinal NaPi-IIb transporters (50). TRPV5-/- mice displayed a 
significant upregulation of NaPi-IIb proteins in the ileum, which might evoke phosphate 
hyperabsorption. Here, we postulate that downregulation of renal NaPi-IIa results in 
hyperphosphaturia in TRPV5-/- mice as a compensatory response to the increased 
phosphate absorption. Whether the NaPi-IIa downregulation could also be an effect of the 
hypervitaminosis D needs further investigations.
TRPV5-/-/Atp6v1b1-/- mice exhibited growth retardation and died before 6 wks of age. 
The lethal phenotype is likely to be affected by the hydronephrosis, which could be 
explained by the premature formation of renal stones that physically obstruct the urine 
flow. This resembles the occurrence of hydronephrosis in congenital nephropathy that is 
often caused by a functional obstruction in the renal pelvis (51). Another explanation could 
be that the hydronephrosis arises in response to the pressure produced by the severe 
polyuria, dilating the CD, and leading to kidney damage. This might also clarify the 
individual differences in severity of the hydronephrosis, polyuria, and early age of death 
observed in TRPV5-/-/Atp6v1b1-/- mice. A similar observation was previously done in the 
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Acid-base status determines 
the renal expression of Ca2+ and Mg2+ 
transport proteins
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Abstract
Chronic metabolic acidosis results in renal Ca2+ and Mg2+ wasting, whereas chronic 
metabolic alkalosis is known to exert the reverse effects. We hypothesized that these 
adaptations are mediated at least in part by the renal Ca2+ and Mg2+ transport proteins. 
The aim of this study was, therefore, to determine the effect of systemic acid-base status 
on renal expression of the epithelial Ca2+ channel TRPV5, the Ca2+-binding protein 
calbindin-D28K and the epithelial Mg2+ channel TRPM6 in relation to Ca2+ and Mg2+ 
excretion. Chronic metabolic acidosis induced by NH4Cl loading or administration of the 
carbonic anhydrase inhibitor acetazolamide for 6 days enhanced calciuresis accompanied 
by decreased renal TRPV5 and calbindin-D28K mRNA and protein abundance in wild-type 
mice. In contrast, metabolic acidosis did not affect Ca2+ excretion in TRPV5 knockout 
(TRPV5-/-) mice, in which active Ca2+ reabsorption is effectively abolished. This demonstrates 
that down-regulation of renal Ca2+ transport proteins is responsible for the hypercalciuria. 
Conversely, chronic metabolic alkalosis induced by NaHCO3 administration for 6 days 
increased the expression of Ca2+ transport proteins accompanied by diminished urine Ca2+ 
excretion in wild-type mice. However, this Ca2+-sparing action persisted in TRPV5-/- mice, 
suggesting that additional mechanisms apart from up-regulation of active Ca2+ transport 
contribute to the hypocalciuria. Furthermore, chronic metabolic acidosis decreased renal 
TRPM6 expression, increased Mg2+ excretion and decreased serum Mg2+ concentration, 
whereas chronic metabolic alkalosis resulted in the exact opposite effects. In conclusion, 
these data suggest that regulation of Ca2+ and Mg2+ transport proteins contributes 
importantly to the effects of acid-base status on renal divalent handling. 
Introduction
Acid-base homeostasis is known to affect renal handling of the divalents Ca2+ and Mg2+ 
(1-3). Chronic metabolic acidosis, which can occur as a result of clinical disorders such as 
renal failure, distal renal tubular acidosis or chronic diarrhea, is associated with increased 
renal Ca2+ and Mg2+ excretion. Long-standing metabolic acidosis can lead to Ca2+ loss 
from bone and ultimately results in metabolic bone disease, including osteomalacia and 
osteoporosis (4). Conversely, chronic metabolic alkalosis in e.g. the milk-alkali syndrome, 
volume contraction or treatment of nephrolithiasis by bicarbonate supplementation is 
known to decrease urine Ca2+ and Mg2+ excretion (1, 3). However, the molecular 
mechanisms explaining the altered renal divalent excretion during these disturbances of 
acid-base balance remain unknown.
The major part of Ca2+ and Mg2+ reabsorption takes place in the proximal tubule and thick 
ascending limb of the loop of Henle (TAL) through a passive paracellular pathway (1, 3). 
Fine-tuning of divalent excretion by the kidney occurs in the distal convoluted (DCT) and 
connecting tubule (CNT). In the latter segments, active transcellular Ca2+ and Mg2+ 
reabsorption determines the final amount excreted into the urine. Active Ca2+ reabsorption 
consists of Ca2+ entry through the apically localized epithelial Ca2+ channel TRPV5, 
cytosolic transport bound to the calcium-binding and buffering protein calbindin-D28K 
and basolateral extrusion by the Na+/Ca2+ exchanger (NCX1) and a plasma membrane Ca2+ 
ATPase (PMCA1b) (1, 5, 6). Studying the regulation of active Mg2+ reabsorption in DCT has 
been seriously hampered by the lack of identification of the proteins involved (3). TRPM6 
was recently identified as a Mg2+ permeable channel predominantly expressed along the 
apical membrane of DCT (7). Mutations in TRPM6 cause autosomal recessive 
hypomagnesemia, characterized by inappropriately high fractional Mg2+ excretion rates 
and disturbed intestinal Mg2+ absorption (8, 9). This clearly suggests that TRPM6 constitutes 
the apical entry step in active Mg2+ (re)absorption and thus provides an important new 
tool to study this process at the molecular level (7).
Earlier studies including micropuncture experiments suggested that systemic acid-base 
disturbances specifically influence Ca2+ and Mg2+ reabsorption in DCT/CNT (2, 10). 
Hypothetically, regulation of Ca2+ and Mg2+ transport proteins in these nephron segments 
could be involved in the altered renal divalent excretion secondary to changes in acid-base 
status, as was shown for other renal transporters and channels (11-14). We previously 
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acetazolamide (20 mg/kg/day) during 6 days by osmotic minipumps was applied to induce 
metabolic acidosis. This enabled evaluation of the role of urine pH in metabolic acidosis-
induced changes in Ca2+ excretion as well as the role of TRPM6 in the unexplained 
Mg2+-sparing action of acetazolamide.
Metabolic alkalosis: Metabolic alkalosis was induced by oral administration of 0.2 M and 0.1 
M NaHCO3 to TRPV5+/+ and TRPV5-/- mice, respectively. NaHCO3 loading was previously 
shown to induce metabolic alkalosis in rodents (12, 13). Mice receiving 0.2 M or 0.1 M NaCl 
constituted the control group, thereby correcting for possible effects due to the increased 
Na+ load. The latter is particularly important because passive Ca2+ reabsorption is 
functionally coupled to Na+ reabsorption. Mice were treated for 6 days, after which the 
animals were housed in metabolic cages enabling collection of 24 h urine samples under 
mineral oil, preventing evaporation. At the end of the experiment the animals were 
sacrificed, blood samples were taken and kidneys were sampled. The animal ethics board 
of the Radboud University Nijmegen approved all animal studies.
Analytical procedures
Serum and urine Ca2+ and Mg2+ concentrations were determined using colorimetric assays 
as described previously (16, 25). Na+, K+ and Li+ concentrations were measured flame-
spectrophotometrically (Eppendorf FCM 6343, Hamburg, Germany). Urine pH was 
determined using an electronic ion analyzer (Hanna Instruments, Szeged, Hungary) and 
osmolarity was measured with an Osmette A automatic osmometer (Precision Instruments, 
Sudbury, MA).
Real-time quantitative PCR
Total RNA was extracted from kidney using TriZol Total RNA Isolation Reagent (Gibco BRL, 
Breda, the Netherlands). The obtained RNA was subjected to DNAse treatment and reverse 
transcribed using Molony-Murine Leukemia Virus-Reverse Transcriptase (Gibco BRL) as 
described previously (26, 27). Subsequently, the acquired cDNA was used to determine 
TRPV5, calbindin-D28K and TRPM6 mRNA levels in kidney by real-time quantitative PCR on 
an ABI Prism 7700 Sequence Detection System (PE Biosystems, Rotkreuz, Switzerland) as 
described previously (15, 26). In addition, mRNA expression of the housekeeping gene 
hypoxanthine-guanine phosphoribosyl transferase (HPRT) was determined as an 
endogenous control, which enabled calculation of specific mRNA expression levels as a 
ratio of HPRT.
demonstrated that tacrolimus (FK506)-induced Ca2+ and Mg2+ wasting as well as thiazide-
induced hypomagnesemia are associated with decreased renal expression of Ca2+ and/or 
Mg2+ transporters (15, 16). Recently, TRPV5 knockout (TRPV5-/-) mice were generated in our 
laboratory, which display a robust renal Ca2+ leak localized to DCT/CNT illustrating that 
active Ca2+ reabsorption is effectively abolished (17). These mice constitute a unique 
mouse model to determine the role of TRPV5 and active Ca2+ reabsorption in acid-base 
induced alterations of calciuresis.
The aim of the present study was, therefore, to determine the effect of chronic metabolic 
acidosis and alkalosis on the expression of Ca2+ and Mg2+ transporters in the kidney and to 
evaluate their contribution to the altered Ca2+ and Mg2+ excretion. We induced metabolic 
alkalosis by oral NaHCO3 loading and metabolic acidosis by NH4Cl loading as well as 
acetazolamide administration in wild-type and TRPV5-/- mice. Acetazolamide specifically 
inhibits proximal tubular HCO3 reabsorption resulting in metabolic acidosis with, in 
contrast to NH4Cl loading, an alkaline urine pH (18-20). This enabled evaluation of the role 
of luminal pH. Furthermore, while acidosis generally increases urine Mg2+ excretion, 
acetazolamide is known for its unexplained Mg2+-sparing action (21-23).
Materials and Methods
Metabolic acidosis and alkalosis in wild-type and TRPV5-/- mice
Metabolic acidosis: TRPV5-/- mice were recently generated by targeted ablation of the 
TRPV5 gene and genotyped as described previously (17). Ten-wks old wild-type (TRPV5+/+) 
mice and TRPV5-/- littermates were kept in a light and temperature-controlled room with 
ad libitum access to deionized drinking water. Animals were ration-fed standard pelleted 
chow (0.25 % (wt/wt) NaCl; 1.1 % (wt/wt) Ca; 0.2 % (wt/wt) Mg) during the metabolic 
balance studies. To evaluate the effects of metabolic acidosis, mice were randomly 
assigned to a group receiving either 0.28 M (TRPV5+/+) or 0.14 M (TRPV5-/-) NH4Cl via the 
drinking water during 6 days or a control group receiving normal deionized drinking water. 
NH4Cl loading is a generally accepted and validated method to induce metabolic acidosis 
in rodents (11-13, 24). Because the oral fluid intake of TRPV5-/- mice is ~2-fold higher than in 
wild-type mice, the lower NH4Cl concentration in their drinking water ensured a similar 
oral acid load compared to wild-type mice to prevent acid overloading in these TRPV5-/- 
mice. Alternatively, subcutaneous administration of the carbonic anhydrase inhibitor 
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compared to day 6 of treatment (data not shown). Furthermore, blood gas determination 
substantiated the effectiveness of the oral NaHCO3 loading protocol in wild-type and 
TRPV5-/- mice. Serum pH was similar in both genotypes during NaHCO3 loading, while 
serum HCO3- levels in TRPV5-/- mice were significantly higher. This reflects higher pCO2 in 
the latter situation, most probably due to differences in time or depth of anesthesia. 
The absence of this difference in pCO2 between wild-type and TRPV5-/- mice in the other 
treatment groups suggests that there is no intrinsic increased susceptibility to retain CO2 
in TRPV5-/- mice. Interestingly, urine pH was consistently 0.5-1 pH units lower in TRPV5-/- 
mice as compared to the corresponding wild-type mice but, importantly, TRPV5-/- mice did 
not display metabolic acidosis at baseline. Diuresis and Na+ excretion were not affected by 
NH4Cl or NaHCO3 loading, while acetazolamide significantly increased urine volume and 
natriuresis in wild-type and TRPV5-/- mice (table 2).
Ca2+ homeostasis during chronic metabolic acidosis and alkalosis
Genetic ablation of TRPV5 resulted in a strikingly increased calciuresis compared to wild-type 
littermates (figure 1A). NH4Cl loading significantly enhanced urine Ca2+ excretion in wild-type 
mice, whereas Ca2+ excretion was not affected in TRPV5-/- mice. Likewise, acetazolamide 
treatment significantly enhanced calciuresis in wild-type mice, while this effect was not 
Immunohistochemistry 
Staining of kidney sections for TRPV5, calbindin-D28K and TRPM6 was performed on 
cryosections of periodate-lysine-paraformaldehyde fixed kidney samples as described 
previously (7, 28). For semi-quantitative determination of protein abundance, images were 
made using a Zeiss fluorescence microscope equipped with a digital camera (Nikon 
DXM1200), which were analyzed with the Image Pro Plus 4.1 image analysis software 
(Media Cybernetics, Silver Spring, MD). The entire cortex in two separate kidney sections of 
each animal were included in the analysis, resulting in quantification of protein levels as the 
mean of integrated optical density (IOD).
Immunoblotting
Calbindin-D28K protein levels were semi-quantified by immunoblotting as described 
previously (27). In short, kidney cortex sections were homogenized and samples were 
normalized according to protein concentration. Subsequently, protein samples were 
separated on 16.5% (wt/v) SDS-PAGE gels and blotted to polyvinylidine difluoride (PVDF)-
nitrocellulose membranes (Immunobilon-P; Millipore Corp., Bedford, MA) and protein was 
detected using a rabbit calbindin-D28K antibody. 
Statistical analysis
Data are expressed as means ± SEM. Statistical comparisons were analyzed by one-way analysis 
of variance (ANOVA) and Fisher’s multiple comparison. P values less than 0.05 were considered 
statistically significant. All analyses were performed using the StatView Statistical Package 
software (Power PC version 4.51, Berkely, California, USA) on an Apple iMac computer.
Results
Metabolic acidosis and alkalosis in wild-type and TRPV5-/- mice
Oral NH4Cl loading induced a similar metabolic acidosis in wild-type and TRPV5-/- mice, as 
demonstrated by the significantly reduced blood pH and HCO3- concentration (table 1). 
Accordingly, NH4Cl reduced urine pH in wild-type and TRPV5-/- mice compared to their 
respective controls (table 2). Likewise, chronic acetazolamide treatment significantly 
increased urine pH, and decreased blood pH and HCO3- concentration in wild-type mice, 
but not in TRPV5-/- mice. Of note, acetazolamide-induced acidosis and urinary alkalinization 
is often self-limiting. Indeed, urine pH was more alkaline in all animals after 3 days 
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Table 1  Acid-base status during different treatment protocols in TRPV5+/+ and 
TRPV5-/- mice 
  TRPV5+/+ TRPV5-/-
  pH [HCO3-] (mM) pH [HCO3-] (mM)
Controls 7.27 ± 0.01 22.3 ± 0.7 7.26 ± 0.03 21.0 ± 0.5
NH4Cl 7.11 ± 0.05* 17.2 ± 1.3* 7.16 ± 0.01* 18.3 ± 0.7*
ACTZ 7.22 ± 0.02* 19.0 ± 0.9* 7.22 ± 0.01 23.1 ± 0.9
    
NaCl 7.27 ± 0.02 22.6 ± 0.8 7.25 ± 0.02 21.7 ± 0.5
NaHCO3 7.35 ± 0.01*# 25.8 ± 1.0*# 7.35 ± 0.01*# 36.3 ± 3.8*#
Controls, animals receiving deionized drinking water only; NH4Cl, animals receiving 0.28 M (TRPV5+/+) or 
0.14 M (TRPV5-/-) NH4Cl via the drinking water; ACTZ, animals receiving acetazolamide (20 mg/kg/day)  
subcutaneously by osmotic minipump; NaCl, animals receiving 0.2 M (TRPV5+/+) or 0.1 M (TRPV5-/-) NaCl via 
the drinking water; NaHCO3, animals receiving 0.2 M (TRPV5+/+) or 0.1 M (TRPV5-/-) NaHCO3 via the drinking 
water. Data are presented as means ± SEM. * P < 0.05 versus respective TRPV5+/+ or TRPV5-/- controls; #  
P < 0.05 versus respective TRPV5+/+ or TRPV5-/- NaCl-treated mice. 
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Figure 1  Urinary Ca2+ excretion and serum Ca2+ concentration during  metabolic 
acidosis and alkalosis in wild-type (TRPV5+/+) and TRPV5 knockout 
(TRPV5-/-) mice   
The effects of chronic metabolic acidosis and acetazolamide (A) as well as during metabolic 
alkalosis (B) on renal Ca2+ excretion and serum Ca2+ concentration (C and D) were determined 
in metabolic cage experiments (n=9 animals; n=3 animals per cage). Controls, animals that 
received deionized drinking water only; NH4Cl, animals that received 0.28 M (TRPV5+/+) or 0.14 M 
(TRPV5-/-) NH4Cl via the drinking water; Acetazolamide, animals that received acetazolamide (20 
mg/kg/day) subcutaneously by osmotic minipump; NaCl, animals that received 0.2 M (TRPV5+/+) 
or 0.1 M (TRPV5-/-) NaCl via the drinking water; NaHCO3, animals that received 0.2 M (TRPV5+/+) or 
0.1 M (TRPV5-/-) NaHCO3 via the drinking water. Data are presented as means ± SEM. * P < 0.05 
versus respective TRPV5+/+ or TRPV5-/- control group (controls or NaCl-treated animals).
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homeostasis in wild-type mice. Oral NH4Cl loading significantly enhanced Mg2+ excretion 
(figure 2A), which was accompanied by decreased serum Mg2+ levels (figure 2C). 
In contrast, acetazolamide displayed a Mg2+-sparing effect accompanied by a significantly 
increased serum Mg2+ concentration. Likewise, metabolic alkalosis induced by NaHCO3 
treatment significantly reduced urine Mg2+ excretion (figure 2B) and increased the serum 
Mg2+ level (figure 2D).
Renal mRNA and protein expression of Ca2+ transporters
To study the effect of systemic acid-base status on renal Ca2+ transporter expression, 
TRPV5 and calbindin-D28K mRNA levels were determined by real-time quantitative PCR 
analysis and protein abundance was analyzed by immunohistochemistry and 
immunoblotting. NH4Cl loading significantly reduced both TRPV5 and calbindin-D28K 
mRNA levels in kidney cortex of wild-type mice (figure 3A and C). Calbindin-D28K mRNA 
levels were significantly decreased in TRPV5-/- compared to TRPV5+/+ mice. In addition, 
NH4Cl treatment further reduced calbindin-D28K mRNA levels compared to control TRPV5-/- 
mice. Figure 4A shows representative immunohistochemical images of kidney cortex 
probed with anti-TRPV5 and anti-calbindin-D28K antibodies. In addition, calbindin-D28K 
protein abundance was determined by immunoblotting (figure 4B). In line with the mRNA 
levels, semi-quantification of the immunohistochemical analysis showed that NH4Cl 
decreases TRPV5 and calbindin-D28K protein abundance (figures 5A and 5C). These results 
were confirmed by immunoblotting (100 ± 4 versus 63 ± 9% in wild-type and 100 ± 5 versus 
75 ± 8% in TRPV5-/- mice, respectively). Acetazolamide treatment decreased TRPV5 mRNA 
and protein expression in wild-type mice (figures 3A and 5A). Furthermore, calbindin-
D28K protein abundance was reduced in acetazolamide-treated mice (figure 5C), as 
confirmed by immunoblotting (100 ± 1 versus 63 ± 6 and 40 ± 8% in wild-type and TRPV5-/- 
mice, respectively). In contrast to metabolic acidosis, chronic metabolic alkalosis induced 
by NaHCO3 loading increased TRPV5 mRNA and protein expression in wild-type mice 
(figures 3B and 5B). Likewise, calbindin-D28K expression was increased as determined by 
real-time PCR and immunohistochemistry (figures 3D and 5D), as well as by immunoblotting 
(100 ± 41 versus 293 ± 40%). Conversely, calbindin-D28K mRNA and protein levels were not 
significantly increased in NaHCO3-treated TRPV5-/- mice.
Effect of acid-base status on renal TRPM6 expression 
Renal TRPM6 mRNA and protein expression levels were determined by real-time quantitative 
PCR analysis (figure 6) and semi-quantitative immunohistochemistry (figure 7A). Both NH4Cl 
present in TRPV5-/- mice. Serum Ca2+ levels remained unaltered during NH4Cl loading and 
acetazolamide treatment (figure 1C). In contrast to metabolic acidosis, NaHCO3 administration 
significantly reduced urine Ca2+ excretion in wild-type as well as in TRPV5-/- mice (figure 1B). 
Serum Ca2+ levels and urine volume did not differ between the alkalosis and control group 
(figure 1D, table 1). Because Li+ and Na+ are transported in parallel by the proximal tubule, 
endogenous Li+ clearance was used as an inverse measure of proximal tubular Na+ reabsorption, 
to which in turn passive Ca2+ reabsorption is functionally coupled (16). Li+ clearance was 
significantly increased by acetazolamide treatment and NaCl loading in wild-type and TRPV5-/- 
mice, suggesting decreased proximal tubular Na+ reabsorption (table 1). Conversely, NaHCO3 
loading decreased Li+ clearance compared to NaCl-treated controls.
Mg2+ homeostasis during chronic metabolic acidosis and alkalosis
In addition, we evaluated the effect of the different treatment protocols on renal Mg2+ 
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Figure 2  Urinary Mg2+ excretion and serum Mg2+ concentration during meta-
bolic acidosis and alkalosis in wild-type mice    
The effects of chronic metabolic acidosis and acetazolamide (A) as well as during metabolic 
alkalosis (B) on renal Mg2+ excretion and serum Mg2+ concentration (C and D) were determined 
in metabolic cage experiments (n=9 animals; n=3 animals per cage). Controls, animals that 
received deionized drinking water only; NH4Cl, animals that received 0.28 M NH4Cl via the 
 drinking water; Acetazolamide, animals that received acetazolamide (20 mg/kg per d) sub-
cutaneously by osmotic minipump; NaCl, animals that received 0.2 M NaCl via the drinking water; 
NaHCO3, animals that received 0.2 M NaHCO3 via the drinking water. Data are presented as 
means ± SEM. * P < 0.05 versus respective control group (controls or NaCl-treated animals).
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loading and acetazolamide treatment significantly reduced renal TRPM6 mRNA as well as 
protein abundance in wild-type mice (figures 6A and 7B), whereas NaHCO3-treated mice 
displayed increased TRPM6 expression (figures 6B and 7C).
Discussion
The present study demonstrated that systemic acid-base status regulates the expression 
of proteins that are involved in active Ca2+ and Mg2+ reabsorption. Our data showed that 
down-regulation of renal Ca2+ transport proteins is responsible for the hypercalciuria 
during chronic metabolic acidosis. In contrast, the Ca2+-sparing effect of chronic metabolic 
alkalosis was associated with enhanced Ca2+ transporter abundance. However, the 
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Figure 3  Effect of chronic metabolic acidosis and alkalosis on renal mRNA 
expression of Ca2+ transport proteins in TRPV5+/+ and TRPV5-/- mice    
Renal mRNA expression levels of the epithelial Ca2+ channel TRPV5 and the cytosolic Ca2+-
binding protein calbindin-D28K (CaBP28K) were determined during chronic metabolic acidosis 
and acetazolamide treatment (A and C, respectively) and chronic metabolic alkalosis (B and D, 
respectively) by real-time quantitative PCR analysis as the ratio of hypoxanthine-guanine 
 phosphoribosyl transferase (HPRT) and depicted as percentage of respective controls. Controls, 
animals that received deionized drinking water only; NH4Cl, animals that received 0.28 M 
(TRPV5+/+) or 0.14 M (TRPV5-/-) NH4Cl via the drinking water; Acetazolamide, animals that received 
acetazolamide (20 mg/kg per d) subcutaneously by osmotic minipump; NaCl, animals that 
received 0.2 (TRPV5+/+) or 0.1 M (TRPV5-/-) NaCl via the drinking water; NaHCO3, animals that 
received 0.2 M (TRPV5+/+) or 0.1 M (TRPV5-/-) NaHCO3 via the drinking water; n=9 animals per 
group. Data are presented as means ± SEM. * P < 0.05 versus respective TRPV5+/+ or TRPV5-/-  
control group (controls or NaCl-treated animals); # P < 0.05 versus TRPV5+/+ controls.
Figure 4  Immunohistochemical staining and semiquantitative  immunoblotting 
of renal Ca2+ transport proteins in TRPV5+/+ mice    
(A) Representative immunohistochemical images of TRPV5 and CaBP28K staining in kidney cortex 
of wild-type mice. (B) Representative immunoblots for calbindin-D28K. Control, animals that 
received deionized drinking water only; NH4Cl, animals that received 0.28 M NH4Cl via the 
 drinking water; ACTZ, animals that received acetazolamide (20 mg/kg/day) subcutaneously by 
osmotic minipump; NaCl, animals that received 0.2 M NaCl via the drinking water; NaHCO3, 
 animals that received 0.2 M NaHCO3 via the drinking water.
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Ca2+-sparing action persisted in TRPV5-/- mice, suggesting that additional mechanisms 
apart from up-regulation of active Ca2+ transport contribute to the hypocalciuria. 
Furthermore, metabolic acidosis decreased renal TRPM6 abundance as well as Mg2+ 
reabsorption, whereas metabolic alkalosis had the opposite effect. These data indicate that 
regulation of TRPM6 explains the effects of acid-base status on renal Mg2+ handling.
Chronic metabolic acidosis that was induced by NH4Cl loading enhanced Ca2+ excretion and 
decreased the expression of the epithelial Ca2+ channel TRPV5 and the cytosolic Ca2+-binding 
and buffering protein calbindin-D28K in wild-type mice. Both proteins play a central role in 
active Ca2+ reabsorption in DCT/CNT (1). We showed that 0.14 M NH4Cl loading induced a 
similar metabolic acidosis in polydipsic TRPV5-/- mice compared with wild-type mice. 
Importantly, Ca2+ excretion was not altered during chronic metabolic acidosis in TRPV5-/- 
mice, in which active Ca2+ reabsorption is effectively abolished (17). These results indicated 
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Figure 5  Effect of chronic metabolic acoidosis and alkalosis on renal protein 
abundance of Ca2+ transport proteins in TRPV5+/+ and TRPV5-/- mice    
Renal protein expression levels of the epithelial Ca2+ channel TRPV5 and the cytosolic CaBP28K 
were determined during chronic metabolic acidosis and acetazolamide treatment (A and C, 
respectively) as well as chronic metabolic alkalosis (B and D, respectively) by computerized 
analysis of immunohistochemical images. Data were calculated as integrated optical density 
(IOD; arbitrary units) and depicted as percentage of respective controls. Controls, animals that 
received deionized drinking water only; NH4Cl, animals that received 0.28 M (TRPV5+/+) or 0.14 M 
(TRPV5-/-) NH4Cl via the drinking water; Acetazolamide, animals that received acetazolamide  
(20 mg/kg/day) subcutaneously by osmotic minipump; NaCl, animals that received 0.2 M 
(TRPV5+/+) or 0.1 M (TRPV5-/-) NaCl via the drinking water; NaHCO3, animals that received 0.2 M 
(TRPV5+/+) or 0.1 M (TRPV5-/-) NaHCO3 via the drinking water; n=9 animals per treatment group. 
Data are presented as means ± SEM. * P < 0.05 versus respective TRPV5+/+ or TRPV5-/- control 
group (controls or NaCl-treated animals); # P < 0.05 versus TRPV5+/+ controls.
Figure 6  Effect of chronic metabolic acidosis and alkalosis on renal mRNA 
expression of the epithelial Mg2+ channel TRPM6 in wild-type mice    
Renal mRNA expression levels of TRPM6 was determined during chronic metabolic acidosis and 
acetazolamide treatment (A) as well as chronic metabolic alkalosis (B) by real-time quantitative 
PCR analysis as the ratio of HPRT and depicted as percentage of respective controls. Controls, 
animals that received deionized drinking water only; NH4Cl, animals that received 0.28 M NH4Cl 
via the drinking water; Acetazolamide, animals that received acetazolamide (20 mg/kg/day) 
subcutaneously by osmotic minipump; NaCl, animals that received 0.2 M NaCl via the drinking 
water; NaHCO3, animals that received 0.2 M NaHCO3 via the drinking water; n=9 animals per 
treatment group. Data are presented as means ± SEM. * P < 0.05 versus respective control group 
(controls or NaCl-treated animals).
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Mice that receive NH4Cl develop chronic metabolic acidosis that is characterized by a slight 
decrease in blood pH, a reduced serum HCO3- concentration, and, importantly, a low urine 
pH as substantiated in this study (24). Vennekens et al. recently demonstrated that 
extracellular protons inhibit TRPV5 in vitro, by titrating glutamate 522 in the extracellular 
loop between the fifth putative transmembrane domain and the pore region as shown by 
Yeh et al. (31, 32). Therefore, it was suggested that acidification of the DCT/CNT luminal fluid 
during chronic metabolic acidosis explains the decreased Ca2+ reabsorption in vivo (31, 32). 
These data raised the question of whether the regulation of Ca2+ transport proteins is 
secondary to the acidosis per se, or due to the low urine pH. 
This urine acidification has been attributed mainly to parallel enhancement of apical Na+/H+ 
exchanger (NHE3) and basolateral Na+-HCO3- cotransporter activity in the proximal tubule (33-36). 
In contrast, acetazolamide treatment is known to induce metabolic acidosis by diminishing this 
proximal tubular HCO3- reabsorptive capacity (18-20). This would result in an increased luminal pH 
at more distal nephron segments, including TRPV5 and calbindin-D28K-expressing DCT/CNT. In our 
study, acetazolamide-treated mice indeed displayed urine alkalinization. Importantly, acetazolamide 
down-regulated the expression of Ca2+ transport proteins. Thus, luminal pH in DCT/CNT does not 
seem to be crucial in the long-term in vivo hypercalciuric effect of chronic metabolic acidosis. 
Therefore, our data provide a molecular explanation for the increased Ca2+ excretion in clinically 
relevant situations, including chronic renal failure, chronic diarrhea and renal tubular acidosis (RTA). 
In particular, acetazolamide treatment is a common cause of proximal renal tubular acidosis and is 
often associated with Ca2+ nephrolithiasis (37, 38). Taken together, we showed that systemic 
metabolic acidosis, as opposed to associated changes in urine pH, down-regulates Ca2+ transport 
proteins and, thereby, induces hypercalciuria.
Conversely, chronic metabolic alkalosis is known to decrease Ca2+ excretion (2). In this study, 
chronic NaHCO3 administration induced metabolic alkalosis in wild-type as well as TRPV5-/- 
mice. Chronic metabolic alkalosis had a Ca2+-sparing effect and increased renal expression of 
Ca2+ transport proteins in wild-type mice. This suggested that the increased expression of these 
transporters is responsible for the hypocalciuric effect. However, TRPV5 ablation resulting in the 
functional lack of active Ca2+ transport did not preclude this effect, suggesting that upregulation 
of Ca2+ transport proteins in DCT/CNT is not crucial for the induction of hypocalciuria. It is 
interesting that alkalosis did not enhance calbindin-D28K abundance in TRPV5-/- mice. This is in 
line with previous studies from our laboratory, which demonstrated that blockade of the TRPV5- 
mediated Ca2+ influx in rabbit CNT/CCD cells downregulates calbindin-D28K expression (39). 
that down-regulation of Ca2+ transport proteins that are present in DCT/CNT underlies the 
increased Ca2+ excretion during NH4Cl loading. Alternatively, increased Ca2+ mobilization 
from bone has been shown in chronic metabolic acidosis and was suggested to explain the 
Ca2+ wasting (4, 29). Our study provides evidence for a primary renal Ca2+ leak. In line with 
our data, previous micropuncture experiments suggested that tubular Ca2+ reabsorption in 
DCT/CNT is specifically diminished during chronic metabolic acidosis in dogs (2). In contrast, 
Rizzo et al. (30) previously reported that NH4Cl-induced acidosis in rats was accompanied by 
a moderate although significant increase of calbindin-D28K. The reason for the discrepancy 
with our study, which shows a consistent decrease of TRPV5 and calbindin-D28K mRNA as 
well as protein expression, is not known.
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Figure 7  Effects of chronic metabolic acidosis and alkalosis on renal protein 
abundance of the epithelial Mg2+ channel TRPM6 in wild-type mice    
Representative immunohistochemical imaging of TRPM6 staining in kidney cortex (A), which 
enabled semiquantitative determination of renal TRPM6 protein abundance during chronic 
metabolic acidosis and acetazolamide treatment (B) as well as chronic metabolic alkalosis  
(C) by computerized analysis. Data were calculated as IOD (arbitrary units) and depicted as  
percentage of respective controls. Controls, animals that received deionized drinking water only; 
NH4Cl, animals that received 0.28 M NH4Cl via the drinking water; ACTZ/Acetazolamide, animals 
that received acetazolamide (20 mg/kg per d) subcutaneously by osmotic minipump; NaCl, 
 animals that received 0.2 M NaCl via the drinking water; NaHCO3, animals that received 0.2 M 
NaHCO3 via the drinking water; n=9 animals per treatment group. Data are presented as means 
± SEM. * P < 0.05 versus respective control group (controls or NaCl-treated animals).
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It is interesting that we showed that acetazolamide displays a Mg2+-sparing effect in mice. 
This carbonic anhydrase inhibitor is also known to result in a hypomagnesuria in human via 
an unknown mechanism (21-23). Importantly, TRPM6 expression was significantly diminished 
during chronic acetazolamide treatment. This suggests that chronic metabolic acidosis, 
irrespective of cause or associated urine pH, down-regulates TRPM6 expression. At the 
same time, these data are against enhanced active Mg2+ reabsorption explaining the 
decreased Mg2+ excretion. In contrast to Ca2+, the bulk of filtered Mg2+ is reabsorbed in 
TAL, where the Na+-K+(NH4+)-2Cl- (NKCC2) cotransporter is responsible for maintaining the 
required electrochemical gradient (44). Acetazolamide treatment was associated with 
increased urine volume and Na+ excretion, which has been shown to result in extracellular 
volume contraction and enhanced NKCC2 activity (45, 46). Furthermore, metabolic acidosis, 
which developed in acetazolamide-treated wild-type mice, was previously shown to 
increase NKCC2 mRNA and protein abundance (14, 47). Thus, we postulate that these 
additive stimulatory effects enhance passive Mg2+ reabsorption in TAL. Alternatively, 
regulation of the tight junction protein paracellin-1, which is supposed to facilitate 
paracellular reabsorption of Mg2+ in TAL, might be involved (48, 49). Together, these 
mechanisms could counteract the metabolic acidosis-induced TRPM6 down-regulation 
and result in a net Mg2+-sparing effect. 
The mechanism translating the acid-base status to regulation of gene expression remains 
largely unknown. Our results show that transcriptional regulation occurs irrespective of 
urine pH. Because intracellular pH will ultimately reflect pH of the urine, apical or 
intracellular acid sensing does not seem to be involved. Therefore, direct sensing of 
acid-base status by pH-sensitive proteins at the basolateral membrane is likely. In DCT/CNT, 
the extracellular Ca2+/Mg2+-sensing receptor is expressed at the basolateral membrane 
(50, 51). It was recently shown that extracellular pH directly influences the sensitivity of this 
receptor to Ca2+ and Mg2+ (52, 53). Therefore, altered Ca2+/Mg2+ sensing might influence 
transcellular divalent transport in these nephron segments. Furthermore, other basolateral 
proton-sensing receptors or channels might act as an acid sensor regulating Ca2+ and 
Mg2+ transport protein expression (54, 55). Thus, whereas the presented data demonstrated 
the transcriptional and translational regulation of proteins that are involved in active Ca2+ 
and Mg2+ reabsorption, future studies will have to elucidate the exact mechanism by 
which acid-base status affects expression of these transporters. 
This indicated that regulation of the latter protein is highly dependent upon the presence 
of TRPV5. The bulk of filtered Ca2+ is reabsorbed by a passive paracellular mechanism 
primarily localized primarily in the proximal tubule and to a lesser extent in TAL (1). In these 
nephron segments, Ca2+ reabsorption is secondary to Na+ reabsorption and the resulting 
water reabsorption, which creates a favorable electrochemical gradient driving passive 
Ca2+ transport. Determination of Li+ clearance indeed suggested that NaHCO3-treated 
mice show increased proximal tubular Na+ reabsorption and, therefore, possibly display 
enhanced passive Ca2+ reabsorption compared to NaCl-treated controls. Thus, the 
hypocalciuria could alternatively be explained by increased passive Ca2+ reabsorption. 
Taken together, the present data offer insight into the previously unexplained mechanism 
by which administration of HCO3- prevents nephrolithiasis in patients with recurrent kidney 
stones (40, 41). Upregulation of Ca2+ transport proteins in DCT/CNT occurs but is not crucial 
for the Ca2+-sparing effect.
The epithelial Mg2+ channel TRPM6 is the first identified protein involved in active Mg2+ 
reabsorption (7-9). TRPM6 was localized along the apical membrane of DCT, and mutations 
in the gene encoding TRPM6 were shown to cause autosomal recessive hypomagnesemia, 
characterized by inappropriately high Mg2+ excretion and disturbed intestinal Mg2+ 
absorption. In our study, NH4Cl-induced chronic metabolic acidosis decreased renal TRPM6 
abundance accompanied by increased Mg2+ excretion and hypomagnesemia. Conversely, 
chronic metabolic alkalosis increased TRPM6 expression as well as renal Mg2+ reabsorption, 
resulting in hypermagnesemia. There is insufficient functional information available 
regarding the tubular segments involved in the altered Mg2+ reabsorption, but Wong et al. 
(10, 42) previously demonstrated altered Mg2+ reabsorption in the distal tubule during 
metabolic acidosis and alkalosis in the dog. Furthermore, a high extracellular pH was 
shown to enhance Mg2+ uptake in isolated mouse DCT cells, and conversely a low pH 
diminished this uptake (43). Thus, these data suggest that alterations of acid-base status 
regulate TRPM6 expression, thereby affecting renal active Mg2+ reabsorption in DCT 
leading to significant changes in serum Mg2+. We previously demonstrated that thiazide 
administration as well as treatment with the hypomagnesemic immunosuppressant 
tacrolimus (FK506) reduces renal TRPM6 abundance accompanied by increased urine Mg2+ 
loss (15, 16). Therefore, TRPM6 downregulation appears to be a general mechanism 
explaining the renal Mg2+ leak and resulting hypomagnesemia in these important clinical 
situations.
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Abstract
Kidney stone formation is a major socio-economic problem in humans, involving pain, 
recurrent treatment, and renal insufficiency. As most renal precipitates contain calcium as 
a major component, hypercalciuria is the main risk factor for renal stone formation. 
Different forms of hypercalciuria can be classified, which primary arise from defects at the 
main organs involved in calcium homeostasis. A distinction can be made between renal, 
absorptive, and resorptive hypercalciuria, originating from disturbed calcium handling in 
kidney, intestine, and bone, respectively. A positive family history predisposes individuals 
to an increased risk of stone formation, which strongly indicates the involvement of 
genetic susceptibility factors. TRPV5 is the renal epithelial calcium channel that is the 
gatekeeper protein in active calcium reabsorption in the kidney. TRPV5 gene ablation in 
mice leads to severe hypercalciuria, implying that TRPV5 is an interesting candidate gene 
for renal hypercalciuria in humans. This study aims to identify and functionally characterize 
TRPV5 gene aberrations in patients with renal hypercalciuria. The TRPV5 coding region and 
intron-exon boundaries were screened for gene mutations in 20 subjects displaying renal 
hypercalciuria after which identified non-synonymous polymorphisms were functionally 
characterized by patch-clamp analysis. Wild-type and TRPV5 channels including 
polymorphisms were transiently expressed in Human Embryonic Kidney (HEK) 293 cells 
and functionally characterized by path clamp analysis. Genotyping TRPV5 in renal 
hypercalciuria patients revealed 3 non-synonymous  and 5 synonymous polymorphisms. 
Electrophysiological characterization of the TRPV5 mutants did not reveal significant 
functional changes compared to wild-type TRPV5 channel recordings. In this specific 
patient cohort, our data do not support a primary role for TRPV5 in the pathogenesis of 
renal hypercalciuria. However, TRPV5 cannot be excluded as a candidate gene in 
hypercalciuria.
Introduction
Hypercalciuria is the main risk factor in renal calcium stone formation and constitutes 
universally an immense health and socio-economic problem (1, 2). In the United States 
approximately 5% of women and 12% of males develop a clinical episode of kidney stone 
disease in life (3), accompanied by severe pain and recurrent treatment. Approximately 80% 
of the renal stones contain calcium (4). Besides hypercalciuria, other risk factors are low 
urinary volume, dietary components, gender, and previous development of calcium stones 
(5, 6). Moreover, individuals with a positive family history of nephrolithiasis have an 
enhanced risk of experiencing kidney stones in life compared to those without a positive 
history (7). This strongly implies for genetic factors being involved in the pathogenesis of 
hypercalciuria-related renal stone formation.
The identification of a causal factor and the establishment of a categorization system for 
hypercalciuria remain difficult. Currently a tripartite classification is being used, 
distinguishing renal, absorptive, and resorptive hypercalciuria, of which the first two forms 
are the most common ones (8). In the body, the concerted action of kidney, intestine, and 
bone maintain a normal calcium balance. These organs constitute the sites where the 
above-mentioned forms of hypercalciuria primary originate. As many transport proteins 
and hormones are involved in the maintenance of the calcium balance, defects in calcium 
homeostasis may have many causal factors. Therefore, hypercalciuria is a complex trait that 
can be polygenic and multifactorial in its etiology. In the past, several candidate genes 
were identified and associated with hypercalciuria (9, 10). Others were unsuccessful in 
identifying loci or genetic variants linked to hypercalciuria, probably due to its 
heterogeneousity (9, 11-13). Thus, the nature of the genetic defects involved in most cases 
of familiar hypercalciuria remains fairly unknown.
Transient receptor potential vanilloid member 5 (TRPV5) constitutes the rate-limiting 
calcium entry pathway in renal transcellular calcium transport. The gene encoding the 
human TRPV5 channel is mapped to chromosome 7q35 and consists of 15 exons (14). TRPV5 
encodes a protein of 729 amino acids (14, 15). Interestingly, TRPV5 gene ablation in mice 
evokes a robust renal calcium leak, resulting in severe hypercalciuria. Besides hypercalciuria, 
the TRPV5 knockout mice demonstrate bone degradation, decreased bone mineral 
density, hypervitaminosis D, calcium hyperabsorption, normocalcemia, polyuria, and 
increased urinary acidification (16, 17). Regarding the crucial importance of TRPV5 in body 
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Serum and urine biochemistry
Total urinary and plasma calcium concentrations were measured by atomic absorption 
spectrometry (Perkin Elmer 3300, Norwalk, CT, USA). Serum ionized calcium levels were 
determined by an ICA2 electrode (Copenhagen, Denmark). Sodium levels were assessed by 
flame spectrophotometry (Instruments Laboratory, Lexington, MA, USA). Urinary and serum 
phosphate levels were analyzed with a colorimetric reaction on a Technicon RA-XT chemistry 
analyzer (Bayer, Germany). Creatinine levels were measured according to Jaffé’s method 
(RA-XT). Intact (1-84) serum PTH was determined by the Nichols Allegro PTH immunoradiometric 
assay (Nichols Institute, San Juan Capistrano, CA, USA). Serum 25-hydroxyvitamin D3 levels 
were obtained by a radioimmunoassay, whereas 1,25-dihydroxyvitamin D concentration 
measurements were performed with a radioreceptor assay (Incstar, Stillwater, MN, USA). 
Urinary pH values were determined with an electronic ion analyzer.
Phenotype assignment
Hypercalciuria was defined as a 24-hours urinary calcium excretion exceeding 0.1 mmol/kg 
body weight on a non-restricted diet. Renal hypercalciuria was defined by a ratio of fasting 
urinary calcium/creatinine (fasting UCa/UCr) > 0.37 (18).
DNA extraction
DNA sample collection and storage were carried out according to standard methods. In short, 
10 ml of peripheral blood were collected into EDTA-containing tubes at the time of initial 
diagnosis and centrifuged for 10 min at 3000 g to separate buffy coats and plasma. Total genomic 
DNA was isolated from the buffy coat using a QIAmp Blood Kit (Qiagen S.A., Courtaboeuf, France) 
according to the blood and body fluid protocol recommended by the manufacturer. Extracted 
DNA was quantified by spectrophotometrical absorbance measurements.
Genotyping
Oligonucleotide primers were developed for the amplification of each single exon of TRPV5, 
based on the genomic sequence. All primer sets obtained from Biolegio (Nijmegen, the 
Netherlands) that were used to amplify the genomic DNA of TRPV5 by polymerase chain 
reaction (PCR) were depicted in table 1. Because of short intron sequences between exons 
2 and 3, 4 and 5, 6 and 7, 10 and 11 as well as 12 and 13 of TRPV5 these exons were amplified 
and sequenced as single fragments. Primer sequences were located in non-coding regions 
to analyze the intron-exon boundaries as well. PCR product purifications of all exons were 
performed with the GenElute‘ PCR Clean-up Kit (Sigma, St. Louis, MO) or Qiaex® II Gel 
calcium homeostasis and furthermore the renal calcium wasting observed in the knockout 
mice, TRPV5 is an important candidate gene for renal hypercalciuria.
The aim of our study was to investigate TRPV5 as a candidate gene for renal hypercalciuria. 
To this end, 20 patients were selected for hypercalciuria with concomitant polyuria or a low 
urinary pH and included in this study. These patients were screened for TRPV5 gene 
aberrations. The TRPV5 coding sequence and all exon-intron boundaries within the TRPV5 
gene were analyzed. A non-synonymous polymorphism detected in TRPV5 was functionally 
characterized by patch-clamp analysis in Human Embryonic Kidney (HEK) 293 cells.
Methods
Patient selection
Among the patients with idiopathic hypercalciuria, calcium nephrolithiasis, or low bone 
mineral density attending the Department of Physiology of Georges Pompidou Hospital, 
Paris, France, a familial evaluation is commonly proposed. In this retrospective study, we 
screened the families in which at least two family members had idiopathic hypercalciuria 
and selected patients on the basis of the rate of urinary calcium excretion, the 24-hours 
urine output volume, and fasting urinary pH. A selection of 20 renal hypercalciuria patients 
was made. Patients with hypercalcemia, hyperthyroidism, or malignant neoplasm were not 
included. This study was performed in agreement with the bio-ethic French law. Informed 
consent was obtained from all patients participating in the study.
Clinical evaluation
Subjects were evaluated after 2 days on a calcium (400 mg/24 hours) and sodium-restricted 
(150 mmol/24 hours) diet, preceded by a 2-weeks period without anti-acids, non-steroidal 
anti-inflammatory drugs, diuretic agents, glucocorticoids, calcium, phosphate, or vitamin 
supplements. A 24-hours urine sample was collected during the last day of the diet to 
measure total calcium excretion. A 1-hour fasting urine sample was obtained in order to 
measure urinary pH, calcium, and creatinine concentrations. Fasting blood samples were 
obtained and analyzed for plasma total and serum ionized calcium, parathyroid hormone 
(PTH), 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D3, and creatinine levels.
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had resistances between 2 and 5 MΩ when filled with recording solution. Capacitance and 
series resistance were compensated. Access resistance was monitored continuously using 
the automatic capacitance compensation of the Pulse software. Sodium currents were 
measured using a ramp protocol. Cells were held at +20 mV and voltage ramps of 450 msec 
duration each, ranging from -100 to +100 mV, were applied every 5 sec. Extracellular 
solution for sodium currents contained in mM: 150 NaCl, 6 CsCl, 10 glucose, and 10 HEPES/
CsOH (pH 7.4). Calcium currents were studied using a 3 sec voltage step to -100 mV from a 
holding potential of +70 mV. 150 mM NaCl was replaced with an equimolar amount of 
N-methyl-D-glucamine-Cl (NMDG-Cl) from extracellular solution and 10 mM calcium was 
added to measure the calcium current. Current densities were obtained by normalizing the 
current amplitude to the cell membrane capacitance.
Statistical analyses
Electrophysiological data analysis was performed using IgorPro software (Wavemetrics, 
Lake, Oswege, USA). Data were depicted as means ± SEM. Significance was determined 
using Student’s t-test with P < 0.05 considered being statistically significant.
Results
Patient selection and biochemical analyses
In order to investigate the involvement of TRPV5 gene aberrations in hypercalciuria, 20 
subjects were included in this study. Subjects all demonstrated renal hypercalciuria (mean 
fasting UCa/UCr 0.48 ± 0.02), with concomitant polyuria or low urinary pH (table 2). 
The mean urinary sodium excretion was 140 mmol/24 h (range: 40-300 mmol/24 h). All 
patients showed normal serum PTH and calcium levels. Mean 25-hydoxyvitamin D3 level 
was 42 ± 5 nM, whereas the serum 1,25-dihydroxyvitamin D concentration was 110 ± 6 pM.
Sequence analysis in renal hypercalciuria patients
Polymorphisms identified in the coding sequence of TRPV5 in renal hypercalciuria patients 
and expression rates were listed in table 3. The topology of the TRPV5 protein is depicted 
in figure 1. Detected synonymous polymorphisms were L205L, Y222Y, Y278Y, T281T, and 
T344T. The non-synonymous gene aberrations identified were A8V, R154H, and A561T. Both 
the A8V (rs4252372) and R154H (rs4236480) polymorphisms were previously identified and 
listed in single nucleotide polymorphisms (SNPs) databases (http://www.ncbi.nlm.nih.gov/
extraction kit (Qiagen, Hilden, Germany). DNA sequencing was carried out by standard 
procedures at the sequence facility of the Radboud University Nijmegen Medical Centre. 
Subsequently, we assessed the alignment and comparison of the patient sequences with the 
human TRPV5 mRNA sequence, obtained from the NCBI nucleotide database (NM_019841).
DNA constructs
To investigate the channel function of the TRPV5-A8V, R154H, and A561T gene 
polymorphisms, the mutations were each prepared by in vitro mutagenesis (Quickchange® 
[Stratagene]) and cloned into the homologous wild-type rabbit TRPV5 cDNA in the 
pCINeo/IRES-GFP vector. The wild-type TRPV5 and TRPV5 mutant constructs were verified 
by cDNA sequence analyses.
Electrophysiological analysis 
The full-length cDNA encoding wild-type or mutated TRPV5 was transfected into HEK293 
cells, as described previously (19, 20). Patch-clamp experiments were performed in the 
tight seal whole-cell configuration at room temperature using an EPC-9 patch-clamp 
amplifier controlled by the Pulse software (HEKA Elektronik, Lambrecht, Germany). Pipettes 
Chapter 5 TRPV5 gene polymorphisms in renal hypercalciuria
Table 1  Human TRPV5 primer sequences 
Exon Forward Primer Reverse Primer 
1 ‘5-TGCATACACAAGTCATACAGG-‘3 ‘5-AGGTGGGTCAGAGGGTCTGAGG-‘3
2-3 ‘5-TCATTCTGCTATGACTGTCTCTTCC-‘3 ‘5-ACACCCTCCATCTCAAAGTTTCC-‘3
4-5 ‘5-ATCAGGAACCTCCTGAGAGGGATGG-‘3 ‘5-ATGGGCCTCTGGCTTAATTAAGCC-‘3
6-7 ‘5-TCAGCCTAGAACTGAGATATGGGG-‘3 ‘5-ACCTCTATTTCTCCCAGGGCCAGC-‘3
8 ‘5-TAGATGCAGAGGTTTGCTGGTTCC-‘3 ‘5-AGGCCTGATCCTCCTTGGCATCC-‘3
9 ‘5-ACTGATGAGCTGAGTGAGTGATGG-‘3 ‘5-TCCCTGAGTAGCATGGCTTCG-‘3
10-11 ‘5-ACCCACAATGGCAAGTACAATGG-‘3 ‘5-AAGTCCTTGGAGTGAGAGTGACC-‘3
12-13 ‘5-TACCACCCTGGTCACCACTATGC-‘3 ‘5-AAGAATGAGAGTGAACTTTCTGG-‘3
14 ‘5-AGAATAAGTGCTAACCATGTCC-‘3 ‘5-ATGATCCACCATAACATTTTCC-‘3
15 ‘5-TGAGTGAAGCTGGTTGCATGGTGC-‘3 ‘5-AGACAGGCTAATGCAGGCTCCAGG-‘3
Oligonucleotide primers were developed for the amplification of each single exon of TRPV5, based on the 
genomic sequences. All primer sequences were located in non-coding regions to analyze intron-exon 
boundaries as well. 
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calcium peak currents were not significantly different between wild-type TRPV5 and mutant 
channels. In order to investigate whether the calcium-dependent inactivation pattern of 
TRPV5 was changed in the mutant proteins, a 3 sec voltage step to -100 mV from a holding 
potential of +70 mV was applied to the cells. No significant difference was recorded between 
wild-type TRPV5 and mutant TRPV5 calcium-dependent inactivation.
Discussion
A positive family history forms a risk in the development of hypercalciuria. Genes encoding 
calcium transport proteins that are involved in the maintenance of the body calcium 
SNP/). Allele frequency data in the European control population showed 96% C and 4% 
T-allele frequencies for A8V, whereas R154H showed 38% A and 62% G-allele frequencies 
(NCBI ss# assay id: ss69030695). A561T frequencies were not determined in the general 
population so far.
Effect of non-synonymous polymorphism on TRPV5 channel activity
The TRPV5 non-synonymous polymorphisms were characterized by electrophysiological 
analysis. To this end, each construct (wild-type TRPV5 and mutant TRPV5-A8V, TRPV5-R154H, 
and TRPV5-A561T) was transiently transfected into human embryonic kidney (HEK293) cells 
and the current characteristics were analyzed by patch clamp measurements (figure 2). 
HEK293 cells expressing wild-type TRPV5 displayed the typical inwardly rectifying 
current-voltage relation in divalent free solution (figure 2A, 1137 ± 83 pA/pF at -80 mV, n=14) 
and a calcium-dependent inactivation of the calcium current (figure 2C, 938 ± 86 pA/pF at 
-100 mV, n=13). As shown in figure 2B and D, the normalized amplitudes of both sodium and 
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Table 2  Blood and urine biochemistry of included subjects Table 3  TRPV5 gene polymorphisms detected in renal hypercalciuria patients 
   Subjects Normal
Blood   
 Total calcium (mM) 2.26 ± 0.02 2.10 - 2.55
 Ionized calcium (mM) 1.23 ± 0.01 1.15 - 1.32
 Creatinine (mM) 75 ± 3 70 - 125
 PTH (pg/ml) 38 ± 5 11 - 57
 1,25(OH)2D (pM) 110 ± 6 45 - 110
 25(OH) D3 (nM) 42 ± 5 20 - 100
Urine  
 Urinary calcium excretion (mmol/24 hours) 8.5 ± 0.4 < 8.0
 Urinary volume (L/24 hours) 2.4 ± 0.1 1.0 - 1.5
 Fasting UCa/UCr (mmol/mmol) 0.48 ± 0.02 < 0.4
 Fasting urinary pH 6.0 ± 0.1 > 5.0
 Age (years) 44 ± 3 
 Weight (kg) 69 ± 3 
A selection of 20 renal hypercalciuria patients was made. Renal hypercalciuria was defined by a ratio of 
 fasting urinary calcium/creatinine (fasting UCa/UCr) > 0.37 mmol/mmol. Data are expressed as means ± SEM.
Exon Polymorphism Ht patients Hm patients
1 A8V 20% 0%
2   
3   
4 R154H 55% 10%
5   
6 L205L 40% 0% 
 Y222Y 50% 5% 
7 Y278Y 40% 0%
 T281T 50% 5% 
8 T344T 45% 5%
9   
10   
11   
12   
13 A561T 10% 0%
14   
15   
TRPV5 allele expression rates are depicted as % of patients (n=20) demonstrating the specific 
 polymorphism in a heterozygous (Ht) and homozygous (Hm) manner. 
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(21). Interestingly, characterization of the TRPV5 knockout mouse model revealed that a 
functional defect of this channel causes a severe renal calcium leak (16, 22). Muller et al. 
previously screened for TRPV5 gene mutations in 9 families known with autosomal 
dominant hypercalciuria (23). No TRPV5 mutations were demonstrated. In the present 
study, 20 subjects were selected for renal hypercalciuria and concomitant polyuria or 
increased urinary acidification in order to obtain a homogeneous patient cohort. Although 
matched for symptoms presented by the TRPV5 knockout animal model, no disease-causing 
TRPV5 gene aberrations were detected, as revealed from functional, electrophysiological 
analyses (23).
balance are candidate genes in the pathogenesis of hypercalciuria. Interestingly, mice 
genetically ablated for the renal epithelial calcium channel TRPV5 demonstrate a severe 
renal calcium leak. In the present study, TRPV5 gene aberrations were analyzed and 
identified in 20 renal hypercalciuria patients with at least one affected relative. All subjects 
displayed concomitant polyuria or decreased urinary pH, which are symptoms presented by 
TRPV5 knockout mice as well. Synonymous as well as non-synonymous polymorphisms 
were detected in the TRPV5 coding sequences of renal hypercalciuria patients. Electro-
physiological analysis of the TRPV5-A8V, R154H, and A561T mutants compared to wild-type 
TRPV5 did not show significant changes in channel function. In this specific research 
population, our data do not support a primary role for TRPV5 in the pathogenesis of renal 
hypercalciuria. TRPV5 can, however, not be excluded as a candidate gene in hypercalciuria.
An increased risk for the development of hypercalciuria is present when a first-degree 
relative is diagnosed with hypercalciuria (7). This fact strongly indicates for the existence of 
genetic susceptibility factors in the etiology of hypercalciuria. The epithelial calcium 
channel TRPV5, which is a key player in renal active calcium reabsorption was previously 
postulated to be an important candidate gene in calcium metabolism-associated disorders 
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Figure 1  Gene polymorphisms in the TRPV5 calcium channel  
The TRPV5 protein topology is depicted in a putative 3 dimensional model, displaying 6 
transmembrane regions and intracellular N- and C-tails. Depicted in black are the 3 TRPV5 
non-synonymous polymorphisms demonstrated in renal hypercalciuria patients, which were 
functionally characterized by patch-clamp analysis.
Figure 2  Electrophysiological analysis of wild-type and mutant TRPV5 channels  
Sodium (A, B) and calcium (C, D) currents in TRPV5 channels. (A) Current-voltage relations for 
wild-type TRPV5 recorded in divalent free solution. (B) Histogram plotting the peak values at -80 
mV for sodium currents recorded from HEK293 cells transiently transfected with wild-type TRPV5 
or mutant channels. (C) Calcium-induced inactivation of the calcium current was measured with 
10 mM extracellular calcium during a 3-sec step to –100 mV from a holding potential of +70 mV 
in cells over expressing wild-type TRPV5. (D) Histogram plotting the peak values for calcium 
 currents at -100 mV recorded from HEK293 cells over expressing wild-type TRPV5 or TRPV5 
mutant channels. Current amplitudes were normalized to the amplitude of wild-type TRPV5.
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analyses of a non-synonymous TRPV5 gene aberration did not implicate the A561T 
polymorphism in the etiology of renal hypercalciuria. TRPV5 cannot be excluded as a 
candidate gene for hypercalciuria, as TRPV5 gene variants might be involved in other 
hypercalciuric patient cohorts. Due to the heterogeneity of hypercalciuria and the possible 
involvement of multiple calcium transport systems in this complex trait, gene association 
studies should be performed in large, well-characterized patient groups displaying 
hypercalciuria.
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Non-synonymous gene polymorphisms lead to amino acid changes that can alter the 
function of a protein. Therefore, we determined the electrophysiological properties of 
mutated TRPV5 channels containing non-synonymous polymorphisms detected in the 
renal hypercalciuria patients. Patch clamp analysis showed no significant changes in 
sodium and calcium peak currents or calcium-dependent inactivation curves in mutant 
TRPV5 proteins compared to wild-type TRPV5. This finding suggests that the individual 
A8V, R154H, and A561T polymorphisms do not play a key role in the etiology of 
hypercalciuria in this studied patient cohort. TRPV5 cannot be excluded though, as a 
candidate gene for renal hypercalciuria. The heterogeneity of hypercalciuria and the 
potential contribution of several calcium transport systems in this complex trait is 
enormous. Therefore, gene association studies should be preferentially initiated in large, 
well-characterized patient groups. In this perspective, specific haplotypes of several 
polymorphisms together could cause an increased susceptibility to hypercalciuria. 
Previously, unusual SNPs patterns and haplotype differences were identified in the 
intestinal calcium channel TRPV6, a homologue of TRPV5 involved in the absorption of 
calcium in the intestine, among worldwide populations (24). Akey et al. suggested that a 
specific TRPV6 haplotype comprising three non-synonymous SNPs (C157R, M378V, and 
M681T) resulted in a selective advantage during human history. This might indicate a 
different TRPV6 channel function related to specific haplotypes. A recent study investigating 
the functional characterization of these TRPV6 variants by patch-clamp revealed no 
significant differences in biophysical channel function, although calcium-dependent 
inactivation might be affected in the presence of specific TRPV6 haplotypes (25). 
Unfortunately, the polygenic nature and the uncertainties of an exact diagnosis for 
hypercalciuria hamper population-based association studies for genetic hypercalciuria. 
In addition, linkage analysis is a powerful method to identify genes involved in familial 
hypercalciuria. Previously, Reed et al. performed a genome-wide search in 3 families with 
absorptive hypercalciuria. A high logarithm of the odds score >12 was found for the region 
1q23.4 to 24 in which a hypothetical human ortholog of the rat soluble adenylate cyclase 
was identified (26, 27). So far, a causative relationship between soluble adenylate 
cyclase and hypercalciuria has not been identified. The latter investigations underline the 
importance of further efforts to study monogenic causes of hypercalciuria.
In summary, TRPV5 gene polymorphisms were identified in renal hypercalciuria patients 
that were well-characterized and selected for concomitant polyuria or decreased urinary 
pH, symptoms presented by the TRPV5 knockout mouse model. Electrophysiological 
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Introduction
Calcium (Ca2+) homeostasis is important for many physiological processes that take place 
in the body (1). Sufficient amounts of Ca2+ are required for intracellular signaling, muscle 
contraction, neuronal excitation, blood clotting, and bone formation. The concerted 
action of intestinal Ca2+ absorption, bone (de)mineralization, and renal Ca2+ excretion 
maintain a normal Ca2+ balance. This chapter will discuss Ca2+ transport in the kidney and 
intestine. Here, Ca2+ crosses the epithelial cells to reach the blood compartment via passive 
paracellular as well as active transcellular Ca2+ (re)absorption. Active Ca2+ (re)absorption, 
occurring in the proximal intestine, the renal distal convoluted tubule (DCT), and 
connecting tubule (CNT), is highly regulated by the calciotropic hormones (1, 7-9). 
Importantly, that enables an organism to adapt the level of Ca2+ (re)absorption to the 
body’s demand and thereby the blood Ca2+ concentration is tightly maintained within a 
normal, physiological range. The recent molecular identification of the epithelial Ca2+ 
channels TRPV5 and TRPV6 comprises an essential step in the elucidation of key players 
involved in active Ca2+ transport (2, 3). TRPV5 and TRPV6 determine the rate-limiting step 
of Ca2+ entry into the epithelial cells aligning those specific parts of the intestine and renal 
tubular segments that exhibit active transcellular Ca2+ transport (4-6). This thesis aims to 
understand the physiological mechanisms by which the Ca2+ balance is maintained. 
The role of active transcellular Ca2+ (re)absorption in health and conditions like hypercalciuria, 
metabolic acidosis and alkalosis, hypercalcemia, and hypocalcemia are investigated 
extensively and in this chapter, the findings of the research performed are discussed.
Regulation of active Ca2+ (re)absorption by vitamin D
The PTH-vitamin D route
The classically known regulatory pathway of active Ca2+ (re)absorption by calciotropic 
hormones involves sensing of ambient Ca2+ levels by the G-protein coupled Ca2+/
polyvalent cation-sensing receptor (CaSR) in the parathyroid glands. The CaSR is activated 
by elevated blood Ca2+ concentrations, which results in the inhibition of parathyroid 
hormone (PTH) secretion (10). A drop in blood Ca2+ levels leads to inactivation of the 
receptor, which in turn stimulates PTH release by the parathyroid glands. PTH increases 
Ca2+ mobilization from bone and stimulates Ca2+ (re)absorption in intestine and kidney, 
thereby retaining Ca2+ in the body (7). Moreover, PTH establishes the conversion of inactive 
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Hypervitaminosis D and Ca2+ hyperabsorption in TRPV5 knockout mice
Mice genetically ablated for TRPV5 displayed a robust hypercalciuria due to a defect in 
active Ca2+ reabsorption (29). Detailed microcomputed tomography and X-ray analyses 
showed diminished bone mineral density and bone thickness in the TRPV5 knockout mice. 
Interestingly, these mice demonstrated normal blood PTH levels, 3-fold increase of 
1,25(OH)2D3 levels, and normocalcemia. Interestingly, TRPV5 knockout mice displayed a 
significant upregulation of the intestinal Ca2+ transport proteins TRPV6, calbindin-D9K and 
Ca2+ hyperabsorption, indicating the presence of a compensatory mechanism maintaining 
a normal Ca2+ balance during renal Ca2+ wasting (29). In chapter 2, the contribution of 
hypervitaminosis D to the Ca2+ hyperabsorption in TRPV5 knockout mice was investigated. 
By generating the TRPV5/1α-OHase double knockout mice, we assessed that additional 
gene inactivation of 1α-OHase in TRPV5 knockout mice resulted in undetectable blood 
1,25(OH)2D3 levels and therefore abolishment of the increased 1,25(OH)2D3 levels presented 
by TRPV5 knockout mice. This led to the downregulation of intestinal TRPV6 and 
calbindin-D9K expression levels, a drop in blood Ca2+ levels and a more severe bone 
degradation compared with the TRPV5 knockout mice (24). In summary, these data 
demonstrated that the upregulation of intestinal Ca2+ transporters and the resulting Ca2+ 
hyperabsorption in TRPV5 knockout mice were due to a secondary hypervitaminosis D. 
Hereby, TRPV5 knockout mice compensated for the renal Ca2+ loss in an attempt to maintain 
normocalcemia. Interestingly, additional gene ablation of 1α-OHase in TRPV5 knockout 
mice normalized the urinary Ca2+ excretion level to values not significantly different from 
control mice. Thus, relative to the severe hypocalcemia, TRPV5/1α-OHase double knockout 
mice excreted inappropriately high amounts of Ca2+. Smith et al. demonstrated that 
long-term administration of vitamin D and increased blood 1,25(OH)2D3 levels reduce 
cortical bone thickness (30). However, 1,25(OH)2D3 levels were undetectable in 
TRPV5/1α-OHase double knockout mice, which displayed rickets, decreased bone thickness 
and mineralization, noticeably more severe than the bone abnormalities observed in TRPV5 
and 1α-OHase single knockout mice. This indicated that the defect in active renal Ca2+ 
reabsorption is directly responsible for the detected bone abnormalities in TRPV5 knockout 
mice. Furthermore, TRPV5 expression was observed in bone tissue as well, being essential 
for osteoclast-mediated bone resorption (31). These observations assessed the significance 
of transcellular Ca2+ transport in bone tissue and underlined the primary effect of TRPV5 
ablation on bone metabolism. Here, we showed that a tight control of active Ca2+ transport 
by 1,25(OH)2D3 is of utmost importance to maintain a normal extracellular Ca2+ balance, 
especially during a disturbed Ca2+ balance as present in TRPV5 knockout mice.
vitamin D to its biologically active form (1,25(OH)2D3) by the renal cytochrome P450 
enzyme 25-hydroxyvitamin D3-1α-hydroxylase (1α-OHase), whereas 1,25(OH)2D3 inhibits 
PTH production in a regulatory negative feedback manner (11). Previous studies 
demonstrated that 1,25(OH)2D3 stimulates active intestinal and renal Ca2+ transport (12), as 
increased 1,25(OH)2D3 levels facilitate vitamin D receptor (VDR)-mediated gene transcription, 
resulting in the transcription of Ca2+ transporter encoding genes in Ca2+ transporting cells 
(13). This was established by the interaction of the 1,25(OH)2D3-VDR complex with vitamin 
D responsive elements (VDREs) in the promoter regions of target genes (14-17). Several 
genes encoding Ca2+ transporters contained such VDREs (17-19). Eventually, 1,25(OH)2D3 
demonstrated a positive regulatory effect on intestinal and renal active Ca2+ (re)absorption, 
enabling the maintenance of a normal Ca2+ balance (12). Therefore, a lack of 1,25(OH)2D3 
could cause disturbances of the Ca2+ balance.
Vitamin D in disturbances of the Ca2+ balance
Bone disease like osteoporosis, osteomalacia, and rickets occur during vitamin D deficiency. 
During malnutrition and aging these features often occur (11, 20). Moreover, humans with 
a defect in VDR function show bone abnormalities, known as vitamin D-dependent rickets 
type II (21). In the past, genetically modified mouse models were generated in which the 
1,25(OH)2D3 endocrine system was inactivated to further elucidate the in vivo function of 
this calciotropic hormone in Ca2+ homeostasis. Two research groups created the 1α-OHase 
knockout mouse independently (22, 23). The 1α-OHase knockout mice were unable to 
generate 1,25(OH)2D3 and characterization studies demonstrated that absence of 
1,25(OH)2D3 leads to severe hypocalcemia, secondary hyperparathyroidism, decreased 
bone mineral density, rickets, and growth retardation. Intestinal TRPV6 and calbindin-D9K 
expression levels were downregulated, whereas renal TRPV5, calbindin-D28K, and NCX1 
were diminished as well in 1α-OHase knockout mice (24). Repletion of the 1α-OHase 
knockout mice with 1,25(OH)2D3 was associated with restoration of renal and intestinal 
Ca2+ transporter expression levels, and a normalization of blood Ca2+ levels, confirming the 
essential role of these transporters in 1,25(OH)2D3-mediated active Ca2+ (re)absorption 
(22, 23). Furthermore, VDR knockout mice displayed hypocalcemia, bone degradation, 
increased blood PTH levels, and hypervitaminosis D, due to a lack of VDR-mediated gene 
transcription (26, 27). Altogether these investigations underlined that absence of 
1,25(OH)2D3 leads to severe disturbances of the Ca2+ balance and that 1,25(OH)2D3 is of 
crucial importance to Ca2+ homeostasis (28).
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(44, 45). Together with the parathyroid CaSR, the renal CaSR showed to be of crucial 
importance for body Ca2+ handling.
In the proximal tubule (PT) the CaSR is activated by increased urinary Ca2+ levels, which 
inhibits PTH-induced phosphate transporter-retrieval from the apical membrane, and 
results in increased phosphate reabsorption. Hereby, excess loss of phosphate into the 
filtrate that contains elevated Ca2+ concentrations can be avoided, eventually preventing 
renal Ca2+-phosphate precipitation (47). In the TAL, approximately 20-25% of the filtered 
Ca2+ is reabsorbed (40). Since the TAL is impermeable to water, the Ca2+ concentration at 
the basolateral side of the TAL consequently rises. This evokes an increase in the 
reabsorption of NaCl and other solutes along the loop of Henle. The CaSR is highly 
expressed at the basolateral membrane where it senses the extracellular Ca2+ concentration 
(44, 46). This permits a negative feedback mechanism of the reabsorbed Ca2+ onto the cell, 
attenuating Ca2+ reabsorption and preventing hypercalcemia (48). The exact function of 
the CaSR in the distal part of the nephron and the effect of CaSR activation on TRPV5 needs 
further investigation (44, 46). In the CD the CaSR is expressed at the apical membrane in 
principal and intercalated cells (44). In chapter 3 we demonstrated that activation of the 
CaSR in the CD by increased Ca2+ levels triggers urinary acidification and polyuria. Thereby, 
our findings introduce a new regulatory function of the CaSR in the CD and emphasize the 
crucial importance of the renal CaSR in Ca2+ homeostasis.
Hypercalciuria and renal stone formation
Kidney stones
Hypercalciuria forms the main risk factor in kidney stone formation (32). Bound to urinary 
solutes like phosphate and oxalate, Ca2+ precipitates in the urine and the renal tissue (33). 
Patients who suffer from renal stone disease experience serious pain, a high rate of 
recurrence, slowly progressing tissue damage, and eventually renal insufficiency. Recurrent 
clinical treatment is needed (34-36). Thereby, kidney stones are a major socio-economic 
problem in developed countries (34). Different forms of kidney stones occur in humans. 
Most renal stones contain Ca2+. In this perspective, Ca2+-phosphate is present in 79% and 
Ca2+-oxalate in 86% of all cases, though obviously a mixed composition is often present 
and in this combined form, Ca2+ phosphate and Ca2+ oxalate are the main constituents in 
19% and 66% of all stones, respectively. Pure Ca2+ phosphate and Ca2+ oxalate stones occur 
in a 1:11.5 ratio (37). Furthermore, 10% of all stones mainly consist of struvite, 9% of uric acid, 
whereas the last 1% comprises the cystine, ammonium acid urate, and drug-related stones 
(36). Prevention of Ca2+-containing renal precipitates could involve a decreased Ca2+ 
intake, though this was not proven to be effective and might even lead to a reduction of 
bone mineral density (38, 39). Urinary adaptive mechanisms displayed by the hypercalciuric 
TRPV5 knockout mouse model were investigated in chapter 3 to gain insight into the 
molecular mechanisms involved in kidney stone formation during hypercalciuria. Besides 
hypercalciuria, TRPV5 knockout mice demonstrated urinary phosphate wasting, which 
predisposes these animals to renal Ca2+-phosphate precipitation (29). Interestingly, TRPV5 
knockout mice did not form kidney stones. Increased urinary acidification and polyuria 
were consistently present, suggesting an underlying renal molecular mechanism preventing 
Ca2+-phosphate stone formation in TRPV5 knockout mice. These investigations provided 
insight into molecular mechanisms, applicable in kidney stone prevention.
The renal CaSR
It was clear that the kidney plays a key role in the maintenance of a normal Ca2+ balance, 
reabsorbing more Ca2+ in a hypocalcemic state, while excreting Ca2+ during hypercalcemia 
(40). The CaSR in the parathyroid glands regulated PTH release, which is a calciotropic 
hormone crucial for Ca2+ homestasis (10). The identification of the CaSR in the kidney 
indicated an important regulatory function of this receptor in renal Ca2+ handling as well 
(41-43). The CaSR was expressed at multiple sites along the nephron and its cellular 
localization depended upon the region of the nephron where it was expressed (table 1) 
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Table 1  Localization and function of the renal CaSR 
Nephron  Cellular localization Function References
segments
PT Apical Modulation of phosphate reabsorption (46, 47)
TAL Basolateral
 Feedback mechanism on Ca2+ 
  reabsorption in the TAL 
(48)
DCT/CNT Apical and basolateral
 Possible involvement in active Ca2+ 
  reabsorption and urinary acidification 
(44)
CD Apical
 Evoking increased urinary acidification  (49-51),
  and polyuria during hypercalciuria chapter 3  
CaSR, calcium-sensing receptor; PT, proximal tubule; TAL, thick ascending limb of Henle’s loop; DCT, distal 
convoluted tubule; CNT, connecting tubule; CD, collecting duct system. 
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the concomitant occurrence of stomach problems (36, 71). Therapies preventing 
Ca2+-phosphate stone formation could imply the stimulation of urinary acidification. 
Further research would be necessary to acquire insight into the possible working 
mechanism of such an intervention in humans
Polyuria
Final concentration of the urine is determined in the CD where the vasopressin-regulated 
aquaporin-2 (AQP2) water channels are localized in the apical membrane of principal cells 
(72-74). Increased diuresis diminishes the risk for renal crystal precipitation by reducing 
urinary Ca2+ levels. The urinary concentration defect that was demonstrated in TRPV5 
knockout mice and assessed by the significant decrease in urinary osmolarity and the 
polyuria, was caused by downregulation of renal AQP2 expression (figure 1). Interestingly, 
medullary membrane protein fractions, isolated from control and TRPV5 knockout mice 
revealed a significant downregulation of AQP2 proteins in the knockouts. Previous studies 
directly linked Ca2+ and water homeostasis, suggesting an important functional role for 
the renal CaSR (49-51). The localization of the CaSR along the apical membrane of the distal 
part of the nephron and the CD facilitated the activation of the receptor during a 
hypercalciuric state (44, 45). Hereby, a CaSR-mediated downregulation of AQP2 expression 
led to polyuria, assisting the excretion of large amounts of Ca2+. The physiological 
connection between Ca2+ and water balance established an important mechanism by 
which renal stone formation is hampered during a hypercalciuric state. This underlined the 
importance of sufficient hydration in people at risk for kidney stones, although humans are 
able to increase their urinary volume by an average of only 0.3 L/24 hours (75). That 
indicated that adequate hydration is insufficient to prevent stone formation. Therefore, the 
initiation of additional adaptations, like increased urinary acidification, would be important 
to decrease the risk to kidney stones. Furthermore, other putative target mechanisms 
should be studied. In this perspective we postulated the aquaporin-6 (AQP6) protein to be 
important in the regulation of H+-ATPase activity. AQP6 was localized to the intracellular 
vesicles of intercalated cells in the distal part of the nephron and the CD system (76-79). 
The exact functions and implications of AQP6 in renal water and acid-base handling were 
unknown so far. In addition, urinary molecules that retard the formation of Ca2+-containing 
stones should be of great research interest (80-84), in which citrate is already a known 
urinary stone inhibitor in clinical practice (85). The exact implication of other crystallization 
inhibitors for therapeutics applicable in kidney stones should further be investigated.
CaSR activation prevents renal stone formation via modulation of urinary pH
The crystallization of Ca2+-phosphate occurs via the conversion of phosphate to its 
divalent form (HPO42-) in an alkaline rather than in an acidic environment (52, 53). Therefore, 
a decrease in urinary pH prevents Ca2+-phosphate crystal formation. Acid/base transport 
processes take place along different nephron segments in order to control the pH of the 
tubular fluid. Eventually, urinary pH is determined in the intercalated cells of the renal 
collecting duct (CD) where the process of urinary acidification is fine-tuned, and thereby 
completed. In type A intercalated cells of the CD, the vacuolar proton pump H+-ATPase is 
mainly responsible for urinary H+ excretion (54, 55). In chapter 3 we described how the 
exposure to high (5.0 mM) Ca2+ concentrations significantly enhanced H+-ATPase activity 
in CD cells. This, stimulatory effect was absent in CD cells from Atp6v1b1 knockout mice 
that were genetically ablated for the CD-specific B1 subunit of H+-ATPase (56). Moreover, 
the CaSR agonist neomycin increased H+-ATPase activity indicating the modulation of 
urinary acid excretion by CaSR activation. These findings suggested that an increased 
luminal Ca2+ concentration as consistently present in the renal DCT, CNT, and CD of TRPV5 
knockout mice stimulates H+-ATPase activity via apical CaSR activation (figure 1). 
Interestingly, additional gene ablation of Atp6v1b1 in TRPV5 knockout mice resulted in 
normalization of urinary pH levels and led to the tubular precipitation of Ca2+-phosphate 
in the medullary CD. It was known that the formation of alkaline urine increases the risk for 
urinary Ca2+ precipitation (57, 58). Therefore, renal stones commonly occurred in distal 
renal tubular acidosis patients, who display a urinary acidification defect and concomitant 
hypercalciuria (59). Furthermore, treatment with acetazolamide, a carbonic anhydrase 
inhibitor resulting in the alkalization of the urine, increased the risk to drug-induced kidney 
stone formation (60, 61). Our observations unequivocally revealed that the naturally 
occurring increased urinary acidification in TRPV5-/- mice is an essential adaptive mechanism 
preventing renal Ca2+-phosphate precipitation in a hypercalciuric state. So far, therapeutic 
strategies depended on the type of stones occurring and the primary cause of the urinary 
Ca2+ loss (62, 63). Thiazide diuretics were often prescribed in hypercalciuria patients (64) as 
these drugs increase Ca2+ reabsorption, lower the urinary Ca2+ levels, and promote bone 
mineral balances. Unfortunately a complication was a concomitant potassium depletion 
leading to intracellular acidosis and the reduction of urinary citrate levels that increase the 
risk to stone formation (65-68). Additional potassium citrate was therefore commonly 
supplied to the thiazide treatment (69). Potassium citrate could also be individually applied 
to prevent Ca2+-oxalate and uric acid stones (70). Disadvantages of potassium citrate were 
the formation of alkaline urine, promoting the formation of Ca2+-phosphate stones, and 
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Acid-base status and renal Ca2+ and Mg2+ handling
Metabolic acidosis and alkalosis
Blood pH levels are maintained within a constant, narrow range (pH 7.35-7.45). Metabolic 
acidosis refers to a decrease in blood pH levels and is associated with renal Ca2+ and 
magnesium (Mg2+) wasting. Hereby, chronic metabolic acidosis can eventually lead to 
bone degradation and predispose to osteoporosis and kidney stone formation (1, 86-89). 
In contrast, metabolic alkalosis decreases urinary Ca2+ and Mg2+ excretion levels. The exact 
mechanism responsible for the renal divalent wasting and sparing effects during metabolic 
acidosis and alkalosis, respectively, are not known.
Acid-base status modulates renal Ca2+ and Mg2+ transport
Chapter 4 outlined in detail how acid/base status modulates renal Ca2+ and Mg2+ handling. 
In control mice, NH4Cl supplementation induced a metabolic acidosis with a concomitant 
increase of urinary Ca2+ and Mg2+ levels. Downregulation of the renal Ca2+ transport 
proteins TRPV5 and calbindin-D28K in the renal DCT and CNT was responsible for a decrease 
in Ca2+ reabsorption. No change in Ca2+ excretion was detected in mice, genetically 
ablated for TRPV5, during NH4Cl treatment. This indicated that the decrease of renal Ca2+ 
transporter expression levels accounts for the metabolic acidosis-induced hypercalciuria 
(90). Furthermore, metabolic acidosis led to a significant downregulation of transient 
receptor potential melastatin member 6 (TRPM6), the epithelial Mg2+ channel involved in 
active Mg2+ reabsorption. This was accompanied by increased Mg2+ excretion and 
hypomagnesemia. These data clearly showed that metabolic acidosis diminishes active 
Ca2+ and Mg2+ reabsorption in the distal part of the nephron, evoking a renal loss of these 
divalents. To investigate whether the urinary pH level or the blood pH value was 
responsible for this Ca2+ and Mg2+ wasting, acetazolamide treatment, a carbonic anhydrase 
inhibitor that evokes a metabolic acidosis together with an alkaline urinary pH, was applied 
in mice. Since acetazolamide supplementation led to TRPV5 and TRPM6 downregulation, it 
was concluded that a systemic acidosis reduces the expression of Ca2+ and Mg2+ 
transporters. In contrast, the induction of metabolic alkalosis by NaHCO3 in mice, increased 
the renal expression of Ca2+ transporters, which was accompanied by reduced Ca2+ 
excretion. However, this effect was not abolished in the TRPV5 knockout mice, indicating 
that an increase of active Ca2+ reabsorption alone was not accounting for the hypocalciuria 
during metabolic alkalosis. We postulated that alkalosis-induced hypocalciuria is explained 
by increased passive Ca2+ reabsorption. The Mg2+-sparing effect in metabolic alkalosis was 
A
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Figure 1  Renal CaSR signaling in the collecting duct  
(A) In a normal situation, the CaSR at the apical site of principal and intercalated cells of the 
collecting duct is inactivated, AQP2 proteins are responsible for water reabsorption, and 
H+-ATPase proteins pump H+ ions into the urine. (B) In TRPV5 knockout mice, the CaSR is 
activated by increased urinary Ca2+ levels. CaSR activation leads to AQP2 downregulation, 
evoking polyuria. Furthermore, the CaSR triggers urinary acidification by increasing the 
H+-ATPase activity. Both polyuria and increased urinary acidification prevent renal  
Ca2+-phosphate precipitation. (C) Genetic ablation of the Atp6v1b1 gene in the TRPV5  
knockout mice leads to absence of H+-ATPase activity and a decrease in urinary acidification. 
At a urinary pH of 7.4, Ca2+-phosphate precipitates, which leads to renal stone formation.
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leading to symptoms for which hospitalization is required. In the future, characterization of 
the patients should focus on the urine and blood parameters, including blood 1,25(OH)2D3 
levels, urinary pH, volume, and Ca2+ concentrations. Furthermore, specific haplotypes of 
several TRPV5 gene polymorphisms together could cause an increased susceptibility to 
hypercalciuria. In a similar manner, unusual patterns of single nucleotide polymorphisms 
(SNPs) and haplotype differences were identified in the intestinal Ca2+ channel TRPV6, a 
homologue of TRPV5, among worldwide populations (97). Akey et al. showed that a specific 
TRPV6 haplotype comprising three non-synonymous SNPs (C157R, M378V, and M681T) 
resulted in a selective advantage during human history (97). This suggested a change in 
TRPV6 channel function related to specific haplotypes of TRPV6 SNPs. Further studies 
demonstrated a gain of function haplotype of TRPV6 being a risk factor for Ca2+-containing 
kidney stone formation (98). In the past, other candidate genes were identified and 
associated with hypercalciuria or kidney stones (table 2) (48, 99). In this, the primary organ 
from which the hypercalciuria originated differed, including kidney, intestine, and bone. 
Others were unsuccessful in identifying loci or genetic variants linked to hypercalciuria in 
specific populations, likely due to the heterogeneousity of this disorder (100-102). 
Therefore, the nature of the genetic defects involved in most hereditary hypercalciuria 
cases remains fairly unknown. Genome wide association studies should be performed in 
large, well-characterized patient groups with hypercalciuria. Difficulties to exactly classify 
hypercalciuria and high costs such studies consistently hampered these approaches so far. 
Linkage analyses in families with multiple affected members might result in the identification 
of loci, pointing towards interesting candidate genes for renal hypercalciuria.
Future directions
Body Ca2+ handling comprises fundamental physiological processes that maintain a 
normal Ca2+ balance in the body. The research performed in the past years increased our 
knowledge on overall Ca2+ homeostasis in health and disease. The investigations described 
in this thesis demonstrated that active Ca2+ reabsorption is fundamental for Ca2+ 
homeostasis, greatly underlined by the characterization of the unique hypercalciuric 
TRPV5 knockout mouse model. Moreover, the regulation of active Ca2+ reabsorption by the 
calciotropic hormone 1,25(OH)2D3 was strongly emphasized in an in vivo situation since the 
hypervitaminosis D in TRPV5 knockout mice evoked Ca2+ hyperabsorption, compensating 
for the robust urinary Ca2+ wasting. Interestingly, the molecular mechanism that explained 
the result of increased TRPM6-mediated active Mg2+ reabsorption. Together these data 
showed that acid-base status affects renal divalent handling, which leads to significant 
changes in the Ca2+ and Mg2+ balance.
TRPV5 gene defects in renal hypercalciuria
The TRPV5 gene is located on chromosome 7q35 and encodes for the TRPV5 protein that 
counts 730 amino acids. (3, 91, 92). TRPV5 is a candidate gene for renal hypercalciuria, since 
TRPV5 gene ablation in mice leads to a severe renal Ca2+ leak (29). Hypercalciuria increases 
the risk to renal stone formation (93). Furthermore, individuals with a positive family history 
of nephrolithiasis have an enhanced risk to kidney stones (94, 95). These facts strongly 
imply for genetic factors being involved in the pathogenesis of hypercalciuria-related renal 
stone formation in humans. The identification of TRPV5 gene aberrations related to 
hypercalciuria is therefore important for early diagnostics in people at risk for nephrolithiasis 
and facilitates preventive treatment strategies in these subjects. Moreover, knowledge on 
the exact role of TRPV5 in the etiology of hypercalciuria provides a therapeutic target in 
kidney stone disease. Previous investigations revealed no TRPV5 gene mutations that were 
linked to hypercalciuria so far. Muller et al. screened for TRPV5 gene aberrations in 9 
families known with autosomal dominant hypercalciuria (96). No disease-causing mutations 
were found. Chapter 5 described the results from an international collaborative study that 
was designed to collect DNA material of well-characterized hypercalciuria patients. Twenty 
subjects that displayed renal hypercalciuria with concomitant polyuria or increased urinary 
acidification were included. Thus, patients were selected for symptoms resembling the 
phenotypic features of TRPV5 knockout mice in order to obtain a homogeneous patient 
cohort. Furthermore, all patients had at least one affected relative. The coding region and 
intron-exon boundaries of the TRPV5 gene were screened for gene mutations. Despite the 
matching phenotype with the TRPV5 gene ablated mice, no disease-causing TRPV5 gene 
aberrations were detected. Three non-synonymous polymorphisms were found in the 
TRPV5 coding sequences of renal hypercalciuria patients. Electrophysiological analysis of 
the mutants showed no significant changes in TRPV5 channel function. In this specific 
cohort, the data did not support a primary role for TRPV5 in the pathogenesis of renal 
hypercalciuria. TRPV5 could however not be excluded as a candidate gene for hypercalciuria, 
as TRPV5 gene variants may be etiologically involved in other hypercalciuric patients. 
Moreover, gene variants of the TRPV5 promoter region could also be involved in the 
etiology of hypercalciuria. Additionally, people with TRPV5 gene defects might be able to 
adjust to the situation in a naturally occurring manner as present in TRPV5 knockout mice, 
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polyuria and increased urinary acidification in a hypercalciuric state was established, 
underlining the role of the renal CaSR. These investigations provided important knowledge 
for the development of new therapeutic strategies and screening possibilities for kidney 
stone formation. In the future, linkage analysis in large well-characterized patient cohorts 
and affected families might demonstrate the contribution of TRPV5 as well as TRPV6 in 
familiar hypercalciuria. Furthermore, the exact function of the CaSR expressed in the 
intestine should be elucidated (103). Besides the CaSR, pH-sensing receptors were recently 
identified in the kidney. Via these sensor proteins, alterations in urinary and blood pH were 
monitored after which downstream signaling evokes a tight regulation of the body pH 
balance. As urinary pH is an important parameter of renal stone formation, these pH sensors 
might be important therapeutic targets in the prevention of kidney stones. So far, many 
proteins, interacting with or regulating the epithelial Ca2+ channels TRPV5 and TRPV6 were 
recognized. This comprised the identification of the anti-aging hormone klotho, which was 
implicated in the regulation of the Ca2+ balance. Characterization of the klotho knockout 
mouse revealed hypercalciuria, hypervitaminosis D, infertility, short life span, and bone 
aberrations (104) clearly overlapping with symptoms presented by TRPV5 knockout mice 
(29). Upcoming studies of this mouse model should give further insight in the exact (patho)
physiological role of klotho in Ca2+ homeostasis. Altogether, these investigations contributed 
to the understanding of the processes that take place in the body to maintain the Ca2+ 
balance and also raised new issues that require further research in the future.
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Table 2  Monogenic human disorders associated with hypercalciuria or kidney stones 
Gene Protein Disease Phenotype Organ
    of origin
CLCN5 CIC-5 Dent’s disease Impaired urinary acidification,  Kidney
   nephrocalcinosis, kidney stones, 
   renal failure, rickets. 
SLC4A1 AE1 Distal renal tubular  Metabolic acidosis, hypercalciuria, Kidney
  acidosis (dRTA) nephrocalcinosis, kidney stones, 
   osteomalacia, rickets. 
ATP6v1b1 H+-ATPase  dRTA Incomplete urinary acidification,  Kidney
 B1 subunit  metabolic acidosis, hypercalciuria, 
   nephrocalcinosis, hearing loss, rickets, 
   growth impairment. 
CLDN16 Claudin-16 Familial  Hypercalciuria, hypermagnesuria, Kidney
  hypomagnesemia renal failure, nephrocalcinosis,  
  with hypercalciuria  kidney stones, neuromuscular defects.
  and nephrocalcinosis 
  (= FHHNC)  
SLC12A1 NKCC2 Bartter’s syndrome  Salt-wasting, polyuria, metabolic Kidney
  type I alkalosis, hypokalemia, hypercalciuria, 
   nephrocalcinosis, osteopenia. 
KCNJ1 ROMK Bartter’s syndrome  Salt-wasting, polyuria, metabolic Kidney
  type II alkalosis, hypokalemia, hypercalciuria, 
   nephrocalcinosis, fever, vomiting, 
   diarrhea, osteopenia, prematurity 
CASR CaSR Bartter’s syndrome  Hypoparathyroidism, hypocalcemia, Multiple
  type V hypercalciuria, hyperphosphaturia, 
   nephrocalcinosis, kidney stones, 
   seizures, calcifications, rickets
WNK4/ WNK4/ Familial hypertensive Hypercalciuria, mild metabolic Kidney
WNK1 WNK1 hyperkalemia or  alkalosis, normocalciuria
  pseudoaldosteronism 
  type 2  
NPT2 NaPi-IIb Hypophosphatemia  Hyperphosphaturia, hypercalciuria, Intestine
  and absorptive  kidney stones, hypervitaminosis D, 
  hypercalciuria intestinal Ca2+ hyperabsorption, 
   osteoporosis 
SLC5A1 Sodium- Glucose/galactose Hypercalciuria, kidney stones, Intestine
 glucose malabsorption nephrocalcinosis, hypercalcemia,
 cotransporter  glucosuria, diarrhea   
COL1A1/ Collagen type 1 Osteogenesis Bone fractures, hypercalciuria Bone
COL1A2 and 2 imperfect type 1 Hyperparathyroidism,  Bone 
MEN1 Menin MEN1 syndrome with  hypercalciuria, hyperparathyroidism
   nephrocalcinosis, kidney stones 
HBB β-globin β-Thalassemia Hypercalciuria, proximal  Unknown
   tubulopathy, decreased bone 
   mineral density, osteomalacia 
CaSR, calcium-sensing receptor; PT, proximal tubule; TAL, thick ascending limb of Henle’s loop; DCT, distal 
 convoluted tubule; CNT, connecting tubule; CD, collecting duct system. 
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Nederlandse samenvatting
Hoofdstuk 1: Introductie
Het woord calcium komt van het Latijnse Calx, dat kalksteen betekent. Calcium vormt de 
basiscomponent van botten en tanden. Bovendien is calcium nodig voor een goede 
werking van zenuwen en spieren, bij de bloedstolling en bij het transport van stoffen in 
onze lichaamscellen. Melk(producten), groente, noten en peulvruchten bevatten calcium. 
Wanneer er voldoende calcium met de voeding ons lichaam binnenkomt, leidt dit onder 
normale omstandigheden tot een adequate opname van calcium naar de bloedbaan. Een 
calciumtekort kan botontkalking (osteoporose), misselijkheid, spierkrampen, huidproblemen, 
psychische klachten veroorzaken en bij kinderen tot verschijnselen van Engelse ziekte 
(rachitis) leiden. Daarnaast kan teveel calcium in het bloed spierzwakte, maag-, darm-, 
hartklachten en nierproblemen veroorzaken.
Ongeveer 99% van de totale hoeveelheid calcium in het lichaam bevindt zich in het skelet. 
De overige 1% is aanwezig in de extracellulaire vloeistof, waar het bloed deel van uitmaakt. 
Deze extracellulaire calciumconcentratie wordt op peil gehouden door samenwerking 
tussen de darmen, waar calciumopname uit de voeding plaatsvindt, de botten waarin 
calcium wordt opgeslagen en de nieren die het bloed filteren. Tijdens de filtratie van het 
bloed in de nieren vormt zich voorurine waaruit calcium opnieuw wordt opgenomen naar 
het bloed. Gedurende de opname in de darmen (absorptie) en de heropname in de nieren 
(resorptie), moet calcium door een laag van epitheelcellen worden getransporteerd. 
Enerzijds gebeurt dit passief, tussen de cellen door (85%) en anderzijds actief, door de 
cellen heen (10-15%). Daarnaast wordt een klein deel uitgescheiden in de urine. Het actieve 
calciumtransport dwars door de cellen heen bepaalt hoeveel calcium uiteindelijk 
geresorbeerd wordt terug naar het bloed of het lichaam verlaat via de urine. Het actieve 
transport door zowel de darmwand als het nierepitheel gebeurt via eiwitten die calcium 
kunnen transporteren. Dit proces vindt plaats in drie opeenvolgende stappen. Eerst komt 
calcium de epitheelcellen binnen via het calciumkanaal TRPV5 (in de nier) of TRPV6 (in de 
darm). Binnenin de cellen bindt het calcium aan calciumbindende eiwitten, genaamd 
calbindines. Vervolgens diffundeert dit complex gezamenlijk naar de overzijde van de cel, 
welke grenst aan het bloed. Hier wordt calcium tenslotte door NCX1, een eiwit dat natrium 
uitwisselt voor calcium en door PMCA1b, een energiegebruikende calciumpomp naar het 
bloed getransporteerd. Belangrijk is, dat de activiteit van TRPV5 en TRPV6 in grote mate 
bepaalt hoeveel calcium de epitheelcellen transporteren. Dit is de reden waarom we 
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van vitamine D. Bovendien is er een significante afname in de expressie van de 
calciumtransporteurs TRPV6 en calbindine in de darm. De botdikte van de TRPV5-1α-
hydroxylase dubbel knock-outmuizen is verder afgenomen ten opzichte van de TRPV5 
knock-outmuizen. Daarnaast vertonen ze een niet-gesloten groeischijf en een verder 
verlaagde botmineralisatie. TRPV5 knock-outmuizen compenseren voor het verlies van 
calcium in de urine door middel van een verhoogde hoeveelheid vitamine D in het bloed. 
Deze hypervitaminose D leidt namelijk tot vermeerdering van calciumtransporterende 
eiwitten in de darm, hetgeen resulteert in een toegenomen calciumopname. De TRPV5 
knock-outmuizen kunnen door de hyperabsorptie van calcium een normale 
calciumconcentratie in het bloed handhaven. Vitamine D is daarom een hormoon dat 
essentieel is voor het behoud van een normale calciumbalans.
Hoofdstuk 3: Verzuring van de urine voorkomt nierstenen
Nierstenen vormen een gezondheidsprobleem over de gehele wereld. Een periode van 
nierstenen gaat gepaard met zeer veel pijn, terugkomende klachten en herhaaldelijke 
behandelingen. Bovendien kunnen nierstenen leiden tot blijvende nierschade. Wanneer er 
teveel calcium in de urine aanwezig is, bestaat er een risico op het ontstaan van nierstenen. 
Het is van groot belang voor patiënten met (een verhoogde kans op) nierstenen om 
manieren te vinden waarop deze voorkómen of behandeld kunnen worden. TRPV5 
knock-outmuizen zes- tot tienmaal zoveel calcium in de urine verliezen als wild-type 
muizen door een verminderde actieve calciumresorptie in de nier. Nierstenen zijn echter 
nooit waargenomen in TRPV5 knock-outmuizen. Interessante waarnemingen zijn dat 
TRPV5 knock-outmuizen naast hypercalciurie ook een verlaagde zuurgraad (pH) van de 
urine vertonen en tweemaal zoveel urine produceren als wild-type muizen. Naast teveel 
calcium is er bovendien een verhoogde hoeveelheid fosfaat aanwezig in de urine. Toen we 
deze parameters nader onderzochten, bleek dat een toegenomen calciumconcentratie in 
de voorurine een sensoreiwit in de nier, genaamd de calcium-sensing receptor, activeert. 
Deze activering zorgt er voor dat H+-ATPase protonpompen in de nier meer H+ ionen 
(zuur) naar de urine transporteren. Daardoor daalt bij TRPV5 knock-outmuizen de zuurgraad 
van de urine. Een verlaging van de urine pH voorkomt dat calciumfosfaat kan neerslaan in 
de nier, aangezien de oplosbaarheid van calciumfosfaat hoger is in een zure dan in een 
basische omgeving. Verder is gebleken dat er in de nieren van de TRPV5 knock-outmuizen 
ook minder water geresorbeerd wordt van de urine naar het bloed, resulterend in een 
grotere urineproductie. Door deze toename in diurese wordt de calciumconcentratie in de 
urine van de TRPV5 knock-outmuizen verlaagd, wat de kans op het neerslaan van calcium 
TRPV5 en TRPV6 de poortwachters van het actieve calciumtransport noemen.
Actief calciumtransport wordt geregeld door calciotrope hormonen, waaronder 
paraathormoon (PTH) uit de bijschildklier en vitamine D (vaak 1,25(OH)2D3 genoemd). 
Deze hormonen sturen de calciumtransporterende eiwitten in de darm aan om het 
calcium vanuit de voeding op te nemen en in de bloedbaan te brengen. In de nier regelen 
deze hormonen op soortgelijke wijze hoeveel calcium wordt geresorbeerd van de 
voorurine naar het bloed of uitgescheiden via de urine. Het is belangrijk om te weten hoe 
deze processen precies werken. Onderzoek naar de regulatie van calciumtransport geeft 
namelijk inzicht in de wijze waarop we een normale calciumbalans in ons lichaam 
behouden. Met deze kennis kunnen we vervolgens manieren bedenken waarop kan 
worden ingegrepen bij een verstoorde calciumhuishouding. De resultaten van het 
onderzoek staan beschreven in de verschillende hoofdstukken van dit proefschrift en zijn 
hier samengevat.
Hoofdstuk 2: Vitamine D zorgt voor toegenomen calciumopname in TRPV5 knock-
outmuizen.
Om het proces van actief calciumtransport in de nier te onderzoeken in een levend wezen, 
zijn muizen ontwikkeld waarin het gen dat codeert voor TRPV5 is uitgeschakeld. Deze 
muizen noemen we TRPV5 knock-outmuizen. Uit voorgaand onderzoek is gebleken dat 
door afwezigheid van TRPV5 in de nieren van deze muizen aanzienlijk minder calcium op 
actieve wijze wordt geresorbeerd vanuit de voorurine naar het bloed. Er lekt dus teveel 
calcium weg via de urine. Dit noemen we hypercalciurie. Als gevolg van dit calciumverlies 
ontstaat echter geen calciumtekort in het bloed, TRPV5 knock-outmuizen vertonen 
namelijk normale bloed calciumwaardes. Opmerkelijk is dat er verhoogde vitamine D 
spiegels in het bloed worden gemeten. Daarnaast is er bij TRPV5 knock-outmuizen sprake 
van een toename in calciumtransporteiwitten in de darm en een hogere opname van 
calcium uit het voedsel in vergelijking met normale (wild-type) muizen. Bovendien zijn de 
botten van TRPV5 knock-outmuizen dunner dan die van normale muizen en is de 
botmineralisatie verlaagd. Om te bepalen of het verhoogde vitamine D niveau in het bloed 
leidt tot een toename in expressie van calciumtransporteurs in TRPV5 knock-outmuizen, 
zijn deze gekruist met 1α-hydroxylase knock-outmuizen, welke geen actief vitamine D 
kunnen aanmaken. Dit heeft geresulteerd in TRPV5-1α-hydroxylase dubbel knock-
outmuizen. De dubbel knock-outmuizen verliezen ook veel calcium in de urine, maar 
blijken niet in staat te zijn het calciumniveau in het bloed op peil te houden in afwezigheid 
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een metabole alkalose, in tegenstelling tot acidose, een toename van de 
calciumtransporterende eiwitten. Daardoor is er juist sprake van een toename in calcium- 
en magnesiumresorptie en een afname van deze ionen in de urine. Deze studie heeft 
aangetoond dat de zuurgraad van het bloed de expressie van calcium- en 
magnesiumtransporteurs in de nier verandert en daardoor de calcium- en 
magnesiumhuishouding beïnvloedt.
Hoofdstuk 5: Genetische aanleg voor hypercalciurie en nierstenen
Wanneer nierstenen voorkomen in de familie, bestaat er een verhoogde kans op het 
krijgen van nierstenen. Dit doet vermoeden dat erfelijkheid betrokken is bij de vatbaarheid 
voor het krijgen van nierstenen. Het DNA bevat alle informatie die benodigd is voor de 
productie van de bouwstenen van ons lichaam, de eiwitten. Als er een mutatie (verandering) 
op een bepaalde plaats in het DNA zit, kan het resulterende eiwit niet compleet, niet 
functioneel en/of afwezig zijn. Dit leidt mogelijk tot ziekte. TRPV5 is een eiwit waarvoor 
een specifiek stukje van het DNA codeert. Wanneer het TRPV5 gen een mutatie bevat, is 
het mogelijk dat er een defect ontstaat in de calciumresorptie en dit, net als in de TRPV5 
knock-outmuis, leidt tot verhoogde calciumwaardes in de urine. In het onderzoek 
beschreven in hoofdstuk 5 is gezocht naar mutaties in het TRPV5 gen bij twintig mensen 
met hypercalciurie. Hierbij hebben we drie genveranderingen gevonden. Functionele 
testen hebben echter geen verandering in de functie van het kanaal laten zien. Dit 
betekent dat deze varianten in het TRPV5 DNA op zichzelf niet verantwoordelijk zijn voor 
de hypercalciurie bij deze twintig mensen. Dit sluit echter niet uit dat er bij andere mensen 
met een verstoorde calciumhuishouding wel sprake is van een mutatie in het TRPV5 gen. 
Ook is het mogelijk dat samen met dit polymorfisme andere factoren betrokken zijn bij het 
ontstaan van hypercalciurie. Vervolgonderzoek zal dit moeten uitwijzen.
vermindert. Zowel een verlaging van de zuurgraad van de urine en de toename van het 
urinevolume zijn symptomen die op natuurlijke wijze voorkomen in de TRPV5 knock-
outmuizen. Inzicht in de exacte werking van beide mechanismen zijn van cruciaal belang 
in de ontwikkeling van nieuwe therapiemogelijkheden toepasbaar bij nierstenen.
Hoofdstuk 4: Calcium- en magnesiumtransport is afhankelijk van zuur-base status
Voor het normaal functioneren van het menselijk lichaam is het belangrijk dat de zuurgraad 
(pH) van het bloed constant blijft (7.35-7.45). Dit wordt door de nieren en de longen, door 
middel van het respectievelijk uitscheiden en uitademen van zuren en basen, in balans 
gehouden. Wanneer dit niet het geval is en er sprake is van een verlaagde pH van het 
bloed, spreekt men van een acidose. Dit kan onder andere veroorzaakt worden door 
hypoventilatie zoals dat voorkomt bij patiënten met een obstructieve longaandoening 
(respiratoire acidose), door chronische diarree wat leidt tot een verlies aan basische stoffen 
uit het lichaam of door nierfalen. In het geval van een tekort aan base of teveel zuur in het 
lichaam spreekt men van een metabole acidose. Een grote verscheidenheid aan symptomen 
wordt gezien bij een metabole acidose zoals hoofdpijn, misselijkheid, bot- en spierpijn, 
geen eetlust en een versnelde ademhaling. Uiteindelijk kan een acidose hartproblemen, 
flauwvallen en coma veroorzaken. Daarentegen kan juist een verhoogde pH-waarde van 
het bloed (alkalose) ontstaan wanneer grote hoeveelheden zuur het lichaam verlaten 
middels hyperventilatie (respiratoire alkalose), braken of via de urine (metabole alkalose). 
Ook kunnen zowel een kaliumtekort als het gebruik van medicijnen die veel basische 
stoffen bevatten tot een stijging van de bloed pH tot gevolg hebben. De symptomen 
kenmerkend voor een metabole alkalose zijn niet-specifiek en daardoor is de diagnosestelling 
niet altijd eenvoudig. Algehele malaise, een vertraagde ademhaling en een hoge 
urineproductie kunnen symptomen van een metabole alkalose zijn.
Naast dit alles leidt een chronische metabole acidose tot calcium- en magnesiumverlies in 
de urine, terwijl een chronische metabole alkalose resulteert in hypocalciurie en 
hypomagnesiurie, wat betekent dat er een verlaagde hoeveelheid calcium en magnesium 
in de urine aanwezig is. De exacte reden waarom de zuur-base balans in het lichaam de 
uitscheiding van calcium en magnesium in de urine beïnvloedt was voorheen niet bekend. 
Dit hebben we onderzocht. Wanneer bij muizen een metabole acidose geïnduceerd wordt 
met een speciaal zuurbevattend dieet, is er een verlaging van de transporteiwitten 
zichtbaar in de nier, met als gevolg minder calcium- en magnesiumresorptie. Dit resulteert 
in verlies van calcium en magnesium via de urine van de muizen. Daarnaast veroorzaakt 
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Na+ sodium ion
NaCl sodium chloride
NaHCO3- sodium bicarbonate
NaPiIIa sodium phosphate co-transporter IIa
NaPiIIb sodium phosphate co-transporter IIb
NCX1 sodium calcium exchanger 1
NH4Cl ammoniumchloride
OMCD outer medullary collecting duct
OMIM online Mendelian inheritance in man
PAGE  polyacrylamide gelelectrophoresis
PBS phosphate-buffered saline
PCR polymerase chain reaction
PLP periodate-lysine-paraformaldehyde
PMCA1b plasma membrane calcium ATPase
PMSF phenylmethylsulphonylfluoride
PVDF polyvinylidine difluoride
PT proximal tubule
PTH parathyroid hormone
RNA ribonucleic acid
RT-PCR reverse-transcriptase polymerase chain reaction
SD standard deviation
SDS sodium dodecyl sulphate
SDS-PAGE sodium dodecyl sulphate polyacrylamide gel electrophoresis 
SEM standard error of the mean
SNP single nucleotide polymorphism
TAL thick ascending limb of the loop of Henle
TM transmembrane segment
TRPM6 transient receptor potential channel subfamily M, member 6
TRPM7  transient receptor potential channel subfamily M, member 7
TRPV5 transient receptor potential channel subfamily V, member 5
TRPV5-/- TRPV5 knockout mouse
TRPV5-/-/Atp6v1b1-/- TRPV5/Atp6v1b1 double knockout mouse
TRPV5-/-/1α-OHase-/- TRPV5/1α-OHase double knockout mouse
TRPV6 transient receptor potential channel subfamily V, member 6
TRPV6-/- TRPV6 knockout mouse
VDR vitamin D receptor
VDRE vitamin D-responsive element
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cRNA  copy RNA
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IOD integrated optical density
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mRNA messenger RNA
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Dankwoord 
Momenten van stilte en rust werken inspirerend en geven nieuwe energie. Het is goed om 
zo nu en dan stil te staan en te beseffen wat een ieder voor je betekent. Tijdens mijn 
promotie-onderzoek zijn er velen geweest die mij geholpen hebben. Hen wil ik op deze 
plaats bedanken.
Graag wil ik mijn copromoter Dr. Joost Hoenderop bedanken voor de input die hij voor 
mijn project geleverd heeft. Joost, jouw inspanningen hebben onder andere geresulteerd 
in een diermodel dat zeer geschikt is voor het onderzoek naar renale hypercalciurie. Ieder 
hoofdstuk in dit proefschrift beschrijft een gedeelte van het onderzoek dat met dat model 
mogelijk gemaakt is. Daarnaast ook bedankt voor je mooie presentaties en je accurate 
correcties van manuscripten. Ik bewonder (en verwonder me vaak ook over) de 
onuitputtelijke energie waarmee je je inzet voor de wetenschap.
Professor Bindels, beste René. Ik wil je bedanken voor de mogelijkheid bij de afdeling 
Fysiologie te promoveren. Bedankt voor je lessen in de fysiologie, je feedback over alles 
wat met wetenschap en onderwijs te maken heeft en je tips & tricks voor presentaties. 
Ik waardeer dat je veel aanwezig bent op de afdeling en dat we altijd kunnen binnenlopen.
Professor Knoers, beste Nine. Tijdens mijn periode als junior onderzoeker was je mijn 
mentor en zaten we in de PhD commissie. Ontzettend veel dank voor al je steun. Ik heb je 
leren kennen als een gedreven wetenschapper op het gebied van de nefrogenetica. In 
mijn ogen ben je een mooi mens. Nu, met jou als mijn directe leidinggevende mag ik nauw 
met je samenwerken in een geweldig team van enthousiaste collega’s. Samen met onder 
andere Loes, Nel, Iris, Mariette, Barbara, Ernie en jou, zet ik me met veel plezier in voor het 
AGORA project. Nine, bedankt voor alles!
Voor ik begon bij de afdeling Fysiologie zaten Wouter en Qing al in uutje 4. Toen ik erbij 
kwam hadden we al snel het gevoel van “U4: for ever”. Helaas, niets bleek minder waar. 
Qing ging naar de andere kant van het lab en ik verhuisde naar uutje 1, waar ik mijn plaats 
innam bij de vrouwen van het (overigens supersterke) in vivo team. De tijd in U4 zal ik nooit 
vergeten. Samen hadden we geweldige resultaten en tomeloze wetenschappelijke 
discussies. We hielpen en steunden elkaar door dik en dun (met veel kabaal, gegil en 
gejoel). Ik zal het nooit vergeten, voor mij blijft het toch U4ever! Qing, thank you very much 
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Dear collegues from the institute of Physiology in Zurich, thank you very much for the 
wonderful time we had. Prof. dr. Carsten Wagner, thank you for the opportunity to perform 
research in your lab. Paola, thank you for introducing me to the Swiss life. Ana and Christina, 
you taught me all about pH measurements with great patience and music moments by 
Barbra S. Thanks for your help, company, and friendship. Marta, Jana, Shahira, Florina during 
my stay the acid-base group consisted of many great women. I wish you all the best! Rahel 
and Marcel, I’d love to come back and do some sledging down the Hörnli. Thank you for 
your friendship, which made my life easy during the Zurich experience. Gruezi miteinand!
Mijn nieuwe collegae van Antropogenetica, wil ik prijzen om hun kwaliteiten. Barbara Franke 
en haar superteam weten van het meest ingewikkelde  wetenschappelijke vraagstuk een 
succes te maken. Blokfluiten, dansen met de pollepel, verrassend filmen en I-love-appleflaps 
vormen een kleine greep uit de overige talenten die de sectie MF te bieden heeft. Lieve 
mensen, ik heb het naar m’n zin bij jullie. Fijn dat ik met jullie mag samenwerken.
Alle hypercalciuriepatiënten, welke geïncludeerd zijn in de studie beschreven in hoofdstuk 5, 
wil ik bedanken voor hun medewerking aan het onderzoek. Daarnaast wil ik ook stilstaan 
bij de muizenlevens die opgeofferd zijn. Dierexperimenten doe je niet “zomaar”.
De Haantjes: Agnes, Caroline, Charlotte, Dmitri, Erwin, Floor, Inge, Jelle, Jorrit, Lillian, 
Maartje, Mare, Miel, Mirrin, Remco, Roeland en Sjoerd. Een aantal (Floor, Remco en Miel) ken 
ik sinds de eerste dag van onze introductie in Nijmegen, meer dan 10 jaar geleden. 
Studeren, feesten, zeilen, wintersportvakanties, hennen-avondjes, Haantje-weekenden en 
nog veel meer hebben we samen beleefd. Tijdens de avonden in ‘t Haantje was ik er vaak 
niet. Maar als ik er wel was, vond ik het fijn om te merken dat jullie dat waardeerden (of 
deden alsof). We blijven nog even in het dierenrijk: de Geitjes! Anke, Carolien, Floor, Maartje 
en Ruwien, ontspanning is ons motto tijdens de jaarlijkse bungalowparkweekenden. Wat 
zijn ze fijn, wat zijn goed. Karin, Fieke en Esmeralda, meiden van de martini. Er is een flink 
aantal individuen dat een avondje met ons mee zou willen doen. Dit is echter voor slechts 
enkelen weggelegd. De rest mag natuurlijk blijven dromen.
Elisabeth, Mirjam en Anneloes. Bedankt voor de momenten dat ik met jullie over de vloer 
rolde van het lachen. Leuk dat we elkaar af en toe weer zien. Judith! Fijn dat je mijn 
studiegenoot was en mijn vriendin bent. Ik wens je heel veel succes met je opleiding en 
alles wat op je weg komt. Matthijs, ik ken je al vanaf onze eerste werkgroep BGW als een 
for your friendship and cheerful personality. You gave the lab some extra colour. 
Wouter, super dat je bij me wilt staan als paranimf. Ik vind jou een doorzetter en wens je 
succes met je werk als klinisch chemicus. Met jou kent gezelligheid geen tijd. Ik ben blij dat 
je een vriend van me bent.
Esmeralda, ik ken je al vanaf de beginperiode van m’n studie Biomedische Gezondheids-
wetenschappen. Jij nam mij mee naar de SpoCo waarmee we pooltoernooien en 
zeilweekenden organiseerden. Daarnaast wisten we onze practica altijd zeer geroutineerd 
af te handelen. Wij voelden ons geboren wetenschappers! We schreven verslagen en 
nagelden foto’s van een zekere docent op een dartbord. Fijn dat je mijn paranimf wilt zijn 
en dat Patrick en jij me hebben geholpen met de voorbereidingen. Jij weet wat het is om 
te promoveren en dat te vieren! Je bent goed in wat je doet, je bent een schat! Jaimy, jou 
wil ik enorm bedanken voor het ontwerpen van de kaft van dit proefschrift. Ik ben er heel 
erg blij mee!
Mijn collega’s van cel- en integratieve Fysiologie wil ik bedanken voor de gezelligheid, het 
samen-sta-je-sterk gevoel, de vitaliteit en het leven in de brouwerij. Internationaal, gehaaid, 
fanatiek, meelevend, hardwerkend, ambitieus zijn woorden die hier van toepassing zijn. 
AnneMiete, jouw ervaring in het lab, je bijdrage aan de verschillende artikelen, de goede 
gesprekken, ik waardeer het allemaal. Een duwtje in de rug (of een schop onder mijn 
spreekwoordelijke …) van jou zorgden dat ik er weer tegenaan ging. Rob, ik vind je keuze 
om Biomedische Wetenschappen te gaan studeren een hele goede! Yuedan (we love 
sushi), thank you very much for your friendship in and outside the lab. “Jenny Verwenny”, 
wat hebben we een mooie tijd gehad in Zwitserland. Bob, je zegt geen organisatietalent 
te zijn, noch te hebben en daarom heb je mij lang geleden aangeraden zelf mijn 
promotielied te schrijven. Naast dit proefschrift, is ook het lied (wijze: “Als de morgen is 
gekomen”) af. Ik wil je vragen dit voor mij te zingen op het feest. Tom, bedankt voor de 
succesvolle samenwerking tijdens jouw tijd als AGIKO! Kim, als stagiaire bleek je erg handig 
te zijn in het het labwerk. Veel succes met je carrière als afgestudeerd biomedisch 
wetenschapper. Alle oud-collegae wil ik bedanken voor het leggen van de fundering van 
mijn onderzoek. ‘t Was fijn om met jullie samen te werken, leuk om jullie af en toe terug te 
zien. Todd, your arrival at the lab brought a new wave of energy. Your positivity made me 
look at the bright side of research. Thanks for your support, help, and friendship. I wish you 
+ your family the best and I hope we will meet again someday. Huib Croes, Ineke vd Zee 
en Henry Dijkman wil ik bedanken voor alles wat ze mij geleerd hebben.
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Schoonfamilie van Zandvoort en Polman, bedankt voor jullie gezelligheid tijdens bezoekjes, 
etentjes en familiedagen.
“The de Vries family”, bedankt voor familiemomenten, jullie betrokkenheid en ook 
nuchterheid. Ik moet altijd erg lachen om de typische Bavvelder uitspraken, die ik hier 
helaas niet durf op te citeren. Oma Baflo, mijn 90-jarige oma. Het werk dat in dit boekje 
staat, heb ik gedaan toen ik 23-27 jaar was. Ik besef goed dat niet iedereen dezelfde kansen 
heeft gehad op die leeftijd. Bedankt voor de interesse in wat ik nou eigenlijk voor werk 
doe, bedankt voor mijn moeder, bedankt voor het “oma-zijn”.
Een echte Renkema zijn, is iets om trots op te zijn. Een echte Renkema schikt zich naar hoe 
het komt, eet wat de pot schaft, likt het bord vervolgens helemaal schoon, verbouwt z’n 
eigen boontjes, stelt zich vaak in dienst van een ander, is altijd in voor een geintje en blijft 
zichzelf. Ja, ik ben blij dat ook ik een Renkema ben.
Lieve Vivian en Henk, Ruben en Tobias. Wat is het gezellig als jullie dagjes uit plannen naar 
Nijmegen. Ik vind dat jullie een fijn gezin zijn. Viv, ik ben heel trots op je dat je die kanjers 
op de wereld hebt gezet. Fijn dat jullie er zijn!
Lieve pap en mam. Hoe ouder je wordt, hoe meer je merkt dat je op je ouders gaat lijken. 
Bedankt voor mijn opvoeding, ik denk dat jullie het goed hebben gedaan! Ook vind ik het 
bewonderenswaardig hoe jullie ons, 3 totaal verschillende meiden, altijd de mogelijkheid 
geven te doen wat we willen doen. Fijn dat we op het platteland zijn opgegroeid. Soms 
wens ik dat ik bij jullie om de hoek woon, maar dan besef ik ook dat de weekenden waarin 
ik bij jullie ben, elke keer weer een feestje zijn!
Lieve Inez. Wat vind ik het leuk om met je te knutselen, samen Jan Smit te luisteren, te gaan 
dansen bij de Kameleon in Appingedam, muziek te maken of te kletsen aan de telefoon. 
Ik ben heel trots op je omdat je in de catering werkt bij het kerkje Nicolaas, omdat je een 
kunstenaar bent en omdat je over een tijdje op jezelf gaat wonen, net als Viv en ik. En dan 
komen wij leuk bij jou op de thee. Een dikke kus, van mij voor jou!
Fysiologie is de levensverrichtingenleer. Verliefdheid is een bijzondere levensverrichting, 
die door velen als aangenaam wordt ervaren. Gedrag, emoties en denkwijze veranderen 
op een unieke manier en ook het lichaam maakt kenmerkende aanpassingen door. 
vrolijk en optimistisch persoon. Ik hoop dat er tijdens mijn promotie, net als bij jou, af en 
toe wat te lachen valt. Dolle pret was het ook in Villa Fruitvlieg aan de Wolfskuilseweg. 
Geeske, Marianne, Mira, Mirja-Leena, Eva, Charlotte, Kelly, het ga jullie allemaal goed! Clara, 
ik heb veel gehad aan de “reizen” die ik heb mogen meemaken met jou. Ik ben heel blij dat 
ik je ontmoet heb en nog steeds ontmoet op de Westerhelling. Stilte en ontspanning vond 
ik ook bij de cursus fotografie van Wam Valenteijn. Ik hou van hobby’s en in de doka 
werken is als toveren, terwijl de tijd stil lijkt te staan, weg van de haast van alledag. Wam, 
die me leerde “kijken”, overleed in 2007.
Karin, als twee lange blonde Hollanders vielen wij nou niet bepaald op in Uppsala tijdens 
onze stages. Onze trip van Stockholm naar Helsinki, Talinn en Riga was geweldig. Veel 
succes met het afronden van je proefschrift en dan… op naar Boston, samen met Bjorn! JIP, 
peettantes, tuinclub, diaconie, lieve Corrie, Gerrit, Ria en al die anderen. Bedankt voor de 
mooie tijd die we hebben gehad in de Petruskerk. Ik spreek de wens uit dat we die mooie 
tijd voortzetten, weliswaar op een andere locatie, maar zeker met elkaar!
“Lange dagen, slaaptekort, thuisgekomen, ingestort. Maar ik lach me rot en doe m’n ding. 
Ik ben vrijwilliger bij de Spring.” Syl en Arnold, het “Springparadijs” is een creatie die jullie 
delen met ons. Bedankt voor je gastvrijheid, onvergetelijke weken, evaluaties, thema’s, het 
vakantielied, de roef en grandioze vrijwilligersfeesten. Ralph, bedankt dat je me mee hebt 
genomen naar de Spring. Ernst, bedankt voor je mooie gedicht hierboven. Bas en Gabrielle, 
wat was die allereerste vakantieweek samen met jullie een superweek! Gasten van de 
Spring, ik vind het erg gezellig met jullie op vakantie te gaan! Jelmer, Ernst, Marjolein, 
Dirk-Jan, met jullie een week draaien brengt voor mij “magie” in de groep. Eric, bedankt 
voor je zeillessen. Ik vind het hartstikke leuk om vrienden te zijn! Lieve vrijwilligers, wat we 
met elkaar delen (het “Spring-gevoel”) is uniek. Hou dat gevoel vast en vergeet niet dat 
jullie mooie “leidings” zijn.
Lieve Maaike. Sinds de tweede klas van de middelbare school zijn we vriendinnen. Samen 
kozen we voor Nijmegen als onze nieuwe stad. Ik ben blij dat we hier samen zijn. Ik wens 
jou heel veel liefde, geluk en vrolijkheid voor de toekomst.
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Hoe plezierig ook, de verliefde toestand is eindig en niet vast te houden. Even raadselachtig 
als haar begin, is het langzame uitdoven van de verliefde toestand. Gelukkig behoudt een 
mens het vermogen om opnieuw verliefd te worden, vermoedelijk tot de laatste dag. 
(door: Prof. dr. JH Ravesloot, hoogleraar Fysiologie aan het AMC te Amsterdam).
Lieve Maarten. De manier waarop jij met mensen omgaat bewonder ik enorm. Hoe je ze 
op hun gemak stelt en laat lachen. Ik hou van je warmte, je lach, je creativiteit en je 
musikwaliteit. De afgelopen jaren heb jij als geen ander ervaren dat het leven van (de 
partner van) een promovendus niet altijd over rozen gaat. Bedankt voor je steun, al vanaf 
die eerste dag, door al die jaren heen. Fijn dat ik steeds weer opnieuw verliefd mag worden 
op jou. Maarten, ‘k heb je lief.
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Illustration: Island of Research, from: the Science Game (1969)
Stellingen
behorende bij het proefschrift
Renal hypercalciuria
 A physiological TRiP along the calciotropics
1. Hypervitaminose D leidt tot een verhoogde calciumopname in de darmen van TRPV5 deficiënte
muizen, hetgeen een essentieel mechanisme is waarmee het calciumniveau in het bloed op peil
wordt gehouden. -dit proefschrift-
2. Ter voorkoming van calciumfosfaatprecipitatie in de nieren, zouden patiënten met een verhoogd
risico op calciumfosfaat-bevattende nierstenen baat kunnen hebben bij een verlaging van de
zuurgraad van de urine. -dit proefschrift-
3. De zuur-base status van het bloed reguleert de expressie van calcium- en
magnesiumtransporterende eiwitten in de nier, waardoor de resorptie van calcium en magnesium
verandert. -dit proefschrift-
4.  “Vrijheid van metingsuiting” is een concept dat binnen het beoefenen van de proefdierkunde
terecht bij de wet beperkt is.
5. Als wetenschapper is het belangrijk bij subsuccessen stil te staan en deze te vieren.
6. “Waar kom jij weg?” is een Groningse vraag die er minder ver naast zit dan het Brabantse
antwoord “Ik woon langs jou”.
7. Door te flirten bereikt een wetenschapper veelal meer dan wanneer dit achterwege wordt gelaten.
8. Vrouwen binnen de wetenschap moeten veel beter presteren dan mannen om uiteindelijk de top
te bereiken. Gelukkig is dit niet moeilijk.
9. Den bästa ställningen är från Ikea.
10. Het goed kunnen kijken en horen, betekent niet vanzelfsprekend dat er ook wordt gezien,
geluisterd en verstaan.
11. De mens mag een ander niet aandoen wat hemzelf niet mag worden aangedaan.
Kirsten Renkema, 23 januari 2008
